[House Hearing, 107 Congress]
[From the U.S. Government Publishing Office]
THE HUMAN CLONING PROHIBITION ACT OF 2001 AND THE CLONING PROHIBITION
ACT OF 2001
=======================================================================
HEARING
before the
SUBCOMMITTEE ON HEALTH
of the
COMMITTEE ON ENERGY AND COMMERCE
HOUSE OF REPRESENTATIVES
ONE HUNDRED SEVENTH CONGRESS
FIRST SESSION
on
H.R. 1644 and H.R. 2172
__________
JUNE 20, 2001
__________
Serial No. 107-41
__________
Printed for the use of the Committee on Energy and Commerce
Available via the World Wide Web: http://www.access.gpo.gov/congress/
house
__________
U.S. GOVERNMENT PRINTING OFFICE
73-733 WASHINGTON : 2001
_______________________________________________________________________
For sale by the Superintendent of Documents, U.S. Government Printing
Office
Internet: bookstore.gpo.gov Phone: (202) 512-1800 Fax: (202) 512-2250
Mail: Stop SSOP, Washington, DC 20402-0001
------------------------------
COMMITTEE ON ENERGY AND COMMERCE
W.J. ``BILLY'' TAUZIN, Louisiana, Chairman
MICHAEL BILIRAKIS, Florida JOHN D. DINGELL, Michigan
JOE BARTON, Texas HENRY A. WAXMAN, California
FRED UPTON, Michigan EDWARD J. MARKEY, Massachusetts
CLIFF STEARNS, Florida RALPH M. HALL, Texas
PAUL E. GILLMOR, Ohio RICK BOUCHER, Virginia
JAMES C. GREENWOOD, Pennsylvania EDOLPHUS TOWNS, New York
CHRISTOPHER COX, California FRANK PALLONE, Jr., New Jersey
NATHAN DEAL, Georgia SHERROD BROWN, Ohio
STEVE LARGENT, Oklahoma BART GORDON, Tennessee
RICHARD BURR, North Carolina PETER DEUTSCH, Florida
ED WHITFIELD, Kentucky BOBBY L. RUSH, Illinois
GREG GANSKE, Iowa ANNA G. ESHOO, California
CHARLIE NORWOOD, Georgia BART STUPAK, Michigan
BARBARA CUBIN, Wyoming ELIOT L. ENGEL, New York
JOHN SHIMKUS, Illinois TOM SAWYER, Ohio
HEATHER WILSON, New Mexico ALBERT R. WYNN, Maryland
JOHN B. SHADEGG, Arizona GENE GREEN, Texas
CHARLES ``CHIP'' PICKERING, KAREN McCARTHY, Missouri
Mississippi TED STRICKLAND, Ohio
VITO FOSSELLA, New York DIANA DeGETTE, Colorado
ROY BLUNT, Missouri THOMAS M. BARRETT, Wisconsin
TOM DAVIS, Virginia BILL LUTHER, Minnesota
ED BRYANT, Tennessee LOIS CAPPS, California
ROBERT L. EHRLICH, Jr., Maryland MICHAEL F. DOYLE, Pennsylvania
STEVE BUYER, Indiana CHRISTOPHER JOHN, Louisiana
GEORGE RADANOVICH, California JANE HARMAN, California
CHARLES F. BASS, New Hampshire
JOSEPH R. PITTS, Pennsylvania
MARY BONO, California
GREG WALDEN, Oregon
LEE TERRY, Nebraska
David V. Marventano, Staff Director
James D. Barnette, General Counsel
Reid P.F. Stuntz, Minority Staff Director and Chief Counsel
______
Subcommittee on Health
MICHAEL BILIRAKIS, Florida, Chairman
JOE BARTON, Texas SHERROD BROWN, Ohio
FRED UPTON, Michigan HENRY A. WAXMAN, California
JAMES C. GREENWOOD, Pennsylvania TED STRICKLAND, Ohio
NATHAN DEAL, Georgia THOMAS M. BARRETT, Wisconsin
RICHARD BURR, North Carolina LOIS CAPPS, California
ED WHITFIELD, Kentucky RALPH M. HALL, Texas
GREG GANSKE, Iowa EDOLPHUS TOWNS, New York
CHARLIE NORWOOD, Georgia FRANK PALLONE, Jr., New Jersey
Vice Chairman PETER DEUTSCH, Florida
BARBARA CUBIN, Wyoming ANNA G. ESHOO, California
HEATHER WILSON, New Mexico BART STUPAK, Michigan
JOHN B. SHADEGG, Arizona ELIOT L. ENGEL, New York
CHARLES ``CHIP'' PICKERING, ALBERT R. WYNN, Maryland
Mississippi GENE GREEN, Texas
ED BRYANT, Tennessee JOHN D. DINGELL, Michigan,
ROBERT L. EHRLICH, Jr., Maryland (Ex Officio)
STEVE BUYER, Indiana
JOSEPH R. PITTS, Pennsylvania
W.J. ``BILLY'' TAUZIN, Louisiana
(Ex Officio)
(ii)
C O N T E N T S
__________
Page
Testimony of:
Allen, Hon. Claude A., Deputy Secretary, Department of Health
and Human Services......................................... 20
Doerflinger, Richard M., Associate Director for Policy
Development, National Conference of Catholic Bishops....... 78
Fukuyama, Francis, Omer L. and Nancy Hirst Professor of
Public Policy, School of Public Policy, George Mason
University................................................. 87
Guenin, Louis M., Lecturer on Ethics in Science, Department
of Microbiology and Molecular Genetics, Harvard Medical
School..................................................... 55
Kass, Leon R., Addie Clark Harding Professor of Social
Thought and the College, University of Chicago............. 50
Newman, Stuart A., Professor of Cell Biology and Anatomy,
Department of Cell Biology and Anatomy, New York Medical
College.................................................... 67
Norsigian, Judy, Executive Director, Boston Women's Health
Book Collective, Boston University School of Public Health. 76
Okarma, Thomas, President, Geron Corporation, on Behalf of
Biotechnology Industry Organization........................ 45
Perry, Daniel, Executive Director, Alliance for Aging
Research................................................... 72
(iii)
THE HUMAN CLONING PROHIBITION ACT OF 2001 AND THE CLONING PROHIBITION
ACT OF 2001
----------
WEDNESDAY, JUNE 20, 2001
House of Representatives,
Committee on Energy and Commerce,
Subcommittee on Health,
Washington, DC.
The subcommittee met, pursuant to notice, at 10:15 a.m., in
room 2123, Rayburn House Office Building, Hon. Michael
Bilirakis (chairman) presiding.
Members present: Representatives Bilirakis, Greenwood,
Burr, Ganske, Norwood, Cubin, Wilson, Shadegg, Bryant, Buyer,
Pitts, Tauzin (ex officio), Brown, Waxman, Strickland, Barrett,
Deutsch, Stupak, Engel, and Green.
Also Present: Representatives Stearns and DeGette.
Staff present: Marc Wheat, majority counsel; Brent Del
Monte, majority counsel; Kristi Gillis, legislative clerk; and
John Ford, minority counsel.
Mr. Bilirakis. Come to order. The Chair apologizes for his
tardiness, and this hearing will come to order. I want to thank
our witnesses for their time and effort in joining us today for
this very important hearing.
Today, the Subcommittee on Health will continue where the
Subcommittee on Oversight and Investigations, chaired by
Congressman Gene Greenwood, left off. We will examine two
measures, which, in many ways, reflect the discussions of that
hearing: H.R. 1644, sponsored by Congressmen Weldon and Stupak,
and H.R. 2172, sponsored by Congressmen Greenwood and Deutsch.
This is a difficult issue, to say the least, and it
involves many new and complex concepts. But we should all be
clear, I think, about the controversies related to human
cloning. The term ``therapeutic cloning,'' which many people
use to mean any type of cloning that is not intended to result
in a pregnancy, is confusing.
It really includes two, distinct procedures, one of which
is controversial, while the other, I think, is not. The non-
controversial concept of therapeutic cloning is the cloning of
human tissue that does not give rise to an embryo.
The controversial aspect involves the creation of a human
embryo. This latter meaning is also the subject of both of the
bills we will discuss today.
H.R. 1644 seeks to ban the creation of these cloned human
embryos. H.R. 2172 seeks to prevent those who clone human
embryos from implanting them in a surrogate mother.
What are we to make of the discussion today? Some patient
groups want cloned embryos to be created because their tissue
may prove to be valuable in biomedical research. Some companies
would like to clone human embryos because it will lead to a
cheaper way to manufacture tissue.
Writing in 1947, C.S. Lewis observed in ``The Abolition of
Man'' that man's conquest of nature would be complete when he
finally, and I quote him because I think this kind of says it,
``has obtained full control over himself. Human nature will be
the last part of nature to surrender to man. The battle will
then be won. We shall have taken the threat of life out of the
hand of Cloe, and be henceforth free to make our species
whatever we wish it to be. The battle will, indeed, be won. But
who, precisely, would have won it? For the power of man to make
himself what he pleases means, as we have seen, the power of
some men to make other men what they please.''
Human cloning rises to the most essential question of who
we are and what we might become if we open this Pandora's box.
I look forward to the testimony of our witnesses who will help
us understand just what might be in that box.
The Chair now yields to Mr. Brown.
Mr. Brown. Thank you very much, Mr. Chairman, and thank you
for calling this hearing. I want to thank our witnesses, Mr.
Allen especially, for testifying before us. I also want to
thank my colleagues, Mr. Deutsch and Mr. Greenwood, Ms.
DeGette, Mr. Stupak, and Mr. Weldon for their tireless work on
this extraordinarily complicated issue.
The issue today is not about whether to ban the cloning of
a human being, but how to ban cloning in a way that--that best
serves society. Cloning grabbed the spotlight in 1997, as we
know, with the cloning of the sheep Dolly in Scotland.
This remarkable breakthrough in science was followed by
public scrutiny and largely fear. How far away was the science
to clone humans?
President Clinton and the Congress responded immediately.
The President issued a memorandum to the heads of all executive
departments and agencies, making it clear that no Federal funds
would be used for cloning.
Several bills were introduced banning human cloning
research and banning human cloning altogether.
And now, 4 years after scientists developed Dolly, Congress
has remained divided on what we think is the most appropriate
way to ban the cloning of humans.
I want to first thank Mr. Stupak, my colleague, for his
work on this issue. While I may not favor his approach, I
respect his views on this difficult topic.
Congressman Deutsch and Congressman Greenwood have
introduced legislation that I believe is a responsible approach
to banning cloning without restricting promising research. Like
the Weldon-Stupak bill, the Greenwood-Deutsch bill bans human
somatic cell nuclear transfer, the technique used for cloning,
with the intent to initiate a pregnancy.
But in regards to the scope of this bill, their bill
protects all other types of cloning, including therapeutic
embryo cloning.
As the biotech industry will attest to, we are dramatically
close to providing cures and treatment for a wide variety of
illnesses, such as Parkinson's, and Alzheimers, and spinal cord
injury, and heart disease, and diabetes, and kidney disease,
and stroke.
Additionally, with the type--this type of research, it is
possible, medical researchers and scientists tell us, that we
could virtually eliminate the need for organ transplants and
toxic immuno-suppressive drugs.
In terms of preventing human cloning, banning all science
related to human cloning is no more effective than banning the
act of human cloning itself. It would be irresponsible of this
Congress, I believe, to stifle promising medical research under
the auspices of banning human cloning.
What is at risk if we close the door to this type of
research? The ability to regenerate a failing organ, rather
than waiting for a transplant and then hoping the body won't
reject that organ? The ability to stop the onset of juvenile
diabetes so a young child doesn't have to endure injections 3,
4, 5 times a day? The ability to restore the nervous system for
an accident victim left paralyzed? The ability to reverse forms
of muscular dystrophy which rob children of full mobility and,
all to often, tragically, rob them of their adulthood?
Too much is at risk to stop the research before its
potential is fully understood. Thank you, Mr. Chairman.
Mr. Bilirakis. And I thank the gentleman. And I would ask
the members to try to limit their opening statements to as
close to 3 minutes as they possibly can. Mr. Stearns for an
opening statement? You do have seniority, you know?
Mr. Stearns. Mr. Chairman, I bow to your wisdom, and
seniority, and good sense, and I appreciate the opportunity to
give my opening statement. I introduced in the 105th and 106th
Congress my own legislation to prohibit Federal funding for the
cloning of human beings.
The bill I introduced is H.R. 1372, and it also calls for
an international ban on human cloning. I am also a co-sponsor
of H.R. 1644, introduced by my colleague, Mr. Weldon and Mr.
Stupak of Michigan.
The quotation you used for C.S. Lewis, ``Abolition of
Man,'' is terrific. I don't know if you have read that book,
but that book sums up what we are here talking about. C.S.
Lewis was on the leading edge of understanding human rights and
the relationship to human beings and his Maker.
Cloning is a form of playing God since it interferes with
the natural order of creation. We should be very cautious on
how we address this issue. Besides the obvious moral
implications, there are several other compelling reasons why we
should not be cloning human beings.
By far, however, the most compelling is that man lacks the
ability to predict or control the possible consequences of
cloning. The Boys from Brazil, do you remember that movie? That
movie would no longer be fiction. We are actually living in a
world where the cloning of human beings is a very real
possibility.
Ever since the world was made aware of Dolly and then the
infamous Dr. Seed and the possibility of cloning human beings,
significant actions have been taken to outlaw this practice.
As we all know, former President Clinton called for a ban
on the use of Federal funds for research on cloning of human
beings, and President Bush supports a total ban on cloning, I
believe legislation to ban Federal funding on human cloning is
necessary. And the European Convention on Human Rights and Bio-
Medicine, covering not just the European Union, but all
European states, has already outlawed this practice.
Currently in the United States, four States prohibit
cloning, and eight more States have legislation pending to ban
human cloning.
Let us take a look, my friends, at the California law. It
imposes a 5-year moratorium on cloning of an entire human
being. The word ``entire'' is key because some of us consider
an embryo to be a human being.
That is why we must be very cautious in the terminology
that is used because you will hear the words, not for
reproductive purposes, being used frequently in debates about
cloning. That is just one of the many problems associated with
technology that may be used to close humans.
At least seven States have bans to prohibit transferring
the nuclei from a human cell and a human egg. But that doesn't
address the possibility of transferring a human nucleus into a
non-human egg. But that is not the only loophole.
Seven States' proposals ban the creation of genetically
identical individuals, but that leaves another loophole. An egg
cell, donated for cloning, has its own mytochondrial DNA, which
is different from the mytochondrial DNA of the cell that
provided the nucleus. The clone will, therefore, not truly be
identical.
There are many issues raised by the possibility of cloning
humans, including the medical risks that are inherent in such
procedures. These risks should cause great alarm for each of us
this morning.
In 1998, the Farm Animal Welfare Council of the United
Kingdom Minister of Agriculture called for a moratorium on
commercial uses of animal cloning because of serious welfare
problems encountered when animal species have been cloned.
So, to attempt such a technique on humans, which has caused
deformities, large fetuses, and premature deaths in sheep and
cattle is not being responsible.
Let us not forget that it took 273 tries to develop a
Dolly. That begs a question: what about the other 272 animals?
Most of them were either aborted, destroyed, or maimed.
Obviously, we do not want to do this to human beings.
There are also compelling and serious ethical and moral
implications involved with the cloning of humans. Theologians--
theologians and ethicists have raised three broad objections.
Cloning humans could lead to a new eugenics movement where,
even if cloning begins with a benign purpose, it could lead to
the establishment of scientific categories of superior and
inferior people.
Cloning is a form of playing God since it interferes with
the natural order of creation, and cloning could have long-term
effects that are unknown at this time.
Mr. Bilirakis. Would the gentleman finish up? The time has
expired.
Mr. Stearns. People have a right to their own identity and
their own genetic make-up. And so, Mr. Chairman, I look forward
to our distinguished panels and hearing their answers.
[The prepared statement of Hon. Cliff Stearns follows:]
Prepared Statement of Hon. Cliff Stearns, a Representative in Congress
from the State of Florida
Thank you, Chairman Bilirakis, for holding this important hearing
on legislation to ban the cloning of human beings.
Because I felt so strongly about this issue I introduced
legislation in the 105th and 106th Congresses to prohibit federal
funding for the cloning of human beings. I reintroduced this
legislation in this Congress. The bill is H.R. 1372 and also calls for
an international ban on human cloning. I am also a cosponsor of H.R.
1644, introduced by my colleague from Florida, Mr. Weldon and Mr.
Stupak of Michigan.
Cloning is a form of playing God since it interferes with the
natural order of creation. We should be very cautious in how we address
this issue. Besides the obvious moral implications, there are several
other compelling reasons why we should not be cloning humans. By far,
however, the most compelling is that man lacks the ability to predict
or control the possible consequences of cloning.
The Boys from Brazil is no longer fiction. We are actually living
in a world where the cloning of humans is a possibility.
Ever since the world was made aware of Dolly, and then the infamous
Dr. Seed and the possibility of cloning human beings, significant
actions have been taken to outlaw this practice.
As we all know, former President Clinton issued a memorandum
calling for a ban on the use of federal funds for research on cloning
of human beings and the European Convention on Human Rights and
Biomedicine, covering not just the EU, but all European states has
already outlawed this practice.
President Bush and Secretary Thompson oppose the use of human
somatic cell nuclear transfer either for reproductive purposes or for
therapeutic purposes.
Even though President Clinton called for the prohibition of federal
funds for cloning of human beings and President Bush supports a total
ban on human cloning, I believe legislation to ban federal funding of
research on humans is necessary.
Currently, in the United States four states prohibit cloning and
eight more states have legislation pending to ban human cloning.
Let's take a look at the California law. It imposes a five-year
moratorium on cloning of an entire human being. The word entire is key
because some of us consider an embryo to be a human being. That is why
we must be very cautious in the terminology that is used because you
will hear the words not for reproductive purposes being used frequently
in debates about cloning. That is just one of many problems associated
with technology that may be used to clone humans.
At least seven states have bans to prohibit transferring the
nucleus from a human cell into a human egg, but that doesn't address
the possibility of transferring a human nucleus into a ``nonhuman
egg.''
But, that is not the only loophole. Seven state proposals ban the
creation of ``genetically identical'' individuals, but that leaves
another loophole. ``An egg cell donated for cloning has its own
mitochondrial DNA, which is different from the mitrochondrial DNA of
the cell that provided the nucleus. The `clone' will therefore not be
truly identical.''
There are many issues raised by the possibility of cloning humans,
including the medical risks that are inherent in such procedures. These
risks should cause great alarm for each and every one of us. In 1998
the Farm Animal Welfare Council of the UK Minister of Agriculture
called for a moratorium on commercial uses of animal cloning because of
serious welfare problems encountered when animal species have been
cloned. So, to attempt such a technique on humans, which has caused
deformities, large fetuses and premature deaths in sheep and cattle is
the height of irresponsibility.
Let's not forget that it took 273 tries to develop Dolly. That begs
the question, what about the other 272 animals? Most of them were
either aborted. destroyed, or maimed. Obviously, we do not want to do
this with human beings.
There are also compelling and serious ethical and moral
implications involved with cloning of humans. Theologians and ethicists
have raised three broad objections. Cloning humans could lead to a new
eugenics movement, where even if cloning begins with a benign purpose,
it could lead to the establishment of ``scientific'' categories of
superior and inferior people. Cloning is a form of playing God since it
interferes with the natural order of creation. Cloning could have long-
term effects that are unknown and harmful. People have a right to their
own identity and their own genetic makeup, which should not be
replicated.
I look forward to hearing from our distinguished panel of witnesses
about this complex and compelling problem.
Mr. Bilirakis. The Chair recognizes Mr. Waxman for an
opening statement.
Mr. Waxman. Thank you, Mr. Chairman. Today's hearing--
hearing involves research that holds a great deal of promise
for defeating disease and repairing damaged organs.
The hearing also involves a great deal of confusion, much
of it spilling over from the ongoing political debate about
abortion. I hope the hearing--I hope that the hearing can
further the research and clear up the confusion.
Let me start that effort by clarifying what we mean by
cloning research, because the term means different things to
different people. Some cloning research involves, for example,
using genetic material to generate one adult skin cell from
another adult skin cell. I know of no serious opposition to
such research.
Some cloning research starts with a human egg cell, inserts
a donor complete genetic material into its core, and allows the
egg cell to multiply to produce new cells genetically identical
to the donor's cells. These cells can, in theory, be
transplanted to be used for organ repair or tissue regeneration
without risk of allergic reaction or rejection. There is
controversy about this research, as we will hear today.
Some cloning research starts with a human egg and donated
genetic material, but is intended to go further in an effort to
create what is essentially a human version of Dolly the sheep,
a full-scale, living replica of the donor of the genetic
material. I know of no serious support for such research.
To keep things clear in discussion today, I will use
different terms for these three different aspects of cloning
research. The first widely supported field I refer to as tissue
generation. And I understand that some people call it cell-line
propagation.
The second controversial field I will refer to as genetic
cell replication. Other call--others call it therapeutic
cloning.
And the third unsupported field is widely known as
reproductive cloning. In order to tilt the debate about genetic
cell replication research, some opponents lump it with Dolly
the sheep. No one benefits from such confusion.
If some think research is good and others think it is
wrong, that dispute should be aired clearly and not blurred by
blending subjects or exaggerating claims. If a field of
research is to be prohibited or allowed, we should do so on its
merits.
Some also argue to prohibit genetic cell replication
research because it might, in the wrong hands, be turned into
reproductive cloning research. I cannot support this argument.
So a--such a prohibition is no more reasonable than to
prohibit all clinical trials because researchers might give
overdoses deliberately. It is as much overreaching as
prohibiting all organ transplant studies because an
unscrupulous person might buy or sell organs for profit.
All research can be misused. That is why we regulate
research, investigate abuse of subjects, and prosecute
scientific fraud and misconduct.
If researchers give drug overdoses in clinical trials, the
law requires they be disbarred and punished. If someone were to
traffic an organ, the law requires they be prosecuted. We
should clearly define what we believe is wrongdoing, prohibit
it, and enforce that prohibition.
But we should not shut down beneficial work, clinical
trials, organ transplants, or genetic cell replication because
of a risk of wrongdoing.
In closing, I want to acknowledge that principled people do
differ in this area. Some believe that a fertilized egg,
whether it is inside a womb or inside a test-tube, is the same
as a human being.
They are logically consistent when they oppose genetic cell
replication. They are also logically opposed to abortion, to in
vitro fertilization as it is generally practiced, and to some
methods of family planning.
I don't question their sincerity, but I sincerely do not
agree with them. And I do not believe that the Congress should
prohibit potentially lifesaving research on genetic cell
replication because it accords a cell, a special cell, but only
a cell, the same rights and protections as a person.
I look forward to hearing from the witnesses today. Thank
you very much for holding these hearings.
Mr. Bilirakis. And I thank the gentleman. Mr. Greenwood for
an opening statement?
Mr. Greenwood. Thank you, Mr. Chairman, and I do
particularly appreciate your holding this hearing. The humorist
and social critic H.L. Mencken once wryly observed that, ``For
every complex problem, there is a solution that is simple,
neat, and wrong.''
Today, this committee has before it two competing bills to
outlaw the cloning of human beings. Mr. Weldon's bill, H.R.
1644, while commendable in its intent, suffers from the weight
of Mr. Menschen's observation.
It is a simple and straightforward solution to a very
complex matter of science, but it is, unfortunately, wrong. It
seeks to ban all forms of cloning which involve the use of the
cells of human beings.
The measure which Mr. Deutsch and I--the measure which Mr.
Deutsch and I have introduced, however, while perhaps failing
the simplicity test, does confront the need to provide a
sophisticated solution to a complex problem.
The admonition we try to follow is the one which Einstein
recommended: ``Everything should be made as simple as possible,
but not simpler.''
Esentially, our bill would seek to outlaw all attempts at
reproductive human cloning, while permitting further and very
carefully circumscribed research in the areas of somatic cell
nuclear transfer, a process that holds out a very real promise
of a new kind of therapy known as regenerative medicine.
Briefly, this promising therapy would replace damaged or
dead cells with healthy, and vigorous, new, and transplantable
cells, thereby enabling physicians to treat millions of those
who now suffer from chronic diseases, such as diabetes, stroke,
heart disease, Parkinson's disease, and spinal cord injury.
This is about allowing people who are in coma to open their
eyes, and stand up, and return to their family. This is about
allowing people who are paralyzed, quadriplegics, to walk
again. That is what is at stake here.
I have had an opportunity to review the written testimony
of our distinguished panel of witnesses here today, and I
believe it is fair to say that while all of them oppose
reproductive cloning, not all are convinced that cloning
research is without merit.
Indeed, two of our scholars will testify that their support
of Mr. Weldon's bill is more a matter of public policy; one
might even say politics, rather than good science. Simply
stated, it would appear that they do not think that
reproductive cloning can be effectively banned once the
research genie has been let out of the bottle.
But that approach still begs the question I asked in my
opening remarks at our first hearing on cloning earlier this
year. The question this generation must ask is this: what
should we do with this science? We must not only address the
problems that come about from the use of the technology, but
the foregone opportunities, cures for diseases, ailments, and
illnesses that may be lost. Should we entirely ban this
technology?
And I reject the premise that we are unable to distinguish
between the dangers of untrammeled scientific experiments on
the one hand, and new paradigms in biomedical research on the
other.
We owe it to ourselves and our posterity to have more faith
in our ability to guide and direct human conduct than this
cramped approach would allow.
One of our witnesses, though not himself a scientist,
asserts that any form of research into therapeutic cloning is,
``as morally abhorrent as it is medically questionable.''
His objection is that embryonic cells are, in actuality,
``new, living human beings.'' Even if we were to accept this
premise, which I do not, what are we to make of in vitro
fertilization? Each year, thousands, if not hundreds of
thousands, of human embryos are discarded. Should this process,
too, be outlawed? Shouldn't this practice also be construed as
morally repugnant given the witness's definition?
And make no mistake; in vitro fertilization is not free of
very complex and difficult, moral, ethical, and legal
controversies. Issues of third-party donations of sperm or
eggs, surrogate mothers, embryo division, sex selection of
children, genetic testing, and potential genetic engineering,
even rights of ownership, all are present in this practice.
But here, as one of our other witnesses recently pointed
out, dogma is overcome by human desire. For while some clergy
may condemn in vitro fertilization, 75 percent of the American
people favor the practice as a means for a loving couple to
bring a child into the world.
Then, there is the reality of the old-fashioned method of
reproduction that we call sex. It is simply not true in the
human body that every time an egg and sperm are joined human
life begins.
On the contrary, quite frequently the embryo fails to
attach to the uterine wall and is flushed out of a woman's
body. What are we to make of this, when the largest loss of
embryos is a result of the natural order of things human?
Mr. Bilirakis. Would the gentleman please finish up? The
time is----
Mr. Greenwood. Mr. Chairman, I would ask unanimous consent
for an additional 1 minute to complete my opening statement?
Mr. Bilirakis. We are getting away from that 3-minute thing
that I asked----
Mr. Greenwood. Well, Mr. Chairman, since it is my bill, I
wondered if I could just have this indulgence?
Mr. Bilirakis. Without objection, it will----
Mr. Greenwood. Thank you.
Mr. Bilirakis. [continuing] be the case.
Mr. Greenwood. In making this observation, I do not mean to
be glib. On the contrary, I wish to admonish all of us that we
should exercise great care when we make pronouncements about a
mystery as deep as the creation of human life. The question
about when life begins is too profound to be settled here
today.
And in any case, this is not what this hearing is about.
And if we cannot all agree on when life begins, we can all of
us: Christian, Muslin, and Jew agree to this, I think, that
every child is a new idea in the mind of God, and that this is
now, and will be forever, the essence of humanity.
Using this definition, human clones would be replicates,
the human equivalent of an epilogue. This is where I choose to
draw the line. I oppose it; it must be outlawed.
And where there is a risk of some morally bankrupt
charlatan pursuing reproductive cloning, we must make it
abundantly clear that that man or woman is a pariah, even as we
embrace the child who may be born of such an effort.
But make no mistake; the wistful hope of some of today's
witnesses that in outlawing every aspect of cloning, we will
somehow eliminate attempts to accomplish human cloning is a
little more than whistling in the dark.
And I hope that they will forgive me when I observe that by
embracing a universal ban on cloning, it is they who would be
guilty of throwing the baby out with the bath.
The philosopher Arthur Schopenhaeur observed that, ``All
truth passes through three stages. First, it is ridiculed.
Second, it is violently opposed. Third, it is accepted as being
self-evident.''
I believe that this is precisely what occurred in the case
of in vitro fertilization, and I believe we will look back upon
this hearing today and recall that the same was true of the
remarkable medical breakthroughs made possible by therapeutic
cloning.
In 1846 when the Scottish physician, James Simpson, urged
the use of chloroform to reduce the----
Mr. Bilirakis. Mr. Greenwood, I am sorry, but you are 2
minutes over, sir.
Mr. Greenwood. Very well.
Mr. Bilirakis. Mr. Deutsch for an opening statement?
Mr. Deutsch. Thank you, Mr. Chairman. I would ask the
members of the that they would accept my written statement in
full into the record.
Mr. Bilirakis. Without objection, that will be the case for
every member of the subcommittee.
Mr. Deutsch. I would like the chairman and ranking member
for holding a second hearing on this important and complex
subject. I understand that this is a powerful issue with many
points of view to be heard and discussed.
I hope that members listen carefully to the testimony of
our witnesses, and use this opportunity to better understand
the scientific and ethical issues surrounding human cloning.
Our actions today when proceed with these bills will have a
profound effect on the future of scientific discovery and the
health and welfare of our constituents. We have a
responsibility to proceed in a thoughtful and considerate
manner that acknowledges the future benefits of scientific
research, while accepting and protecting against the current
flaws in the cloning process.
Mr. Chairman, I believe it is fair to say that no one
sitting on this stage thinks we should allow reproductive
cloning at this point in time. The process has clearly been
shown to be imprecise and dangerous. Of the animals that have
been cloned to date, none have been free of abnormalities.
The great majority of cloned animals die at birth or soon
after. Those that survive often suffer from kidney, brain, or
immune system abnormalities. Even Dolly the sheep, successfully
cloned only after more than 270 attempts, suffered some severe
obesity.
With these apparent risks, though highly prevalent in
animals, it is imperative that we ban reproductive cloning and
that we devote appropriate resources to upholding this ban.
That being said, it is clear there are significant benefits
to be derived from therapeutic cloning, as several of our
witnesses will testify. Since our last hearing on the subject
in March, I have worked closely with Congressman Greenwood to
develop legislation that we believe protects the public from
the precarious and uncertain nature of reproductive cloning,
while preserving promising biomedical research.
Specifically, the Greenwood-Deutsch legislation bans the
use of human somatic cell and nuclear transfer with the intent
to initiate a pregnancy, and imposes severe criminal and civil
sanctions on any person or company that breaks this law. This
language is the guts and substance of our legislation.
However, we have purposefully drawn a bright line in the
bill between reproductive cloning and therapeutic cloning. Our
legislation specifically protects the use of human somatic cell
nuclear transfer to clone molecules, DNA, cells, or tissues.
This is one of the most promising areas of research for
diseases like Alzheimers, Parkinson's, and diabetics--diabetes,
just to name a few.
To ban therapeutic cloning, as the Weldon-Stupak
legislation does, would be a travesty for the millions of
people in our country whose lives are affected on a daily basis
by these devastating conditions.
I won't go into detail of the myriad of cures and
treatments that therapeutic cloning could provide, as Dr.
Okarma and Mr. Perry will more than adequately make this point
with their testimony.
I only emphasize the importance of understanding the clear
distinction between reproductive cloning, which we need to
unequivocally ban, and therapeutic--therapeutic cloning, which
we unequivocally need to protect.
As we have moved toward this hearing, there have been
questions raised by supporters of the Weldon-Stupak bill about
the ability of our bill to effectively eliminate reproductive
cloning without banning the creation of cloned embryos.
Let me state now that I am committing to working to tighten
and amend the legislation to ensure it fits our intended policy
objectives. However, I believe there are inherent flaws in the
logic of some of these issues that were raised with the
Greenwood-Deutsch legislation.
For instance, a recent ``Dear Colleague'' issued by Dr.
Weldon implies there is no way to enforce a ban on transferring
a cloned embryo to a woman's uterus if there is no ban on
creating those embryos. My response to Dr. Weldon's concern is,
how will you enforce your ban on creating cloned embryos?
One benefit of the Greenwood-Deutsch legislation is that it
prospectively addressees the enforcement issue by requiring all
entities that plan on performing human somatic cell nuclear
transfer to register with the FDA.
That registration will contain an attestment they are aware
of the prohibition on reproductive cloning and will not engage
in any violation of that prohibition.
Additionally, by specifically stating in the legislation
that it is a crime to intend to use human somatic cell nuclear
transfer to initiate a pregnancy, our bill allows the FDA to
intervene in a potential reproductive cloning scenario even
prior to the creation of a cloned embryo. The Weldon-Stupak
legislation forces the FDA to delay intervention until an
embryo has been cloned.
I would like to address one final issue before I wrap up my
statement. One of those issues that neither bill addresses is
that--the products derived from therapeutic cloning.
If the Weldon-Stupak legislation passes and therapeutic
cloning is banned in the United States, there is no doubt that
bio-tech companies will simply move off-shore and continue
their research elsewhere.
The question we are then faced with is, will we also ban
the potential lifesaving product as the result of this off-
shore--off-shore therapeutic cloning? Will we deny our
constituents access to these phenomenal products?
If we deem therapeutic cloning to be unethical, how can we
possibly reverse course and reap the benefits of off-shore
research? This is a question for another time, but it is one
that I think members should be aware of as they contemplate the
effects of our actions on future discoveries.
In closing, I would like to again caution members against
making a quick decision on this issue. There are obviously many
points of view to be considered, and our witnesses today will
add significant substance to this debate.
However, we are essentially debating a single tradeoff: it
is more important to enact a broad ban----
Mr. Bilirakis. Please finish up.
Mr. Deutsch. [continuing] that would prohibit research, or
should we spend a little extra enforcement to narrow a ban on
reproductive cloning while allowing lifesaving research to
continue? I ask the members to keep that in mind as we proceed.
Thank you, Mr. Chairman.
Mr. Bilirakis. Dr. Ganske for an opening statement.
Mr. Ganske. Thanks, Mr. Chairman. I will be brief. Cloning
a human being is immoral, period. I believe there is wide-
spread, bipartisan agreement on that. Some people sort of shrug
their shoulders and say, ``Well, somebody is going to clone a
human being. What can you do about it?''
I say we rise up in moral outrage and that we pass laws,
both in this country and internationally, to prevent the
cloning of a human being.
We need to look carefully at the total issue. There are
some who would say we should not allow stem-cell research.
There are some that would say we shouldn't allow any
``cloning'' at all.
And Mr. Chairman, I remember years ago, when I was taking
care of a little boy who had a 95 percent burn over his entire
body, and it was one of the first uses of cell lines that were
grown from that little boy.
Now, under some definitions, that could be termed a
cloning, a product to create those sheet of epithelium that
were used.
As we look at this issue, let us agree, no cloning of human
beings, and let us also look very closely at the language of
any legislation so that we do not prevent the ability to
effectively treat certain disease conditions. And with that, I
yield back.
Mr. Bilirakis. Thank you, gentleman. Mr. Stupak?
Mr. Stupak. Thank you, Mr. Chairman, and thank you for
holding this very important and timely hearing. I think it is
obvious which bill I support, H.R. 1644, the Weldon-Stupak
Human Cloning Prohibition Act of 2001.
H.R. 1644 amends the U.S. Criminal Code to ban the creation
of cloned human embryos for research or reproductive purposes.
What our bill would do is to prohibit performing, or attempting
to perform, human cloning; participating in an attempt to
perform human cloning; shipping or receiving the product of
human cloning for any purpose; and importing the product of
human cloning for any purpose.
It draws a very bright line as to what activities are
specifically prohibited. Many people have attempted to paint
this bill as hand-cuffing the bio-technology and bio-research
efforts currently underway.
The truth is, there is no cloned human embryo testing going
on. And so, the arguments we will hear against this bill today
will be conjecture at best; as in, we think this may happen,
but we are not sure. Well, Mr. Chairman, I would like the
researchers to be a bit more sure before they begin creating
human clones.
The Weldon-Stupak bill intentionally steers clear of issues
such as animal cloning, in vitro fertilization or IVF, and
allows cloning techniques to produce DNA, cells other than
human embryos, tissues, and plants.
It also stays clear from stem cell research because, and I
want to make this point very clear, stem cell research is being
done on existing embryos at IVF clinics. The Weldon-Stupak bill
does not prohibit this type of research on existing human
embryos that are already slated for destruction. Therefore,
stem cell research can and will go on.
This is not a Republic versus Democrat issue. H.R. 1644
reflects that. Currently, we have 105 co-sponsors, 19 of which
are Democrats, much more bipartisan than any other cloning
bill.
Some people have painted this bill as a pro-life vehicle.
This is not true. I would like to point out the United
Methodist Church has endorsed the Weldon-Stupak bill, as well
as our witness today, pro-choice advocate, Judy Norsigian.
H.R. 1644 is an ethical bill about an ethical, moral, and
legal problem. And I am proud that is able to reach across the
divisive pro-life/pro-choice lines.
Another point that will be brought up in today's hearings
by pro-cloning advocates will be what is called therapeutic
research. Briefly, these advocates say that cloning of human
embryos is essential for organ transplant.
To explain, let us say I have a faulty heart. Pro-cloning
researchers will say, ``Let me clone myself, using an embryo,
exact my own stem cells within to grow new heart cells to
replace the damaged. Then, implant these cells.''
This will, so the theory goes, cut down on transplant
rejection and cut down on the brutal immuno-suppressive drugs.
My question is, why not clone my heart cells and cut out on the
uncertain step of directing embryonic stem cells to become
heart cells?
Finally, some have mentioned their concern with the lack of
a sunset date, thus forever ruling out human embryo cloning.
This is not true.
The Weldon-Stupak bill has a provision that directs
scientists to come back to us when they feel that can make an--
when they feel they can make a strong case for human embryo
cloning. This puts the burden of proof on the researchers,
which is where it should be.
One last distinction between our bill and the other human
cloning bills: our bill bans a specific act. The Greenwood-
Deutsch bill, for example, bans intent, a much more blurred
standard.
Thank you, Mr. Chairman. I look forward to the testimony of
our witnesses, and I welcome Mr. Allen, the Deputy Secretary of
HHS.
Mr. Bilirakis. The Chair thanks the gentleman. Dr. Norwood
for an opening statement?
Mr. Norwood. Thank you very much, Mr. Chairman, and I will
try to get you back on schedule. I will be brief. Let me say to
Mr. Allen, we are delighted you are here. And I thank you very
much, Mr. Chairman, for holding this hearing.
I am really here today to listen. What was once considered
science fiction now has become a reality, human cloning. And
with that reality comes the ability to discover new treatments
and treatments for conditions and diseases, perhaps even ways
of preventing them from occurring at all.
I believe that we should move cautiously in considering any
legislation that would arbitrarily close the door on important
avenues of research.
Now, we have two bills before us, and I am a co-sponsor of
the Weldon-Stupak bill. But I admit, I am also very interested
in the approach Mr. Greenwood has taken. I believe that we need
to give these bills great scrutiny to make sure that we
understand all the potential consequences of both bills.
Again, Mr. Chairman, I thank you for holding this hearing.
I commend you for your efforts to further examine this issue of
cloning, and I look forward to hearing from our witnesses
today, and would gladly yield back the balance of my time.
Mr. Bilirakis. And I thank the gentleman for that. Mr.
Strickland for an opening statement?
Mr. Strickland. Thank you, Mr. Chairman. Mr. Chairman, I
woke up this morning, thinking about a young man in my district
who is in his late 20's who, in his early 20's, had a serious
car accident, and is unable to even breathe on his own. He has
24-hour care. He has back-up power in case the electricity
would fail so that he could continue to breathe.
That young man, I hope someday, will have hope that he, and
others like him, will no longer be required to spend his entire
life in bed, being cared for by others.
I was thinking of him because I knew I was coming to this
hearing, and I knew that what we were going to be talking about
this morning was very important. I absolutely agree with what
Dr. Norwood just said. We should be very careful that we not
close the door, at least at this stage of our knowledge, on
efforts to advance science and medicine.
We are opposed to the cloning of human beings. But we need
to be very careful; and I hope we, as a committee, will be
very, very careful, that we not allow theology or philosophy or
politics to interfere with the decisions that we make here, but
that we make sure that the decisions we make are based upon
sound science.
I am a United Methodist. My friend, Mr. Stupak, is a Roman
Catholic. But I think neither of us can allow our churches to
tell us how to respond to this issue. I am not--I am not
implying that that is true of either of us, but I do believe
that there is a danger with this issue of allowing it to get
caught up in matters which are apart from science and our
responsibilities as Representatives to support sound science.
I haven't made up my mind on which bill I am going to
support, but I am convinced that what we are doing today is
important and vital, and it will ultimately affect huge numbers
of the American people. And for that reason, we ought to
approach it with the utmost seriousness of purpose.
Thank you, and I yield back my time.
Mr. Bilirakis. And I thank the gentleman. Mr. Bryant for an
opening statement?
Mr. Bryant. Thank you, Mr. Chairman. I have been sitting
over here, making notes and deciding whether I want to give an
opening statement or not, and trying to move things along. And
I thought I could echo and join in my--my good colleague from
Michigan's statement, Mr. Stupak.
And I certainly agree with him 100 percent, and I thought I
could end it right there. But as I continue to hear some of the
statements about--being made about this research and the need
for it, which I don't quarrel with that, and I don't quarrel
with these many, many difficult circumstances, these terrible
cases where people have been hurt or--or have diseases; and
certainly somewhere down the road, perhaps research can
discover a cure or something to help them.
And we all support that. Those are terrible cases. But we
do look at things like theology, and philosophy, and even
politics, up here on everything we do. We operate in a world
not purely humanistic, not just on science. We draw lines all
the time out there.
We don't let prisoners sell their organs, or anybody, for
that matter, sell their organs. We don't require prisoners to
give up organs because they are in prison. We don't grow
people. We don't create people for organ harvesting and things
like that, and other body parts. We don't kill seniors, at
least yet, for lack of a quality of life and things like that.
So, I think we operate in a bigger world than simply sound
science. There is no question sound science plays a role in so
many things. But yet, when you are dealing with such deep,
moral issues, for many of us who do have a clear definition of
where we think life begins, I think you could find people that
could say anything about that.
Some say at the beginning, when the sperm meets the egg,
perhaps now survivability and with the technology that we have
got to keep these little premature babies alive, you know, when
is that? The law in my State, in Tennessee, in civil cases is
viability. And some might even say, you can argue through
partial-birth abortion, is it doesn't begin until the baby is
actually born.
You have got people that will say all kinds of definitions
there. And if I am going to make a mistake on when that life
begins, I am going to try and err on the side of life, and give
the benefit, the most generous benefit.
Even in our criminal courts today and our law system,
people who are sentenced to death have layers of appeal because
we give them the benefit of the doubt. And yet, in situations
like this where perhaps we are creating lives there and then
destroying those lives, there is no--no one advocating for
them.
So, I think there are difficult issues here.
Unquestionably, there are terrible cases that we have to deal
with. We have to have this research. And I am just optimistic,
and hopeful, and encouraged that there are other ways we can
get to this research through the tissue replication, as I
understand it--I am not a doctor--something short of having to
create, in my--in my belief, a life, and then destroy that life
to help these very difficult circumstances.
And again, I just--I hope there is another way to do this.
And I am encouraged, and I am glad to have all of the different
opinions here today. I want to listen as much as I can. We have
got schedules for--we are in and out a lot.
But I do--I did feel it necessary to at least respond in
part to some of the statements that are being made in--in this
regard. And for that, Mr. Chairman, I thank you again for
holding this very important hearing, and I would yield back my
time.
Mr. Bilirakis. The Chair certainly thanks him. Mr. Green
for an opening statement?
Mr. Green. Thank you, Mr. Chairman, and thank you for
holding the hearing on these two bills which address the
controversial issue of human cloning. Cloning was once the
subject of science fiction novels. Many of us associate cloning
with the disturbing notion of designer babies or a human race
that is void of individuality or spirit.
And we remember Huxley's ``Brave New World'' and the
frightful images it conjured up of genetically manipulated and
cloned individuals. What was once science fiction could become
a reality.
In 1997, the cloning of Dolly the sheep opened up all our
eyes to the possibility of human cloning. Human cloning either
for therapeutic or reproductive purposes raises a number of
ethical concerns that this committee and our Nation must
consider.
If animal cloning has taught us anything, it is that
cloning has significant risk. Miscarriages, birth defects, and
genetic problems are the norm when it comes to cloning. Less
than 3 to 5 percent of cloned animal embryos survive. In fact,
it took more than 270 tries before scientists were able to
clone Dolly.
Despite these risks, a March 28 Oversight and
Investigations Subcommittee hearing demonstrated that there are
fringe groups who intend to clone human beings without regard
to the consequence of such activities.
I think that most people on this panel would agree that the
risk associated with human reproductive cloning far outweigh
any potential benefits, and that this kind of activity should
be banned. That much is evident as both of the bills we're
considering ban human cloning for reproductive purposes.
However, there is another side to cloning, therapeutic
cloning, which holds great promise for the treatment of a range
of diseases such as diabetes, heart disease, organ failure,
spinal cord injury, and Parkinson's disease.
Many members of the scientific community believe that in
order to unlock these mysteries, we must perform research on
cloned human embryos. That is where these two bills depart.
Mr. Chairman, no one in this room knows any degree of
certainty whether cloning research will achieve the goals it
has promised, but we will never know the full potential of this
technology if we stop it in its tracks.
Rather than throwing up an arbitrary roadblock on these
scientific avenues, as one of these bills does, we should
proceed with caution. And I hope the committee will consider
all of the elements before we pass legislation which could have
a chilling effect on research for treatments of some of our
most dreaded diseases. Thank you, and I yield back my time.
Mr. Bilirakis. The Chair thanks the gentleman and will ask
for the statement of Mr. Pitts.
Mr. Pitts. Thank you, Mr. Chairman, and thank you for
convening this important hearing today on the issue of human
cloning. As science rapidly advances in our Nation and our
world, we, as legislators, are faced with ethical dilemmas as
we attempt to make sure that our world doesn't begin to
resemble Huxley's ``Brave New World.''
While we want to encourage lifesaving, scientific advances,
we must not let science advance in a moral vacuum. Americans
agree. In fact, in a poll by Time/CNN in March of this year, 90
percent of those polled opposed human cloning.
While there is agreement that we must ban cloning, there is
disagreement on the best way to do this. And today, we will
hear testimony on two, radically different approaches to
banning cloning.
The Greenwood bill would place a 10-year moratorium on
implanting a cloned embryo in a woman's uterus. The Weldon bill
would ban both the creation of a cloned embryo and the
implantation of a cloned embryo.
Regardless of whether members are pro-choice or pro-life,
it can be argued that the only effective way to ban cloning is
the way it is done in the Weldon bill.
For example, if there were only a ban on implanting a
cloned embryo, what happens when one of the cloned embryos is
implanted in a woman's uterus, which we know could occur at
some point? Would the woman be taken into custody and forced to
have an abortion?
Regardless of the moral issues that some of us have with
the Greenwood approach of creating life for the explicit
purpose of research and then destroying it, I simply believe
that this approach of only banning implantation is completely
unenforceable.
Roe v. Wade, the Supreme Court decision, guarantees women
the right to choose. I can't imagine that supporters of Roe, or
anyone else for that matter, would force a woman who has had a
cloned embryo implanted in her uterus to have an abortion. This
is not China.
Another determination that needs to be made when we
consider these young, living, human embryos is do they have the
quality of people or property? If they are property, then we
can do with them what we wish, including research,
experimentation, destruction.
If they have the quality of people, although very tiny,
very young, live human beings, they should not be created for
experimentation and destruction and harvesting, no matter how
sophisticated or therapeutic or regenerative.
As someone has said previously, human cloning is immoral.
Are we going to permit the creation of a whole new class of
human beings just for research, experimentation, harvesting,
and destruction?
So, I fear the outcome of anything less than a complete ban
on cloning, both embryonic and reproductive, would result in
cloned human beings in America actually being implanted and
being born.
I look forward to hearing the testimony from our
distinguished panel of witnesses today.
Mr. Bilirakis. The Chair thanks the gentleman. Mr. Barrett
for an opening statement?
Mr. Barrett. Thank you very much, Mr Chairman. I will be
brief. I want to thank you for convening this hearing. I think
that previous members from both sides of the aisle and both
sides of this issue have pointed to the thorny nature of the
debate that we face today.
And I--rather than expounding on what may or may not
happen, I am frankly looking forward to hearing from the--from
the different witnesses to see what the administration's
viewpoint is, and what the various other members of the panel
have to offer. So, I would yield back the balance of my time.
Mr. Bilirakis. I thank the gentleman. Let the record show
that Ms. Wilson and Mr. Buyer are present, and have waived an
opening statement. And even though she is not a member of this
subcommittee, Ms. DeGette has requested the opportunity to make
a brief opening statement, and the Chair now recognizes her.
Ms. DeGette. Thank you, Mr. Chairman. And it is really good
to be back with my colleagues, even just for a brief moment. At
the Oversight and Investigations hearing we held in March, all
of us were horrified, collectively, at the testimony of experts
in animal cloning who talked about the results that we don't
hear about in the media with Dolly and so on, but the failed
results and the grotesque results that came from animal
cloning.
And we agreed, collectively, that cloning--human cloning
was immoral, and that human cloning was impractical and should
not occur. What is--we were also equally horrified at the
cavalier attitude of some of the proponents of human cloning
who testified at that hearing.
And we were all shocked about their complete lack of
understanding about the moral, ethical, and physical
implications of attempting human cloning.
And so, I welcome legislation to ban cloning. But at the
same time, we need to understand what so many of my colleagues
have talked about today here.
Increased understanding about the human genome, as well as
the rapid advancement of technology, have prompted significant
controversy about the possible application of cloning
techniques of humans and whether there are appropriate
applications.
The Greenwood-Deutsch bill prevents the abuses of human
cloning while, at the same time, allowing for appropriate
continued research in an area of science that holds answers,
answers which could affect the lives of millions of Americans
who are affected by so many diseases, as we have heard, from
diabetes to Alzheimers to Parkinson's to different kinds of
paralysis, and on, and on.
Therapeutic cloning, if appropriately done and if it is
matched with appropriate safeguards, can hold so many of the
keys that it would be irresponsible for Congress to pass
legislation which would not allow this very targeted type of
research to continue.
And so, Mr. Chairman, I thank you for having this hearing,
and I also would caution my colleagues; we must be very
careful. We cannot pass a bill simply because it seems
politically expedient.
Too many lives of Americans are at risk. And we need to be
very careful that while we are banning human cloning, we also
don't stop research that will benefit so many millions of
Americans. With that, I yield back the balance of my time.
Mr. Bilirakis. I think the gentlelady. That completes
opening statements. As I had said earlier, the opening
statements of all members of the subcommittee are made a part
of the record.
[Additional statements submitted for the record follow:]
Prepared Statement of Hon. Ed Whitfield, a Representative in Congress
from the State of kentucky
Thank you Mr. Chairman. The debate on human cloning represents one
of the most controversial and important issues facing our nation and
society today. Rapid advances in biotechnology have transformed what
was only recently an abstract hypothetical question into a very
tangible and pressing legislative problem.
The American people look to their representatives in Washington for
leadership and careful deliberation on the subject of human cloning. As
a Committee, we are charged to reach a conclusion that will preserve
the sanctity and uniqueness of human life without impeding important
biomedical research that promises to improve the health of millions of
Americans.
While both the Weldon-Stupak and Greenwood-Deutsch bills explicitly
ban the cloning of human beings, their differing approaches attempt to
resolve the predicament using varying degrees of restriction. H.R. 1644
enjoins all research utilizing somatic cell nuclear transfer,
prohibiting both reproductive and therapeutic cloning procedures. In
H.R. 2172, however, Reps. Greenwood and Deutsch limit the ban to
include only human embryonic cells intended for developing human
clones. Any use of the nuclear transfer technology for purposes other
than developing a human clone would remain lawful.
Our challenge is to carefully consider the potential benefits and
dangers of human cloning technologies, avoiding any unintended
consequences of permitting or banning cloning research. I look forward
to listening to the testimonies of our panel of witnesses and the
opinions of my colleagues in order to reach a satisfactory answer to
this most difficult question.
______
Prepared Statement of Hon. Barbara Cubin, a Representative in Congress
from the State of Wyoming
We are fortunate today in that we have many powerful incentives to
drive innovation; incentives that on the surface seem less than
admirable: money, power, glory, prestige.
I say fortunate however because without the many innovations we
have seen over the past decade--in medicine, technology, energy,
aerospace and so on, we would not be living as comfortably as we are
today.
In fact, some of us might not even be here without the many
breakthroughs in medical science. For that, we should be very grateful.
There is however another aspect to innovative research, one of
which we should be particularly mindful.
At what point does research go too far? At what point does research
lead us to a place where maybe we shouldn't be? It is herein that lies
the controversy.
It seems like we are in a race to understand the great mysteries of
life, death, birth, disease, race, time--and the many other unknowns
that we face.
In so many ways, discovery has been a blessing to us, especially
when it comes to medical science, but sometimes we are in such a hurry
to see what we can do that we don't stop long enough to decide whether
we should.
One prime example of that is the cloning of human beings. This
process comes dangerously close to wielding one of the most awesome
forces in nature.
We haven't the slightest idea what to expect in the aftermath of
cloning humans and, quite frankly, I think it is a dangerous
proposition with which to play.
I want us to stop and think carefully about what we do in the name
of research. It can be a wonderful thing, but it also demands great
responsibility and humility.
As I consider this issue in the grand scheme of things, I cannot
support cloning human embryos, and am very concerned about the
possibility of cloning these embryos solely for research purposes, only
to destroy them later. That just doesn't hold true to my idea of the
spirit and intent of medical research.
I look forward to hearing from our witnesses today, and appreciate
the chairman indulging me on this issue.
Mr. Bilirakis. And the Chair now welcomes Mr. Allen, with
apologies for your sitting there all of this time listening to
us talk. But you are probably relatively accustomed to that.
Mr. Allen is the Deputy Secretary of the Department of
Health and Human Services. Sir, your written statement, of
course, is already a part of the record. We will set the clock
at 10 minutes. And I would hope that you would supplement and
compliment that written statement. Please proceed.
STATEMENT OF HON. CLAUDE A. ALLEN, DEPUTY SECRETARY, DEPARTMENT
OF HEALTH AND HUMAN SERVICES
Mr. Allen. Thank you, Mr. Chairman and members of the
committee I am Claude Allen, Deputy Secretary of the Department
of Health and Human Services. And while it is true that having
sat through all of the opening statements, it has been very
enlightening.
This is, indeed, my first appearance before this committee
in this capacity, as I have been on the job all of 2 weeks now.
I do want to say that I appreciate this opportunity to
discuss the position of the administration regarding the
cloning of human beings. Secretary Thompson is working this
week at the Health Resources and Services Administration, and
regrets that he could not personally be here to give this
testimony.
The moral and ethical issues posed by the prospect of
cloning human beings are profound and demand our unflagging
attention. And I know the members have given much of your
attention in that very way.
Secretary Thompson and President Bush make it very clear
that they oppose any and all attempts to clone a human being.
We oppose the use of human somatic cell nuclear transfer
cloning techniques either to assist human reproduction or to
develop cell or tissue-based therapies.
At the same time, the Secretary and the President strongly
support other approaches to development of these therapies,
such as research with genes, cells, or tissues from humans or
animals consistent with current law.
Current biomedical science is riddled with vast areas of
uncertainty about somatic cell nuclear transfer techniques and
the consequences of their use. We, therefore, believe that any
attempt to clone a human being, not only would present a grave
risk to the mother and the child, but also would pose deeply
troubling moral and ethical issues for humankind.
Further, we support both the Presidential directive already
in place that prohibits the use of Federal--of government funds
for cloning human beings and the current restrictions on HHS
appropriations that bar the use of Federal Government funds to
create human embryos for research purposes.
The American Medical Association Policy Statement E2.147
issued in 1999 stated further--that further investigation and
discussion of the harms and benefits of human cloning is
needed, and the potential for unknown physical and
psychological harm, including violations of privacy and
autonomy, are significant.
Ian Wilmont, as many have already noted, the scientist who
cloned Dolly the sheep, has come out publicly against human
cloning, stating that the risks inherent in cloning mammals are
so great that it is ``criminally irresponsible'' to experiment
with humans.
After 4 years of experience in animal cloning techniques,
the failure rate is 98 percent. Animals that survive have
problems with abnormal--abnormally high birth weight, extra
large organs, heart troubles, even poor immune systems. These
animals are often euthanized to end their suffering.
It is clear that this administration has a moral imperative
to prohibit the use of cloning technology for the purposes of
creating a human being for reproduction or for research.
At the same time, we look forward to working with the
committee and the members on your--and the colleagues in
Congress in sustaining life-giving research into cell and
tissue-based therapy to combat disease.
On behalf of Secretary Thompson and the President, let me
thank you all for holding this hearing. It does address very
critical issues that we must confront.
I will end by saying that I think Mr. Pitts, Congressman
Pitts, really stated it the best when he said that we must not
let science advance in a moral vacuum. The times in society
when we have done that have resulted in great disasters, times
when we have turned our back on our fellow men and women in
this country and around the world.
We believe, at the Department of Health and Human Services,
that the committee's work should be applauded in carefully
considering and carefully reviewing these matters that have
such critical importance to the future of not only those who
may benefit from therapy, but also for society itself.
With that, I will stop and entertain any questions. There
are many other issues that I think have been addressed in my
written statement. Mr. Chairman, if I may also, at the very
beginning, I meant to apologize for the committee receiving my
testimony late last evening.
It is not designed to prevent you from having an
opportunity to review it. It was simply late in the night that
we were able to get it finally worked out and get it up here to
you. So, please accept my apologies for that, as well as the
Department's.
[The prepared statement of Claude A. Allen follows:]
Prepared Statement of Claude A. Allen, Deputy Secretary, Department of
Health and Human Services
Mr. Chairman and Members of the Committee, I am Claude Allen,
Deputy Secretary of the Department of Health and Human Services. I
appreciate this opportunity to discuss the position of the
Administration regarding the cloning of human beings.
BACKGROUND
The moral and ethical issues posed by the prospect of cloning human
beings are profound and demand our unflagging attention. Secretary
Thompson and President Bush oppose any and all attempts to clone a
human being. We oppose the use of human somatic cell nuclear transfer
cloning techniques either to assist human reproduction or to develop
cell- or tissue-based therapies. At the same time, we strongly support
other approaches to development of these therapies, such as research
with genes, cells, or tissues from humans or animals, consistent with
current law.
Any attempt to clone a human being not only would present a grave
risk to the mother and the child but also would pose deeply troubling
moral and ethical issues for humankind. Further, we support both the
Presidential directive already in place that prohibits the use of
federal funds for cloning human beings and the current restrictions on
HHS appropriations that bar the use of federal funds to create human
embryos for research.
These matters are of special interest to the Department of Health
and Human Services because attempts to use cloning technology to clone
a human being are subject to both the biologics provisions of the
Public Health Service Act and the drug and device provisions of the
Federal Food, Drug, and Cosmetic Act. On March 28, an FDA
representative testified on this subject before the House Energy and
Commerce, Subcommittee on Oversight and Investigations. As indicated
then, because of unresolved safety questions on the use of cloning
technology to clone a human being, FDA will not permit such attempts.
In 1998, FDA described its position in a widely circulated ``Dear
Colleague'' letter.
In keeping with the provisions of its statutory responsibilities,
FDA's role in these matters is limited to scientific, technical and
regulatory considerations. However, as noted by the President as well
as by the National Bioethics Advisory Commission, additional concerns
beyond the scope of FDA's role remain to be resolved ( especially the
broad social and ethical implications of cloning human beings, such as
whether the use of human somatic cell nuclear transfer is morally
acceptable under any circumstance.
COMMENTS ON PENDING LEGISLATIVE PROPOSALS
The Administration favors the passage of specific legislation to
prohibit the cloning of a human being, including cloning techniques
either to assist human reproduction or to develop cell- or tissue-based
therapies. We look forward to working with the Congress to achieve this
goal. For today, I present our comments on the Cloning Prohibition Act
of 2001 (H.R. 2172, introduced by Mr. Greenwood) and the Human Cloning
Prohibition Act of 2001 (H.R. 1644, introduced by Mr. Weldon),
respectively.
H.R. 2172
H.R. 2172 focuses on preventing (a) the use of human somatic cell
nuclear transfer (SCNT) technology to initiate a pregnancy or (b) the
shipment or transportation of the product resulting from such
technology if the product is intended to initiate a pregnancy. The bill
does not restrict any other uses of human SCNT, such as creating human
embryos for research purposes. This is a major concern to the
Administration.
To foster enforcement of its provisions, the bill requires that an
individual who intends to perform human SCNT register his/her name and
place of business. This registration must include a statement or
attestation, signed by the individual, declaring that he/she is aware
of the prohibitions specified in the bill and will not engage in any
activity that violates them. The registration requirement could cover a
substantial number of academic and industrial laboratories.
The bill amends the Federal Food, Drug and Cosmetic Act to provide
for criminal and civil penalties for any of the bill's prohibited
activities. Moreover, to protect the confidentiality of the information
that will be collected as a result of the registration process, the
bill requires that the Secretary not disclose any of this information
unless the registrant has provided authorization in writing or the
disclosure does not identify either the individual or his/her place of
business.
H.R. 1644
H.R 1644 amends Title 18 of the U.S. Code to prohibit (a)
performing or attempting to perform human cloning, (b) participating in
an attempt to perform such activity, or (c) shipping, receiving, or
importing the product of human cloning. To achieve these ends, the bill
defines ``human cloning'' as follows:
``The term `human cloning' means human asexual reproduction,
accomplished by introducing the nuclear material of a human
somatic cell into a fertilized or unfertilized oocyte whose
nucleus has been removed or inactivated to produce a living
organism (at any stage of development) with a human or
predominantly human genetic constitution.''
As we interpret the bill, it prohibits not only the use of human
somatic cell nuclear transfer to initiate a pregnancy but also all
other applications of somatic cell nuclear transfer with human somatic
cells, such as cloning to produce cell- and tissue-based therapies.
This is consistent with Secretary Thompson's and the President's views.
Scientific research that is not specifically prohibited in the bill
is unrestricted by it. Examples of research that are not prohibited are
the use of nuclear transfer or other cloning techniques to produce
molecules, DNA, cells other than human embryos, tissues, organs,
plants, or animals other than humans. Penalties for violation of the
bill's prohibitions include at least $1 million in civil penalties and/
or up to 10 years in prison.
We support this bill's intent of banning human cloning, but believe
that it warrants further review to resolve some technical issues.
CONCLUSION
HHS applauds the Committee for addressing the issues associated
with cloning human beings and welcomes the initiative of
Representatives Greenwood and Weldon in offering specific legislative
proposals. We look forward to working with the Congress to prohibit
morally offensive uses of cloning technology without stifling the
development of important cell- and tissue-based therapies to combat
human diseases.
Mr. Bilirakis. The Chair, on behalf of the committee,
accepts your apology. Obviously, it is certainly helpful if we
can get it on time.
Mr. Allen. Certainly.
Mr. Bilirakis. The staff--I know the staff was here until,
what, 11:30 last night waiting for the testimony. They didn't
have anything else to do, just sat waiting.
Mr. Allen. Indeed, thank you.
Mr. Bilirakis. The Chair recognizes himself for questions.
Mr. Allen, given the administration's opposition to the
creation of cloned human embryos, what uses of cloning
technology does the administration support? Would it be
anything that doesn't give rise to a human embryo?
Mr. Allen. Mr. Chairman, I believe in my written statement,
on page 6--and I will highlight that for you--we believe that
there is already areas that can and should continue to see the
research advance that are not prohibited by the use of somatic
cell nuclear transfer, techniques such as using--that produce
molecules, DNA, cells other than human embryos, tissues,
organs, plants, and animals.
And we believe that both of those areas are wide open. What
we are focusing on is a very narrow area, and that is the use
of the human cell, the somatic cell, for the purpose of
cloning, whether that be for reproductive purposes or whether
that be for what we have heard earlier described as therapeutic
or research-based work.
Mr. Bilirakis. You and I both have just used the word
``human'' a couple of times. Let me ask you the question; what
is human? If legislation were passed banning the creation of
cloned human embryos, how would the administration interpret
the word ``human''?
Before you go into that, I sould share with you that there
was a news story a while back that scientists created a monkey
that contained a strand of DNA from a jellyfish, which served
as a fluorescent marker for the embryonic-embryonic monkey.
If this were done to a cloned human embryo, would this act
render a human embryo into a chimera and therefore, not
protected under the act? Would it be a loophole? Would the
administration interpret anything that is predominantly human
in origin in its genetic make-up to be considered human for
enforcement purposes?
Mr. Allen. Mr. Chairman, let me first say the
administration has not taken a position on the findings that
you----
Mr. Bilirakis. Yes, that was going to be the next question.
Mr. Allen. [continuing] and I just want to make that very
clear. I think the fact that we would have to even go down that
track to try to guess or define what ``human'' is raises some
serious implications that go back to question both of the
moral, legal, and ethical implications.
However, I think your point of addressing the question, the
word ``in origin'' certainly gives us some parameters to begin
to look at, as we look to try to define that.
We are human because--not simply because of our genetic
make-up because, indeed, we do share 98 percent of our make-up
with, for example, monkeys. But it is those characteristics
that make us distinct from other mammals, even primates that
make us distinct, such as our ability to reason, our moral
conscience. These are things that make us human.
So, I think to try to simply isolate it to a scientific
definition, I think we are defeating the purpose of who we are
as people, as individuals, as a species, that is distinct from
all others. And that is not simply limited to our genetic make-
up.
Mr. Bilirakis. Well, even though the administration has not
taken a position on the Weldon bill--and I think we are all
sort of curious about that--would you feel that maybe there
should be a more succinct definition of the word ``human'' in
any legislation that might progress through the committee?
Mr. Allen. We certainly think that the reason we have
withheld from endorsing either bill in this circumstance is
because we believe there is room for a lot of technical
improvement. And that certainly could serve as one of those
areas that probably would need to be spelled out.
Again, we know that, as a lawyer, that lawyers can
certainly slice and dice words if you are not very careful
about how you define. We would hope that that would not be the
case.
But certainly, that is an area that, should the committee--
and we will go back and look at that. We believe that we have
opportunities to offer some technical advice in that area to
clarify.
Mr. Bilirakis. All right. I do believe that others will
probably raise the question of why you have not chosen to
endorse the bills. So, I will just go ahead and yield. Mr.
Waxman to inquire?
Mr. Waxman. Thank you very much, Mr. Chairman. Now, Mr.
Allen, you say the administration opposes genetic cell
replication and research, cloning that uses human egg cells to
create genetically identical cells, but is not intended to lead
to reproductive cloning to create a human being.
In your statement, you explain why the administration
opposes creation of a human being, but you don't explain why
you oppose research that is not intended to create a human
being. Why?
Mr. Allen. Mr. Waxman, thank you for the question, and I do
want to clarify it and make that very clear why we believe
that. I think that the comments that have been made by the
committee thus far really encapsulate much of that; and that
is, that these are areas that go far beyond just simply
science.
They go to the heart of the moral, legal, and ethical
questions that need to be raised about this area of research
that we are going into.
With regards to why we have not endorsed one of the bills
versus the other, but we strongly believe that we need to ban
both research and reproductive cloning is because leading down
the track of research cloning, it is a very small step to have
an embryo that was created for a clone for research purposes to
be simply implanted into a woman that ultimately leads to----
Mr. Waxman. But don't you draw any distinction between
research that leads toward a human version of Dolly, the sheep,
and research that uses egg cells to develop tissues for organ
repair?
Mr. Allen. Sir, I think you----
Mr. Waxman. Don't you draw those distinctions in your mind?
Mr. Allen. I think you can draw a distinction, but I think
the question, once again, comes back to intent. It gets us to a
place where we would have to interpret the intent of the
individual or company or individuals who are creating for the
purposes of research.
A very simple example: a kid in a candy store. I own a
candy store. My son works in that candy store, has access to
everything; he is passionate about candy. It is a very small
step for him to go from me telling him what is prohibited,
``You may not have that,'' to simply taking one off the shelf
and using it for that purpose.
Mr. Waxman. Yes.
Mr. Allen. I believe that, and the administration believes
that, it is the best interest that, at this time, that we ban
both research, as well as reproductive, cloning because of the
easy step to take that moves us across that line that we all
agree is reprehensible.
Mr. Waxman. But can't you deal with intent? We deal with
intent all the time in the criminal law.
Mr. Allen. The issue of intent is--and the way that the
language is written, and the bill focuses on the intent. But
what we cannot deal with is we cannot stop once that process
has taken place, once a human embryo that has been cloned has
gone from the research laboratory, has been implanted into a
woman, that area, then, we have gone down that path; we have
made that step.
And that is one that raises serious questions about what do
you do at that point? I think there has been questions already
raised about do you--you can punish the person for implanting
it. Do you punish the researcher who did not know the intent of
the person who would ultimately implant that in the----
Mr. Waxman. Well, we are talking about, I gather, the
intent of the researchers. But do you oppose this research
because you think an egg cell with implanted core genetic
material is the same as a human being?
Mr. Allen. I am sorry; I missed----
Mr. Waxman. Do you oppose this research because you think
that an egg cell with implanted core genetic material is the
same as a human being?
Mr. Allen. That is not the basis upon which we are making
this objection and opposition. We are basing it upon, again,
the fear and the concern, the real fear and real concern----
Mr. Waxman. That it will be misused?
Mr. Allen. That is correct.
Mr. Waxman. Okay. Does the administration oppose in vitro
fertilization or research on in vitro fertilization?
Mr. Allen. We do not oppose in vitro fertilization because
there is a very significant distinction. In vitro fertilization
involves the union of an egg cell, that is one set of
chromosomes, with a sperm cell, a second set of chromosomes.
And that is to produce a fertilized egg that has two sets
of chromosomes. The distinction here when we are talking about
the cloning is that the somatic cell nuclear transfer cloning
involves the removal of the egg from a single cell, and the
implantation, or the fusion, with a nuclear material to create
one set that is identical to the source that it came from.
So, there is a fundamental distinction between in vitro
fertilization and what we are talking about here in banning,
and that is to that cell nuclear transfer cloning.
Mr. Waxman. Okay. Well, thank you. Your answers are very
helpful, and we will think them through, and work with you on
this. Thank you, Mr. Chair.
Mr. Bilirakis. I thank the gentleman. Mr. Greenwood to
inquire?
Mr. Greenwood. Thank you, Mr. Chairman, and thank you for
your testimony, sir. If I calculate right, this administration
has been in office about 5 months?
Mr. Allen. That is correct.
Mr. Greenwood. That is right. This is a momentous--you
would agree, I think, that this is a momentous issue for our
future.
Mr. Allen. Absolutely.
Mr. Greenwood. Okay. Could you share with us, with this
committee, with whom did this administration consult in order
to arrive at its position which, as you stated, is that we
oppose the use of human somatic cell nuclear transfer of
cloning techniques either to assist human reproduction, which
we all do, but--or to develop cell or tissue-based therapies.
Now, with whom did you consult? With whom did this
administration consult in order to arrive at that conclusion?
Mr. Allen. Mr. Greenwood, the administration certainly has
expertise within the Department itself, at HHS, whether it be
NIH, the FDA, scientists within the administration. Outside, we
also----
Mr. Greenwood. Did this administration consult with the NIH
and the FDA prior to coming to this conclusion?
Mr. Allen. Certainly, we would have worked with them, and
their input has gone into this decision. At a different level,
however, I will say that it is very clear that, as has been
indicated, that this involves significant policy issues that
bear also on the views of the President and the Secretary as
based upon the science that we have worked with, within the
Department and outside of the Department as well.
Mr. Greenwood. Very complex. For instance, did you bring
BIO, the organization that represents the bio-technology
group--did the administration bring BIO and the scientists who
are involved in this kind of research to consult with them
prior to formulating its views?
Mr. Allen. Certainly throughout the time that this issue
has been around, we have certainly consulted with and worked
with representatives from all communities, the bio-tech
community, the faith community, the legal community. We have
worked with all because this issue does have implications for
all.
And for that reason--I cannot document for you at this
point who everyone has met with within the administration. But
certainly, there has been consultation and work with--as we
have developed these positions.
Mr. Greenwood. Now, Mr. Allen, when you--when you responded
to Mr. Waxman's question on the--and you described the
technical difference between a nuclear transferred embryo, if
you will, and one that is produced by the union of the male and
female reproductive cells--so, you correctly described why--the
technical difference between in vitro fertilization and somatic
and nuclear cell transfer.
Now, what is the ethical distinction that you are making--
that this administration is making here?
Mr. Allen. The administration has not made an ethical
distinction between those two in this regard. What we are
focusing on is--and I think the distinction, with all due
respect, the Greenwood bill, is the distinction that is made
there, that it is appropriate for banning it as far as
reproductive purposes, but allow the research purposes to go
forward.
What we are concerned about, as I have stated earlier, is
the fact that that is a very, very thin line to divide upon
because it is too easy, too simple to cross that line.
Mr. Greenwood. So, if I understand you, sir, what you are
saying is that it is--that this administration's policy is
based on not an ethical decision whether it is good for
humanity to use this regenerative, therapeutic medicine to save
the lives of potentially millions of people, but it is making a
distinction on the basis--basis of that notion that the egg,
that the cloned egg, once that process has occurred, could be
diverted to break the law that I am trying to write, that it
could be diverted for that purpose and go--become used as--for
reproductive cloning.
Is that the administration's position?
Mr. Allen. If I understand your question, Mr. Greenwood,
the administration's position would be that we believe that--
that both reproductive and research purposes of cloning, using
somatic cell nuclear transfer cloning, would be what we support
in prohibiting for the mere reason that it is a very easy leap
from one to the other.
Beyond that, I think it is important to recognize that is
not simply based upon science. It is not simply based upon
moral or ethical considerations. It is based upon the
combination thereof.
And as a policy decision, we believe that, at this time,
that it is important that we send a very strong message that
human--that the production or the creation of a human being by
the means of cloning, whether accidental or intentional, should
be banned.
Mr. Greenwood. Well, we all agree on that. But what I am--
what I am trying to hone in on here is this administration is
not taking the position that something unethical or immoral has
happened at the moment of the somatic cell transfer, but rather
it is the potentiality of that cell then being implanted in the
uterus that is the danger?
Even though we outlaw that in our bill, it is the
potentiality that that could be transferred----
Mr. Bilirakis. Very, very brief response to that.
Mr. Allen. I think that is a fair----
Mr. Bilirakis. The gentleman's time has expired.
Mr. Allen. Yes, I think that is a fair summation of the
position.
Mr. Greenwood. Thank you.
Mr. Bilirakis. Mr. Deutsch?
Mr. Deutsch. Thank you, Mr. Chairman. You indicated that
the administration supports legislation to ban therapeutic and
reproductive cloning. Can you indicate how this ban that you
endorse will be enforced?
Mr. Allen. Well, I believe, at this point, what we are
looking at is the enforcement mechanisms that are cited in the
bills before us. Certainly, the FDA plays a role in that as it
regulates both the biological and other aspects, both under the
products bill as well as the FDA's other statutory authority to
do so.
It has enforcement mechanisms, and we currently do that in
other areas. And we believe this would be similar to that as
well.
Mr. Deutsch. All right. Again, just from an enforcement
standpoint, would you wait until you hear a tip or require some
information indicating that someone wants to clone, or will you
act perspectively by doing random site visits and interviews?
Mr. Allen. I believe the FDA does both at this time. We
receive tips, and we do act upon random site visits consistent
with the authority that the FDA already has in both of these
areas.
Mr. Deutsch. All right. The administration budget recites
the grim statistics on the lower number of site inspections on
foreign and domestic facilities under FDA jurisdiction. The FDA
cannot even identify all the facilities that make prescription
drug ingredients that are introduced into commerce in this
country.
FDA and Customs inspect less than 1 percent of imports of
food, drugs, and other items under FDA jurisdiction. NIH says
that it lacks expertise on the subject of cloning. What
assurance can you give that the administration is serious about
enforcing a ban on human cloning?
Mr. Allen. We would work with--in this area, certainly
there are a number of options available to the administration.
Certainly, we can re-deploy existing resources within the
Department to try to begin to address these issues, as well as
seek additional appropriation should that be necessary to do
so.
But the FDA currently believes that it is able to enforce,
and does enforce, the laws as they currently exist. And this
would be simply a further area for----
Mr. Deutsch. Is the deterrent effect of the Weldon bill
sufficient prevention for the cloning of humans?
Mr. Allen. Could you resay----
Mr. Deutsch. The Weldon bill, the prohibitions that it has,
do you believe that is a sufficient deterrent?
Mr. Allen. We believe that the Weldon bill does suggest,
and leads in the right direction, of what we believe is a
policy statement that should be enforced. And that is a total
ban on human cloning. We believe there are some technical
adjustments to the bill that probably could improve upon, and
that is what we are willing to work with the committee and the
Congress on to try to accomplish.
Mr. Deutsch. Earlier this year, the Oversight and
Investigations Subcommittee held a hearing on the subject of
human cloning. At that hearing, and the media events
approximate to it, various individuals, some claiming to be
aliens, made statements to the effect that they intended to
clone a human being in the United States in the near future.
The FDA testified that they were aware of these claims and
were investigating the matter. Can you tell us, in detail, what
steps the administration has taken since then to investigate
these matters and, if necessary, to stop human cloning.
Mr. Allen. I know that the administration--the FDA is
currently looking into these assertions of the possible
existence of a human cloning laboratory here in the United
States. And it is FDA policy not to discuss publicly
investigation techniques or strategy.
However, Dr. Zahn is here from the FDA, has testified on
these areas in the past, and I believe she would be prepared to
give you some more detail on that at the appropriate time.
Mr. Deutsch. So, it is fair to say that there is an ongoing
investigation then?
Mr. Allen. It is fair to say that we are aware of it and
are investigating, yes.
Mr. Deutsch. Okay, let me ask you a question regarding the
administration's position. You know, obviously, there is this--
the issue that--in terms of what we call therapeutic cloning,
that the research potential is incredibly dramatic. And the
administration's proposal, as I understand it at this point, is
to ban those.
And I understand the policy reasons why you are suggesting
to ban those. I think what is clear from my opening statement,
I mentioned that it is clear that this research is going to go
on whether or not the United States bans it.
It is going to go on in other countries because other
countries do not consider it the same as the administration's
position. Would that then be the administration's position to
ban the importation of drugs that were--that were basically
researched or, in fact, substances that were the benefits of
human--of stem cell research?
What would the administration's position be in that area?
Mr. Allen. The administration has not taken a position on
that at this point. What we are focusing on are the two bills.
Of course, the Weldon bill does--I am sorry, the Weldon-Stupak
bill does focus on importation and banning that.
And for that reason, we believe that that is an appropriate
response under the legislation to do so. But the administration
has not formulated a position as to----
Mr. Deutsch. Again, I really--I am going to ask that
question again and try to hear a clear answer because, to me,
it is--it is, you know, really almost shocking what you have
just said, that in a case of the research--because this is
not--I mean, it is hypothetical at this point, but some of the
potential seems incredible, as Mr. Strickland mentioned.
And I think talking about the reality, talking to families,
talking to real people who are suffering from incredibly
debilitating illnesses where it is clear that the potential to
make, you know, absolutely miraculous recoveries, that, in
fact, your position would be that if those drugs existed to
cure paralysis, to cure cancer, that your position would be
that those drugs would not be able to be imported into the
United States of America.
Mr. Bilirakis. Let us finish up here.
Mr. Allen. Certainly. Congressman Deutsch----
Mr. Bilirakis. The time has expired.
Mr. Allen. [continuing] it should not be remarkable that we
are not outright saying that we would allow the importation of
that. The FDA does that every day. There are many drug
therapies and other techniques that may have been developed
elsewhere, but we have a responsibility to protect the health
and safety of Americans.
And absent a review of that and consideration of the impact
that that may have on human life, it would not be irresponsible
to say we would ban it at this point. But we leave open the
possibility and the prospect that should there be developed,
and should there by, hypothetically, therapies that could
benefit American people, it will go through the same process by
which we would allow that to take place and to be imported into
this country.
Mr. Bilirakis. Dr. Ganske to inquire?
Mr. Ganske. Thank you, Mr. Chairman, and thank you, Mr.
Allen, for being with us today. Up until just a few days ago,
Secretary of Health and Human Services, Tommy Thompson, was
saying that he, ``wasn't sure what the President's position
was.''
Now, we have your statement today, and this is the
President's position. Is that right?
Mr. Allen. That is correct.
Mr. Ganske. And this is the Secretary's position?
Mr. Allen. That is correct also.
Mr. Ganske. All right. Well, let us--I just want to be
absolutely clear on this. On page 5, you say, ``As we interpret
the bill, it prohibits not on the use of human somatic cell
nuclear transfer to initiate a pregnancy, but also all,''
underline that, ``all other applications of somatic cell
nuclear transfer with human somatic cells, such as cloning to
produce cell or tissue-based therapies.''
That is consistent with Secretary Thompson's and the
President's views? Let us just be absolutely clear.
Mr. Allen. That is correct.
Mr. Ganske. Okay. So, now, are you saying that it is the
administration's position that it should be illegal for anyone
to do somatic cell nuclear transfer?
Mr. Allen. Within the context of the jurisdiction of the
United States, that is correct. That is what we have the
authority to control.
Mr. Ganske. So, the ongoing work in that area you would
make illegal?
Mr. Allen. At this point, what the administration's
position is, as stated there, is indeed the use of somatic stem
cell nuclear transfer cloning techniques are what we are
focusing on here. And that is the administration's position.
Mr. Ganske. How does the administration answer the groups
like Juvenile Diabetes, and the groups that are concerned with
spinal cord injury, the groups that are looking--that the--the
kidney failure groups that are looking to potentially be--we
have a tremendous shortage of kidneys. They are looking for an
opportunity to be able to develop a kidney. I am kind of
interested in an answer.
Mr. Allen. The position. It is focusing solely on the use
of a technique of somatic cell nuclear transfer for cloning
purposes. We are not saying that other techniques that are
currently proven to be efficacious for the very issues that you
have raised could not be continued. That research is untouched.
Mr. Ganske. Is the administration aware that there are a
number of very pro-life United States Senators who have
expressed an opinion on this, such as former Senator Connie
Mack and others who would probably vehemently disagree with
the--this administration's position?
Mr. Allen. We are aware that the position the
administration has taken is based upon the concern for--as the
bills presented here today point out, and that is, is that
there are no therapies that have been developed in the area
that rely upon embryonic--rely upon pre-natal cloned cells.
That point has not been taken, and it does not take away
all the other therapies, all the other research that is ongoing
to provide for the cures that you are talking about. We believe
that there is no boundaries that have been established for the
vacuum that is created.
And if we allow and say that we support the use of cloned
cells for that purpose, if we say that we support that, that
opens up the----
Mr. Ganske. Is it this administration's position that the
FDA currently has the authority, then, to stop this procedure?
Mr. Allen. While we believe that that is not necessary for
this discussion, that position to address this, because under
the legislation, particularly the Weldon-Stupak bill, it
alleviates the need to arrive at that position because it bans
both reproductive and research in those areas.
Mr. Ganske. Do you think--but do you think the FDA has the
authority to stop this now?
Mr. Allen. I cannot give you a personal opinion on that.
The administration, certainly the FDA, can speak to that
specifically. Dr. Koon has spoken to that in the past, and I
believe she is prepared to do so if----
Mr. Ganske. Is the FDA making plans, then, to go into
private laboratories to stop this type of research?
Mr. Allen. Those plans are not underway at this time. That
is not the----
Mr. Ganske. But consistent with the administration's
statement here that that would be--I mean, that would be
consistent with this administration's statement.
Mr. Allen. Upon the passage of the legislation, this
administration would be prepared to work with the committee to
implement the law to the full effect, according to the
regulations that are provided.
And any other--any further clarifications of all that would
be necessary, we would be willing to seek that from the
Congress.
Mr. Ganske. Thank you, Mr. Chairman.
Mr. Bilirakis. Mr. Stupak to inquire?
Mr. Stupak. Thank you, Mr. Chairman. Mr. Allen, I would
like you to clarify a statement you made regarding tissue-based
therapies. You and the administration only object to tissue-
based therapies derived from cloned human embryos. Is that
correct?
Mr. Allen. I am sorry, I could not hear.
Mr. Stupak. Sure. The administration, and you representing
the administration, only object to tissue-based therapies
derived from cloned human embryos, correct?
Mr. Allen. That is correct.
Mr. Stupak. In fact, our bill specifically says, is it your
understanding, that we do not restrict areas of scientific
research in the use of nuclear transfer or other cloning
techniques to produce molecules, DNA, cells, other than human
embryos, tissues, organs, plants, or animals, other than human
beings. Is that correct?
Mr. Allen. That is correct.
Mr. Stupak. And so, some of the questions like the
statement Mr. Strickland made, and even the question Mr.
Deutsch asked, what if, our bill also, in this last part
sentence of the Congress, also says if further therapies or
research becomes available, they could always come back before
the legislative body and say we need some relief in this area
as we are doing this research.
We leave it to the scientists to tell us when to come back,
and not just a prohibition. Is that your understanding?
Mr. Allen. That is our understanding. In fact, for those
two reasons, the section--subsection (d), the scientific
research, where it makes very clear what this--this bill not
forescribe, make it a reason why we believe that those
therapies can continue, those efforts of research continue, and
why the administration believes that it is appropriate to speak
very strongly on what we do prohibit and support.
Furthermore, we believe that the--the ability here for
science does change. And if the science demonstrates that
embryonic cloning is ethicacious, safe, and effective, there is
an opportunity again, a safety clause here, that allows for
review.
And we believe that that also is an appropriate way to
address the issue.
Mr. Stupak. And the administration, it does not object to
other forms of tissue replication or cell-based therapies, do
they?
Mr. Allen. No.
Mr. Stupak. Pardon?
Mr. Allen. No, we don't.
Mr. Stupak. Okay. Are there any therapies, medical uses
from cloning, even stem cells, in existence right now?
Mr. Allen. We are not aware of any, no.
Mr. Stupak. Okay. Thank you, Mr. Chairman, and I yield
back.
Mr. Bilirakis. I thank the gentleman. Dr. Norwood?
Mr. Norwood. Mr. Allen, I am going to basically ask you to
repeat yourself. I am only going to ask you two questions, and
I want you to take plenty of time and give us a lengthy, clear-
cut answer. Does the administration support the Greenwood bill?
Mr. Allen. We do not support the Greenwood bill because it
does allow for research cloning. So, we do not support the
Greenwood bill.
Mr. Norwood. And is that the only reason?
Mr. Allen. That is principally a reason. There are other
reasons that we would want to look at--again, there are
technical issues that we would need to address. I could
highlight a couple of those: one, just the impact that it has
on inconsistency among the States.
It was stated earlier that a number of States have already
acted in this area. The Greenwood bill preempts much of what
those--what other States may do in those areas. And so, that
would cause for some concerns.
Some States that have varying degrees of how these address
these issues--by preempting some and not others, it does create
for some interpretation issues, as well as enforcement issues
for the Department.
Those would be principally some of the areas that we would
have concerns about.
Mr. Norwood. All right. To your knowledge--and the
Congressman can speak for himself; but to your knowledge, has
Congressman Greenwood worked with the administration to see if
he could--if the two of you could work this out?
Mr. Allen. To my knowledge--again, personally, I have only
been on-board for a very short while. So, therefore, I am not
aware of--and we would be certainly willing to sit down with
Congressman Greenwood to talk about that and address many of
these issues.
But I think on the policy issue, the policy decision
about--which the administration is very clear on, is the
prohibition against all forms of cloning.
Mr. Norwood. I will yield.
Mr. Greenwood. Thank you, gentleman, for yielding. Here is
a problem we have, Mr. Allen. We all agree, the administration,
everybody in this room, everybody probably--practically
everyone in the Congress, we need to ban human reproductive
cloning.
And if we don't do something legislatively, we may very
well, very soon, be in a position where people are actually
trying to do something that we all agree is very unsafe and
very unethical, and that is to try to create human beings
through cloning.
There is huge disagreement on the second part of this, the
therapeutic part. And I would predict, I think accurately, that
we are never going to get a Weldon-style bill through the U.S.
Senate.
There was precedent for that when the Republicans were in
control, and you are certainly not going to get a Weldon-type
bill that bans the therapeutic cloning through the Senate.
So, now we are in a position that we are going to fail, as
a Nation, to ban reproductive cloning because we can't get past
this issue of therapeutic cloning. And what I have been trying
to argue is, if we want to prohibit therapeutic--the
reproductive cloning, let us do it, which is what our bill
does, and leave to another day the debate about he therapeutic
cloning. And I guess my question----
Mr. Norwood. Excuse me, I have got to reclaim my time to
get to the next question.
Mr. Greenwood. Okay, all right. Well, let me----
Mr. Norwood. But you----
Mr. Greenwood. I thank the gentleman for yielding.
Mr. Norwood. Mr. Allen, does the administration support the
Weldon-Stupak bill?
Mr. Allen. The administration does not actively endorse the
Weldon-Stupak bill for the reasons I have cited. Also, there
are some areas that we believe that are technical questions
that----
Mr. Norwood. Well, speak up. What are those areas?
Mr. Norwood. A couple of those areas, for example, is in
the bill itself--one of the concerns is within the definition
section, define of the term ``asexual reproduction.'' There
were some concerns about the ability to maneuver around the
word of what--without defining specifically what asexual
reproduction is would be one area that we would certainly want
to work with and clarify.
The issue of importation, banning of the importation of--I
believe--I am not sure exactly--Congressman Waxman raised the
question about that. What would actually be banned? Will we be
banning--if a child was born that was the product of cloning,
would we be ban that?
Also, the meaning of ``nuclear material'' is another
question. I know that--what we think the intent of the bill is,
but we would want to seek clarification of what nuclear
material would be. Those are just a few areas that----
Mr. Norwood. And well, I am in the cautionary, so just
quickly and last, does the White House believe we need to
legislate this year on this issue?
Mr. Allen. The White House has not taken a position as far
as legislating. We do believe that there is significant concern
and significant harm based upon statements that have been made,
whether real or fictitious, however close they may be.
But we do believe that there is a significant concern that
if we do not legislate in this area, that we could move very
quickly down this track, whether it is for research purposes
that could ultimately lead to reproductive purposes for
cloning. So, we would say yes, we believe that there needs to
be some action in this area this year.
Mr. Norwood. I suspect we all agree with that. So, I hope
you will encourage the White House crew to work with Mr.
Weldon, and Mr. Stupak, and Mr. Greenwood, because we need to
get this done.
Mr. Allen. We will do that.
Mr. Bilirakis. Mr. Pitts to inquire?
Mr. Pitts. Thank you, Mr. Chairman. Secretary Allen, to my
knowledge, three people: a Dr. Bosalier, Dr. Okarma, and Dr.
Zabos have informed the committee that they all intend to clone
human embryos.
How has the FDA, or has the FDA, used their authority to
monitor and regulate the activities of these researchers who
intend to clone human embryos, two of whom, we are told, intend
to implant?
Mr. Allen. Without discussion--discussing or disclosing the
FDA's techniques for investigation, we will say that we have
taken these claims very seriously. And in some instances,
contact has been made with the principals who said that they
intend to do this.
And we have discussed very carefully with them the
requirements for such--beginning of such research. For example,
the FDA requires that an investigational new drug application
be filed by anyone or any entity that seeks to begin moving
down this track. None have been filed.
And thereby, we would notify and work with any of these
individuals to let them know that that is a requirement, and
that FDA would seek to enforce in that area.
Mr. Pitts. I have an enforcement question. The FDA says
they have the power to regulate the entire cloning process if
the intent is to implant the cloned embryo into a surrogate
mother.
If FDA officials showed up at a laboratory, how could they
distinguish between those cloned embryos destined for
destruction by experimentation and those destined for
implantation?
Mr. Allen. That is an excellent question. And that is the
reason why we believe that you must ban all, because you cannot
make the distinction based upon intent. And whose intent are we
referring to? Is it the intent of the one who created the clone
through the process, or is it the intent of that individual who
seeks to implant?
Those are questions that must be worked out. And the FDA
does not have the ability to make that discern--to discern
that.
Mr. Pitts. And one final question: on the bottom of page 2
of your written testimony, you state, ``Additional concerns
beyond the scope of FDA's role remain to be resolved,
especially the broad social and ethical implications of cloning
human beings, such as whether the use of human somatic cell
nuclear transfer is morally acceptable under any
circumstance.''
Yet, your written testimony also states that, ``The
administration opposes the use of human somatic cell nuclear
transfer cloning techniques either to assist human reproduction
or develop cell or tissue-based therapies.''
That sounds to me as if that additional concern has been
resolved by the administration. Am I correct?
Mr. Allen. If I understand your question, the answer will
be yes.
Mr. Pitts. Okay, thank you, Mr. Chairman.
Mr. Greenwood. Would the gentleman yield? Would the
gentleman yield?
Mr. Pitts. I will be happy to yield.
Mr. Greenwood. Mr. Allen, if you came into a laboratory
where this kind of research with somatic transfer was taking
place, and you find on that laboratory table an egg that has
had its genetic material transferred and a gun, how do you
know--how do you--isn't the question of what the intent is the
same for--in both instances?
In other words, why not confiscate the gun and the cells
because we don't know what the intent is of the user, whether
the user intends to commit a crime with either one of those?
It seems to me to be a very strikingly absurd position to
say that in most instances, we respect the freedom of
individuals to say that they have not committed a crime until
they commit one. But in this instance, we want to stop them
before because we do not understand what their intent is. What
is the distinction there?
Mr. Allen. Mr. Greenwood, I think it really raises the
question about the intent language in your bill, specifically.
And I think that that--I would turn that back to you and say
that that is the concern that we have with your bill, is that
it requires us to figure that out.
And we have no way of doing that, top figure out whether a
set of embryos are set for research purposes as opposed to
being shipped and ultimately used for reproductive purposes.
And the way to deal with it at this point is to ban both.
Mr. Greenwood. Thank you, gentleman, for yielding.
Mr. Bilirakis. I thank the gentleman, as a courtesy to a
member of the full committee--well, no, I see that Mr. Green
has now appeared. Mr. Green to inquire?
Mr. Green. Yes, Mr. Chair. And I know we have a vote on, so
I will be as quick as I can.
Mr. Bilirakis. No, it is a recess.
Mr. Green. Oh, okay, that is even better.
Mr. Bilirakis. You still can be brief though.
Mr. Green. Oh, okay, I will try and be brief, then, Mr.
Chairman.
Mr. Allen, your statement that the administration opposes
somatic cell nuclear transfer for both therapeutic and
reproductive purposes, but that it supports other approaches to
development of these therapies such as research of genes,
cells, or tissues from humans or animals consistent with
current law--can you elaborate on the phrase ``consistent with
current law''?
Current law, for example, provides that Federal funding is
available for research that uses embryonic stem cells. Are we
to take from your statement the administration has now settled
on its position on the matter? I guess current law is a----
Mr. Allen. If I understand your question referring to stem
cell research, the President will make a statement. He will
make a decision as to the administration's position on stem
cell research, embryonic stem cell research.
That is not my place to do that. And he will make that
statement, and it will be a very clear statement about that.
What we are focusing on here is solely on the issue of cloning
and using cloned human embryos for the purpose, whether it be
for stem cell research or for reproductive purposes as well.
So, it is a very narrow review. The issue of stem cell
research will be discussed at a later date by the President,
himself.
Mr. Green. Okay, but does the administration--the
administration does not support the use of any kind of research
into human cloning for stem cell research, or is that something
we are going to wait for the Secretary?
Mr. Allen. The answer would be--if it uses human cloning,
then the answer would be no.
Mr. Green. Okay. You indicate that the concerns of scope of
the FDA role remain to be resolved, such as whether the use of
human somatic cell nuclear transfer is morally acceptable in
any circumstances.
Elsewhere in your statement, you clearly support a total
ban on SCNT. Yet, this argued statement I just quoted implied
that you are not sure, that the administration's position could
change.
Under what circumstance, if any, would the administration
support therapeutic use of human somatic cell nuclear transfer?
Mr. Allen. We believe that it is a very responsible
position to say that we should ban this entire area at this
point. Science may advance. There may be therapies that can be
developed based first upon animal cloning techniques to see
whether they are ethicacious in humans.
Thereby, one of the reasons why the Weldon-Stupak bill, we
believe, has some advantages to it is that it does allow for a
review period after a scientific panel has looked at this
entire area.
And for that reason, we believe that--that it is important
that we remain flexible on what might be without being absolute
in that position.
Mr. Green. I don't think I have anything else. Thank you,
Mr. Chairman; I yield back.
Mr. Bilirakis. I thank the gentleman. Ms. Cubin to inquire?
Ms. Cubin. I don't have anything.
Mr. Bilirakis. Thank you. Mr. Brown, do you have----
Mr. Brown. No, I am not ready yet.
Mr. Bilirakis. We are all finished up with the exception of
extending courtesy to a member of the full committee, Ms.
DeGette.
Ms. DeGette. Thank you so much, Mr. Chairman. And again, I
appreciate your courtesy. Mr. Allen, you had testified, I
believe in response to Mr. Greenwood's question, that the way
the administration developed its position on this issue was you
have experts internally, and you also consulted the NIH. Is
that correct?
Mr. Allen. The NIH would be considered internally as well.
Our position is----
Ms. DeGette. Okay, but you did consult the NIH?
Mr. Allen. The NIH would certainly be a part of the
Department----
Ms. DeGette. And were----
Mr. Allen. [continuing] and their opinions would be----
Ms. DeGette. [continuing] they consulted here, sir?
Mr. Allen. Their opinions would certainly have weighed into
where we are, yes.
Ms. DeGette. Okay, because the reason I ask is on March 26,
we received a letter from Ruth Kirchstein, who is the acting
Director of the NIH, who said, ``NIH, itself, lacks experience
in this area of cloning research,`` and they declined to
testify in the March hearing we had in the Oversight and
Investigations Subcommittee because they didn't have any
experience.
Mr. Chairman, I would ask unanimous consent to submit that
letter for the record.
Mr. Allen. And I appreciate that, but that is not
inconsistent with what I have----
Ms. DeGette. Okay, thank you----
Mr. Allen. [continuing] said in that we are working with--
--
Ms. DeGette. [continuing] sir, I just--I just want----
Mr. Allen. [continuing] the NIH.
Ms. DeGette. [continuing] the record to be clear the NIH
does not feel it has expertise in this area. Now, let me ask
you, Mr. Allen, you had testified, I believe in response to Mr.
Pitts' questioning, that you go into these labs, you see these
cells sitting here, and you can't really tell what they are
for. So then, all this research might as well be banned.
Is it the administration's position that in vitro
fertilization should be banned as well since, when we walk into
labs, if we see fertilized eggs, we don't know what is going to
happen with those?
Mr. Allen. The answer would be no.
Ms. DeGette. Why not?
Mr. Allen. Because in vitro fertilization--there is a
distinction between the two, and I think I explained a little
earlier----
Ms. DeGette. Well, I know the distinction between the two,
but here is my concern. If you walk into a research lab, and
you see a bunch of fertilized eggs, how are you going to know
what the purpose is? Is the purpose going to be to take the--to
take the DNA out and to clone cells, or is the purpose going to
be to go in and implant those for in vitro fertilization?
How are you going to know the difference when you see that
matter in a research lab?
Mr. Allen. Well, we don't know the difference when we see
that matter in----
Ms. DeGette. Okay.
Mr. Allen. [continuing] the research lab.
Ms. DeGette. So, how--how is it that you are going to allow
one but not the other?
Mr. Allen. In vitro fertilization is something that is
already regulated under FDA. And therefore, the protocols, the
processes, and procedures would have already been considered by
FDA, and have been reviewed. And this certainly----
Ms. DeGette. Well, but the--I don't suppose it has been
reviewed by FDA under the Weldon-Stupak bill or the Greenwood
bill, right?
Mr. Allen. That is correct. And in both of those
circumstances, that protocol would be developed upon passage--
--
Ms. DeGette. Well, how--do the----
Mr. Allen. [continuing] of the legislation.
Ms. DeGette. [continuing] little cells have nametags? I
mean, how are you going to know? I don't--I am not meaning to
be flip here, but you walk into a research lab; how are you
going to know the purpose of those fertilized eggs?
Mr. Allen. All the more reason why, in this area of
cloning, when we are talking about cloning cells--one point
that I think is important to make, what this legislation again
does not prohibit, it does not prohibit in vitro fertilization.
It does not prohibit twinning of cells for the purpose of
implantation.
Ms. DeGette. Okay, but those----
Mr. Allen. But those are issues that we----
Ms. DeGette. But they can't be--the difference cannot be
visually determined. Would that be correct?
Mr. Allen. I am not the scientist here. I would imagine
that you are correct, that it is not--that is correct.
Ms. DeGette. Okay, thank you. Now, I have another question.
I am sorry, they only give us 5 minutes, and I am already
pushing my----
Mr. Allen. But I assume you want me to give you full
answers and complete answers so that it is not incorrect for
the record. So, if you would----
Ms. DeGette. Let me ask you one more question, which is
that in the Weldon-Stupak bill, and you just talked about this
for a moment when Mr. Green was questioning you, that bill says
that the scientific community can come back if they feel like
cloning research would be necessary for some non-human
reproductive purpose, correct?
I think it says the scientific community can come back and
request----
Mr. Allen. No, actually, it requires the scientific--it
requires a report to be issued to the Secretary and the
President that will already affirmatively address that in a 5-
year period.
Ms. DeGette. Okay.
Mr. Allen. Prior to that time----
Ms. DeGette. Okay, what----
Mr. Allen. Prior to that time----
Ms. DeGette. Uh-huh.
Mr. Allen. [continuing] if there is--if there are advances
that are made known, certainly the Department would be looking
at that as we are ongoing in this area.
Ms. DeGette. Right. Here is my question to you: if we ban
the research, how are they going to be able to make a report?
If they can't do the research, how are they going to be able to
tell you what the benefits of this type of research would be?
Mr. Allen. Very simply, in that they can do the research in
other mammals.
Ms. DeGette. But that is not----
Mr. Allen. They can do the research----
Ms. DeGette. But that is not this exact type of research,
right?
Mr. Allen. Correct, it is not because----
Ms. DeGette. Okay.
Mr. Allen. [continuing] this is an area that we are talking
about banning.
Ms. DeGette. So, you are saying they----
Mr. Allen. Can I actually----
Ms. DeGette. [continuing] can transfer animals----
Mr. Allen. [continuing] just finish an answer--complete the
question because I want to----
Ms. DeGette. Go ahead.
Mr. Allen. [continuing] give you a complete answer. And I
think that--that the record is entitled to see that----
Ms. DeGette. Go ahead, finish.
Mr. Allen. [continuing] very clear. Is the answer is very
clear; the research, the language of the Weldon-Stupak bill
allows for ongoing research and consideration of the scientific
ethicacy of all of these areas that we are talking about.
Currently, what we are talking about is that you can do
this in every other area, but there is no indication that there
are therapies that have been developed, nor should--the
position of the administration is nor should they be at this
point, absent an indication that they would be both safe,
ethicacious, and that there are moral, legal boundaries that
are put around that research.
Ms. DeGette. Thank you.
Mr. Bilirakis. The gentlelady's time has expired. Mr.
Allen, the in vitro fertilization would ordinarily take place
in a research lab?
Mr. Allen. Not likely.
Mr. Bilirakis. Ordinarily, not likely?
Mr. Allen. Usually, it takes place in a fertility clinic.
Mr. Bilirakis. Right. So, ordinarily, they wouldn't be side
by side on a table, or a group of tables in a laboratory?
Mr. Allen. That is correct, Mr. Chairman.
Mr. Bilirakis. Mr. Burr to inquire.
Mr. Burr. Am I the last, Mr. Chairman?
Mr. Bilirakis. You are not the last; Mr. Brown will be the
last.
Mr. Burr. Could I pass to Mr. Brown and come back to me?
Mr. Bilirakis. If Mr. Brown is willing to----
Mr. Burr. I am still trying to get caught up on the----
Mr. Bilirakis. [continuing] accept that pass.
Mr. Brown. Mr. Burr, I probably could.
Mr. Bilirakis. No, no----
Mr. Burr. I will say some nice things about Mr. Brown.
Mr. Bilirakis. [continuing] discussion on tax cuts now.
Mr. Brown. Well, Mr. Chairman, since you brought up the tax
cut and you always seem to need to do that----
Those of you that don't come to this hearing, don't get
that. It is really rather a stupid inside joke, but
nonetheless. I yield my 5 minutes actually to Ms. DeGette.
Thanks.
Ms. DeGette. Thank you, Mr. Chairman. Just a couple more
questions.
Mr. Allen. Certainly.
Ms. DeGette. You had, I think, testified in response to
someone's question that we have not yet seen any kind of
scientific--direct scientific result from human stem cell
research, which is accurate, I believe, right?
Mr. Allen. I don't think I--that is not correct.
Ms. DeGette. Okay.
Mr. Allen. We do know that there were use of human stem
cell research in some of the Parkinson's and Alzheimers cases
that were absolutely disastrous. So, we do have some evidence
of their use.
Ms. DeGette. But we also have some evidence from Canada,
don't we, about the use of stem cell research in Type-1
diabetes?
Mr. Allen. I will have to defer to you on that. I have not
seen that.
Ms. DeGette. Okay, well, I will let you know because I am
the co-chair of the Congressional Diabetes Caucus, that we have
seen some promising----
Mr. Allen. Oh, I wasn't----
Ms. DeGette. [continuing] stem cell research in Canada. And
also, in April, scientists at the National Institutes of Health
used mouse embryonic stem cells to generate insulin-producing
organs resembling the islets of the pancreas. Were you aware of
that research?
Mr. Allen. I was aware of that.
Ms. DeGette. So, I think you would agree with me we are
seeing some very promising stem cell research coming out, would
you not?
Mr. Allen. Actually, I think the two examples you posited,
it demonstrates that use in other mammals, that it is been very
promising. But in use of humans, it has not been.
Ms. DeGette. Well, actually, there has been some use in
humans in other countries and----
Mr. Allen. Those two examples you have posited that are--
that is what I am going on.
Ms. DeGette. Yeah.
Mr. Allen. I am not the scientist.
Ms. DeGette. And actually, I think you were the one that
testified that mammal research is often transferrable to
humans, which is why we do research on mammals.
Mr. Allen. Which is why we should perfect mammal research
prior to experimentation on humans.
Ms. DeGette. I don't think anybody would disagree with
that, certainly with cloning. Let me ask you another question,
which is, as I--what is the administration's position on
products which may be developed by use of this type of cloning
process, perhaps developed overseas?
Let us say, for example, some kind of products that
dramatically, positively impact Parkinson's patients are
developed, would it be the administration's position that those
products should be banned in the United States?
Mr. Allen. They would be subjected to the same protocol
that other products would be subjected to by the FDA before
they are allowed to be--allowed to be utilized in the United
States. We do that with other areas. We have done it in the
area of----
Ms. DeGette. Sure.
Mr. Allen. [continuing] cancer, so it would be the
similar----
Ms. DeGette. Well, as I understand the Weldon-Stupak bill,
products developed with this type of cloned material would
banned. So, would the administration support that part of the--
that bill?
Mr. Allen. That is one of the areas that I said that we
would need to work out with technical assistance with the bill
patrons to consider and see what impact it has on other areas
of what we do approve of and support.
Ms. DeGette. Now, getting back to your point about FDA
approval, is--I know safety and ethicacy are two of the
criteria used by the FDA in deciding whether or not to approve
a drug.
For example, if we had a Parkinson's drug that was
developed overseas with use of these cloned techniques, would--
I would assume the FDA will use those same standards in
deciding whether to approve the drug, unless it was banned,
right?
Mr. Allen. I would--if I understand your question
correctly, I would say that is correct. And it goes back to
your prior question. That is why we believe that having a
period--an absolute ban on that is imperative.
However, the administration is not saying that we are not
willing to look at--look at what has been done. And that is
not----
Ms. DeGette. I am sorry----
Mr. Allen. [continuing] inconsistent.
Ms. DeGette. [continuing] I am kind of confused because you
are--on the one hand, you are saying that we should have a ban
on these products. But then, you are saying, well, we need to
look at it. I don't know what you mean by that.
Mr. Allen. What I mean by that is very clear. I think it is
very imperative, and the administration believes it is
imperative, that we take a position, a very clear position, on
what we believe is----
Ms. DeGette. Yeah, I get that, but what is that----
Mr. Allen. You got that part.
Ms. DeGette. [continuing] clear position? That is not what
I get.
Mr. Allen. Okay, the clear position is that the
administration is opposed to the use of stem cell nuclear
transfer cloning for research or reproductive purposes.
Ms. DeGette. Well, obviously, the reproductive purposes, we
all----
Mr. Allen. Research or----
Ms. DeGette. [continuing] agree on that.
Mr. Allen. [continuing] reproductive.
Ms. DeGette. Now, on the research, let us say a drug is
developed----
Mr. Bilirakis. The gentlelady's time, or I should say the
gentleman's time, is expired.
Ms. DeGette. Thank you.
Mr. Bilirakis. Mr. Burr to inquire?
Mr. Burr. I thank the Chair's indulgence. Mr. Allen, tell
me what the administration says to those folks around this
country that potentially might be waiting for a breakthrough
into the current research that is out there.
Mr. Allen. Well, the administration's position would be
that there are ample existing therapies and treatments, and
very promising areas to address many of these areas--many of
these concerns, whether it is for cancer, organ, bone marrow
transplants. I saw an article in the paper this morning.
And we believe that we should be very aggressive in
pursuing, and very aggressive in supporting, that research.
Mr. Burr. Is the research that is currently being done, are
the scientists that are currently working on somatic cell
nuclear transfer, are they wrong? Is there something there that
HHS and this administration sees that says they won't be
successful?
Mr. Allen. We believe that there is something that the
research, thus far--I think the discussion earlier was in the
area of where we have seen some of this occur is in the stem
cell research area where there was use of embryonic stem cells
for Parkinson's and Alzheimers that had very deleterious
effects on the individuals that the therapies were used on.
In this area, we believe also that we need to be very
careful, extremely careful, of going down that road because of
the impact not only on the mother and child that may be
produced as a result of cloning, but also the impact that it
has on society. There are psychological; there are also moral--
--
Mr. Burr. Is this a policy decision or is this a scientific
decision?
Mr. Allen. We believe that it is a policy decision that is
based on the science. And that is why I think, contrary to
the----
Mr. Burr. Who made this decision?
Mr. Allen. This is the decision of the President and the
Secretary of Health----
Mr. Burr. And they made----
Mr. Allen. [continuing] and Human Services.
Mr. Burr. [continuing] that decision, when?
Mr. Allen. I am here providing that position.
Mr. Burr. I know you are here delivering the message today.
When did they make the decision? When did you and the Secretary
have a conversation relative to this decision?
Mr. Allen. My conversation--again, I have been on-board all
of 2 weeks, so I will have--I would have talked with the----
Mr. Burr. Well, clearly, it must have----
Mr. Allen. --Secretary during that time.
Mr. Burr. [continuing] happened sometime in that period.
Mr. Allen. So, it happened within that period. I cannot
speak specifically for when the President made his mind up
about this issue. I do know that----
Mr. Burr. Do we condone----
Mr. Allen. [continuing] when the----
Mr. Burr. Do we condone the research that is currently
going on in the U.K. as it relates to stem cell research?
Mr. Allen. I am not here to comment on the efforts of the
work that is done in other countries. We have a
responsibility----
Mr. Burr. Do we condone----
Mr. Allen. [continuing] for what takes place in----
Mr. Burr. If they were to--if they were to----
Mr. Allen. If I may----
Mr. Burr. [continuing] make legal----
Mr. Allen. [continuing] Finish my----
Mr. Burr. [continuing] human cloning, would we come out
against that policy?
Mr. Allen. Again, that is something that is left for the
British Government and its citizens to decide what is in their
best interest and what is----
Mr. Burr. So, if they----
Mr. Allen. [continuing] appropriate for them. It is not for
us to decide.
Mr. Burr. If they passed a law that made legal human
cloning, we would not come out in this country in opposition to
human cloning in the U.K.?
Mr. Allen. Again, I see no reason why I should provide a
position to comment on what the U.K. has done or is doing. I
think it is imperative that, from our perspective, we look at
what the United States does.
The United States is a leader in the world, both morally--
serving as a moral force, as well as looking at science and the
advancement of it. And we believe, at this time, that this the
wrong-headed to----
Mr. Burr. Would one conclude that the administration sees
no scientific value out of additional research in stem cell
nuclear transfer?
Mr. Allen. That is incorrect.
Mr. Burr. They do see promise?
Mr. Allen. The administration believes that it is
inappropriate at this time for us to proceed forward with
research in this area.
Mr. Burr. Do they see promise in this area, or do they see
no promise?
Mr. Allen. I am not sure that I can give you an either/or.
I think that certainly----
Mr. Burr. Well, it is a scientific question.
Mr. Allen. [continuing] we believe that there is promise--
--
Mr. Burr. [continuing] and I think you alluded to the
fact----
Mr. Allen. [continuing] we believe that there is scientific
evidence----
Mr. Burr. [continuing] that if cancer was----
Mr. Allen. [continuing] that there is promise as we work
within mammals and see the ethicacy there. The application to
humans at that point is something that we would certainly need
to look at and consider.
That is, again, the reason why we believe that the Weldon-
Stupak bill provides for the vehicle through which further
analysis, further review, and further comments to be made on
that area.
Mr. Burr. Mr. Chairman, I am sorry that I wasn't here for
the full discussion. And I am sure I will have follow-up
questions. I would ask unanimous consent that we be allowed to
send those directly to the Agency?
Mr. Bilirakis. Without objection, that is the case. I think
that ends this portion of the hearing, Mr. Allen. We appreciate
your being here. Obviously, there will be questions that will
be forwarded to you. We would request timely responses.
It is a tough issue, and I am not sure that anybody has
really counted votes in terms of either piece of legislation as
they may be re-molded. But I would like to think that we are
intent on moving, at some point, on this issue.
So, please take a little bit of leadership on it, and work
with the principals.
Mr. Allen. Certainly, we--and we look forward to working
with the members. Thank you.
Mr. Bilirakis. Thank you. Thank you very much, sir. The
second panel consists of Mr. Thomas Okarma, President of the
Geron Corporation, here on behalf of the bio-tech industry; Dr.
Leon Kass, Addie Clark Harding Professor of Social Thought and
the College from the University of Chicago; Mr. Louis Guenin,
lecturer on ethics and science with the Department of
Microbiology and Molecular Genetics, Harvard Medical School;
Dr. Stuart Newman, Professor of Cell Biology and Anatomy for
the Department of Cell Biology and Anatomy, New York Medical
College; Mr. Dan Perry, Executive Director of Alliance--with
the Alliance for Aging Research; Ms. Judy Norsigian, Executive
Director of the Boston Women's Health Book Collective-
Collective, associated with Boston University, Boston
University School of Public Health; Mr. Richard Doerflinger,
Associate Director for Policy Development with the National
Conference of Catholic Bishops; and Mr. Francis Fukuyama, Omer
L. and Nancy Hirst Professor of Public Policy for the School of
Public Policy at George Mason University.
Lady and--where is Ms. Norsigian? Ms. Norsigian and
gentlemen, welcome. Thank you so much for being here. You have
had to sit through 2 hours of this. But believe me, that is not
really a long period of time when you take into consideration
how we function up here and the usual interruptions we have
running in for votes.
But we do have a little bit of a break in the sense that
there is a recess on the floor. So, hopefully, we can go
uninterrupted, for a short period of time anyhow, and maybe
complete it.
Your written statement is a part of the record. We will set
the clock at 5 minutes. Hopefully, you can complete your
statement within that period of time. If you go over for a
short period of time, I won't call you on it. But I would
appreciate it if you would compliment and supplement your
written statement.
We will start off with Mr. Okarma. Please proceed, sir.
STATEMENTS OF THOMAS OKARMA, PRESIDENT, GERON CORPORATION, ON
BEHALF OF BIOTECHNOLOGY INDUSTRY ORGANIZATION; LEON R. KASS,
ADDIE CLARK HARDING PROFESSOR OF SOCIAL THOUGHT AND THE
COLLEGE, UNIVERSITY OF CHICAGO; LOUIS M. GUENIN, LECTURER ON
ETHICS IN SCIENCE, DEPARTMENT OF MICROBIOLOGY AND MOLECULAR
GENETICS, HARVARD MEDICAL SCHOOL; STUART A. NEWMAN, PROFESSOR
OF CELL BIOLOGY AND ANATOMY, DEPARTMENT OF CELL BIOLOGY AND
ANATOMY, NEW YORK MEDICAL COLLEGE; DANIEL PERRY, EXECUTIVE
DIRECTOR, ALLIANCE FOR AGING RESEARCH; JUDY NORSIGIAN,
EXECUTIVE DIRECTOR, BOSTON WOMEN'S HEALTH BOOK COLLECTIVE,
BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH; RICHARD M.
DOERFLINGER, ASSOCIATE DIRECTOR FOR POLICY DEVELOPMENT,
NATIONAL CONFERENCE OF CATHOLIC BISHOPS; AND FRANCIS FUKUYAMA,
OMER L. AND NANCY HIRST PROFESSOR OF PUBLIC POLICY, THE SCHOOL
OF PUBLIC POLICY, GEORGE MASON UNIVERSITY
Mr. Okarma. Good afternoon. I am Tom Okarma, President and
CEO of Geron Corporation in Menlo Park, California. Geron is a
biopharmaceutical company focusing on discovering, developing,
and commercializing therapeutic and diagnostic products in
oncology, drug discovery and regenerative medicine.
Today, I am testifying on behalf of my company and the
Biotechnology Industry Organization. BIO represents more than
950 biotechnology companies, academic institutions, State bio-
tech centers, and related organizations in all 50 U.S. States
and 33 other nations.
Mr. Chairman and members of the subcommittee, thank you for
the opportunity to testify today at this important meeting on
cloning. In my testimony today, I would like to make three
points.
First, Geron Corporation, BIO, and the overwhelming portion
of scientists and physicians oppose human reproductive cloning
of human beings.
Second, however in our shared zeal to prevent reproductive
cloning, we must not prevent research on tissue cloning, which
is fundamental to enable the development of safe and effective
cellular transplant patient therapies that could, and we
predict will, revolutionize medicine.
Third, the objective of the research is to develop a
scalable process to enable the direct conversion of a somatic
or body cell into a pluripotent cell without consuming oocytes
and without generating embryos.
Such a process would allow the generation of transplantable
replacement cells that would not be rejected by the immune
system. First, ban reproductive cloning. It would be extremely
dangerous to attempt human reproductive cloning. It took over
270 attempts before Dolly was successfully cloned.
In fact, in most animals, reproductive cloning is no better
than a three to 5 percent success rate; that is, very few of
the cloned animal embryos implanted in a surrogate mother
animal survive.
The others either die in utero, sometimes at very late
stages of pregnancy, or die soon after birth. It is simply
unacceptable to subject humans to those risks.
To allow human reproductive cloning would be irresponsible.
Worse yet, it could lead to a back-lash that would stifle the
numerous beneficial applications of therapeutic cloning
technology, some of which I will now describe.
It is critical, therefore, to distinguish the use of
cloning technology to create a new human beings from other
appropriate and important uses of the technology, such as
cloning specific human cells, genes, and tissues that do not
and cannot lead to a cloned human being.
The full potential of this technology comes from its use in
regenerative medicine. Many diseases result in the disruption
of cellular function or the destruction of tissue. Heart
attacks, stroke, diabetes, are all examples of common
conditions in which critical cells are lost to disease.
Today's medicine is completely unable to restore this loss
of function. Regenerative medicine is a new therapeutic
paradigm that holds the potential to cause an individual's
currently malfunctioning cells to begin to function properly
again, or even to replace dead or irreparably damaged cells
with fresh, healthy ones, thereby restoring organ function.
The goal of the research is to produce transplantable cells
that provide these benefits without triggering immune rejection
of the transplanted cells. This could be used to treat numerous
diseases such as diabetes, heart disease, stroke, Parkinson's
disease, and spinal cord injury.
For example, today, we have learned how to turn
undifferentiated human pluripotent stem cells into human
neurons, human liver cells, and human heart muscle cells. These
human replacement cells function normally in vitro, raising the
possibility for their application in the treatment of
devastating diseases affecting these tissue types.
This would, for example, allow patients with heart disease
to receive new heart muscle cells that would improve heart
function. Cellular cloning techniques are a critical and
necessary step in the production of sufficient quantities of
vigorous replacement cells for the clinical treatment of
patients.
Somatic cell nuclear transfer research is essential if we
are to achieve our goals in regenerative medicine. We must
understand the biological properties of the egg cell and the
transferred nucleus that cause a differentiated cell to turn
into a pluripotent one.
This process is called ``reprogramming,'' and we are still
not sure how it works, which is why we need to perform the
research.
At Geron, our aim is to harness and therapeutically apply
the power of this biology. Once we fully understand
reprogramming, we will be able to develop specific cells for
transplantation without immune rejection.
We will do that by taking a differentiated cell from a
particular patient, reprogramming it back to form a pluripotent
cell from which we can produce the differentiated cells we need
for transplantation back into that individual.
By using the patient's own cells as starting material, we
will avoid complications due to immune response rejection.
However, this is precisely the research that would be
banned by the Weldon bill. Because the Weldon bill does not
distinguish between reproductive cloning and the use of cloning
for research purposes, it will cutoff this work and prevent its
therapeutic applications from reaching patients.
In contrast, the bipartisan bill introduced by
Representatives Greenwood and Deutsch and others bans
reproductive cloning appropriately, but allows the continuation
of research.
BIO supports Greenwood-Deutsch because it strikes the
appropriate balance between prohibiting acts that are unsafe
and unethical, while promoting vital medical research.
Last, it is critical to emphasize that once we understand
the molecular biology of reprogramming, we will no longer need
to use egg cells or to create blastocysts. The commercial
process envisioned would transform a somatic cell, such as a
skin cell, into a pluripotent cell directly, without the use of
oocytes or the creation of blastocysts.
Moreover, understanding the biology of reprogramming is a
critical step to improve the usefulness of so-called adult stem
cells. Ironically, the Weldon bill will also be a set-back for
adult stem cell research.
In conclusion, Mr. Chairman, human reproductive cloning
remains unsafe, and the ethical issues it raises have not been
reasonably resolved. It should be prohibited.
However, as Congress seeks to outlaw reproductive cloning,
it must not write legislation that will stop research using
cloning technology.
Unfortunately, the Weldon bill fails that test. Simply put,
enactment of the Weldon bill will stop critical therapeutic
research in its tracks. Only Greenwood-Deutsch strikes the
right balance. Thank you.
[The prepared statement of Thomas Okarma follows:]
Prepared Statement of Thomas Okarma, President and CEO, Geron
Corporation on Behalf of the Biotechnology Industry Organization
Good afternoon. My name is Thomas Okarma. I am the President and
CEO of Geron Corporation in Menlo Park, California. Geron is a
biopharmaceutical company focused on discovering, developing, and
commercializing therapeutic and diagnostic products for applications in
oncology, drug discovery and regenerative medicine. Geron's product
development programs are based upon three patented core technologies:
telomerase, human pluripotent stem cells, and nuclear transfer.
I am testifying today on behalf of my company and the Biotechnology
Industry Organization (BIO). BIO represents more than 950 biotechnology
companies, academic institutions, state biotechnology centers and
related organizations in all 50 U.S. states and 33 other nations. BIO
members are involved in the research and development of health care,
agricultural, industrial and environmental biotechnology products.
Mr. Chairman, and members of the Subcommittee, thank you for the
opportunity to testify today at this important hearing on cloning. Let
me start by making our position perfectly clear: BIO opposes human
reproductive cloning. It is simply too dangerous technically and raises
far too many ethical and social questions.
That's why BIO wrote to President Bush earlier this year and urged
him to extend the voluntary moratorium on human reproductive cloning
which was instituted in 1997. I would respectfully ask for this letter
to be included in the hearing record.
It would be extremely dangerous to attempt human reproductive
cloning. It took over 270 attempts before Dolly was successfully
cloned. In fact, in most animals, reproductive cloning has no better
than a 3-5% success rate. That is, very few of the cloned animal
embryos implanted in a surrogate mother animal survive. The others
either die in utero--sometimes at very late stages of pregnancy--or die
soon after birth. Only in cattle have we begun to achieve some
improvements in efficiency. However, scientists have been attempting to
clone many other species for the past 15 years with no success at all.
Thus, we cannot extrapolate the data from the handful of species in
which reproductive cloning is now possible to humans. This underlines
that this would be an extremely dangerous procedure.
It is simply unacceptable to subject humans to those risks. Rogue
and grandstanding so-called scientists who claim they can--and will--
clone humans for reproductive purposes insult the hundreds of thousands
of responsible, reputable scientists who are working hard to find new
therapies and cures for millions of individuals suffering from a wide
range of genetic diseases and conditions.
The Food and Drug Administration (FDA) has publicly stated that it
has jurisdiction over human reproductive cloning experiments and that
it will not approve them. BIO supports that view and hopes that the
next FDA commissioner--whoever that might be--will assert FDA's current
statutory authority forcefully.
There are also many ethical concerns raised by the specter of
cloning. As noted in BIO's letter to the President, ``Cloning humans
challenges some of our most fundamental concepts about ourselves as
social and spiritual beings. These concepts include what it means to be
a parent, a brother, a sister and a family.
``While in our daily lives we may know identical twins, we have
never experienced identical twins different in age or, indeed,
different in generation. As parents, we watch with wonder and awe as
our children develop into unique adults. Cloning humans could create
different expectations. Children undoubtedly would be evaluated based
on the life, health, character and accomplishments of the donor who
provides the genetic materials to be duplicated. Indeed, these factors
may be the very reasons for someone wanting to clone a human being.''
As you can see, Mr. Chairman, many of these issues strike at the
heart of beliefs and values that are inherent in the human condition.
What does it mean to be an individual? How should we view our parents,
brothers, sisters, and children? How does the world around us influence
our intellectual, physical and spiritual development? These are just a
few of the questions raised by human cloning. In my view, reproductive
cloning would devalue human beings by depriving them of their own
uniqueness.
To allow human reproductive cloning would be irresponsible. Worse
yet, it could lead to a backlash that would stifle the numerous
beneficial applications of therapeutic cloning technology--some of
which I will describe today--that could lead to cures and treatments
for some of our most deadly and disabling diseases.
BENEFICIAL USES OF CLONING TECHNOLOGY
It is critical to distinguish use of cloning technology to create a
new human being (reproductive cloning) from other appropriate and
important uses of the technology such as cloning specific human cells,
genes and other tissues that do not and cannot lead to a cloned human
being (therapeutic cloning). These techniques are integral to the
production of breakthrough medicines, diagnostics and vaccines to treat
many diseases. They could also produce replacement skin, cartilage and
bone tissue for burn and accident victims, and result in ways to
regenerate retinal and spinal cord tissue.
Let me briefly explaining a cloning technology--somatic cell
nuclear transfer--and how it is used for research purposes. First, the
nucleus of an egg cell is removed. In its place, we insert the nucleus
of an already differentiated cell (a cell that performs a specific
function in the body). Chemicals are added to stimulate the egg to
start dividing. At about 3-5 days, a blastocyst is formed which
contains an inner cell mass comprised of undifferentiated, pluripotent
cells. These cells are removed and used for research. The research
value of these cells is enormous. These stem cells have the potential
to form any cell in the body and can replicate indefinitely. Studies in
animals demonstrate that this could lead to cures and treatments for
millions of Americans who suffer from diseases and disabilities such as
diabetes, stroke, Parkinson's Disease, heart disease, and spinal cord
injury.
As exciting as that is--it's only a part of the story. The full
potential of this technology comes from its use in regenerative
medicine.
REGENERATIVE MEDICINE
Many diseases result in the disruption of cellular function or
destruction of tissue. Heart attacks, strokes, and diabetes are
examples of common conditions in which critical cells are lost to
disease. Today's medicine is unable to completely restore this loss of
function. Regenerative medicine, a new therapeutic paradigm, holds the
potential to cause an individual's currently malfunctioning cells to
begin to function properly again or even to replace dead or irreparably
damaged cells with fresh healthy ones, thereby restoring organ
function.
The goal of Geron's regenerative medicine program is to produce
transplantable cells that provide these therapeutic benefits without
triggering immune rejection of the transplanted cells. This could be
used to treat numerous chronic diseases such as diabetes, heart
disease, stroke, Parkinson's Disease and spinal cord injury.
At Geron, therapeutic cloning technology is one of the techniques
we use to create pure populations of functional new cells that can
replace damaged cells in the body. For example, we are learning how to
turn undifferentiated human pluripotent stem cells into neurons, liver
cells and heart muscle cells. Thus far, these human replacement cells
appear to function normally in vitro, raising the possibility for their
application in the treatment of devastating chronic diseases affecting
these tissue types. This would, for instance, allow patients with heart
disease to receive new heart muscle cells that would improve cardiac
function. Cellular cloning techniques are a critical and necessary step
in the production of sufficient quantities of vigorous replacement
cells for the clinical treatment of patients.
Somatic cell nuclear transfer research is essential if we are to
achieve our goals in regenerative medicine. We must understand the
biological properties of the egg cell (and the transferred nucleus)
that cause a differentiated cell to turn into a pluripotent cell. This
process is called ``re-programming''--and we're still not sure how it
works. That's why we need to continue to perform research.
At Geron, our aim is to harness and therapeutically apply the power
of this biology. Once we fully understand re-programming we will be
able to develop specific cells for transplantation without immune
rejection. We'll do that by taking a differentiated cell from a
particular individual and re-programming it to form a pluripotent cell
from which we can produce the differentiated cells we need for
transplantation back into that individual. By using the patient's own
cells as starting material, we will avoid complications due to immune
response rejection.
However, this is precisely the research that would be banned by the
Weldon bill. Because the Weldon bill does not distinguish between
reproductive cloning and use of cloning for research purposes, it will
cut off this work and prevent its therapeutic applications from
reaching patients. In contrast, the bi-partisan bill introduced by
Reps. Greenwood, Deutsch, and others bans reproductive cloning but
allows the continuation of research. BIO supports Greenwood/Deutsch
because it strikes the appropriate balance between prohibiting acts
that are unsafe and unethical, while promoting vital medical research.
It is important to emphasize that once we understand the molecular
biology of re-programming, we will no longer need to use egg cells or
create blastocysts. Therefore, this technology is likely to be used
only for a short, finite period of time. Moreover, understanding the
biology re-programming is a critical step to improve the usefulness of
adult stem cells. Ironically, therefore, the Weldon bill will also be a
setback to adult stem cell research.
CONCLUSION
As the current Congress pursues legislative prohibitions on human
reproductive cloning, we urge caution and a distinction between
reproductive and therapeutic cloning. We all agree that given the
current safety and social factors, human reproductive cloning is
repugnant. However, it is critical that in our enthusiasm to prevent
reproductive cloning, we not ban vital research, turning wholly
legitimate biomedical researchers into outlaws, and thus squelching the
hope of relief for millions of suffering individuals.
Our nation is on the cusp of reaping the long dreamed of rewards
from our significant investment in biomedical research. The U.S.
biotech industry is the envy of much of the world, especially our
ability to turn basic research at NIH and universities into applied
research at biotech companies and in turn, into new therapies and cures
for individual patients. Using somatic cell nuclear transfer and other
cloning technologies, biotech researchers will continue to learn about
cell differentiation, re-programming, and other areas of cell and
molecular biology. Armed with this information, they can eventually
crack the codes of diseases and conditions that have plagued us for
hundreds of years, indeed, for millennia.
In conclusion, Mr. Chairman, human reproductive cloning remains
unsafe, and the ethical issues it raises have not been reasonably
resolved. It should be prohibited. However, as Congress seeks to outlaw
reproductive cloning, it must not write legislation that will stop
research using cloning technology. Unfortunately, the Weldon bill fails
that test. Simply put, enactment of the Weldon bill will stop critical
therapeutic research in its tracks. Only Greenwood/Deutsch strikes the
right balance.
Thank you for the opportunity to testify. I'll be happy to answer
any questions.
Mr. Bilirakis. Thank you. Dr. Kass, please proceed, sir.
STATEMENT OF LEON R. KASS
Mr. Kass. Thank you, Mr. Chairman, for the opportunity to
testify before the subcommittee. I am Leon Kass. I am a
professor at the University of Chicago. I have been
professionally concerned for over 30 years with the ethical
implications of biomedical technologies.
These technologies have now brought us to a crucial fork in
the road where we are compelled to decide whether we wish to
travel down the path that leads to the brave, new world. That,
and nothing less, is what is at stake in your current
deliberations about whether we should tolerate the practice of
human cloning.
And if I may say so, I have heard Members of Congress say
that we should be very careful not to jeopardize the health
benefits that are available from research cloning. I think we
should be very careful before we take any step that might lead
us in an accelerated path down this road toward the brave, new
world. Care has to be exercised on both sides.
I am here to testify in favor of a national ban on human
cloning, and in particular, in favor of H.R. 1644, the Human
Cloning Prohibition Act 2001, for two reasons.
First, I believe that cloning human beings is unethical,
both in itself and, importantly, in what it will surely lead
to. And second, I believe that this bill offers us the best,
indeed the only, reasonable chance of preventing human
reproductive cloning from happening.
In the written testimony, I give the ethical arguments as
to why we should object to human reproductive cloning. Having
heard no dissent on that, I will simply skip over that and take
it for granted that we agree on that, and speak only about the
legislative approaches.
But I do want to say one thing here. There is more at stake
in this question than the simple question of cloning, because
what we would be establishing if we say yes to cloning, is that
we will be establishing, as a dangerous principle, the right
that we have to determine in advance the genetic make-up of our
children.
If we won't--don't want to travel down that road, we want
to make sure that we have an effective ban on human cloning
now, before we are overtaken by events. It is important that we
do something now.
Two legislative approaches have been proposed. One would
ban only so-called reproductive cloning by prohibiting the
transfer of a cloned embryo to a woman to initiate a pregnancy.
The other would ban all cloning by prohibiting the creation
even of the embryonic clones.
I had, once upon a time, looked for a third way, but I am
now convinced that an effective ban on reproductive cloning
requires a ban on all cloning, on all cloning, including the
creation of the embryonic clones, and here is why.
Once the cloned embryos are produced and available in the
laboratories and assisted reproduction centers, it will be
virtually impossible to control what is done with them.
Stockpiles of cloned human embryos could be produced,
bought and sold without anyone's knowing it. Efforts at clonal
reproduction would take place out of sight, within the privacy
of the doctor/patient relationship. And moreover, a ban on only
reproductive cloning will turn out to be unenforceable.
Should illicit cloning be discovered, governmental attempts
to enforce the reproductive ban would run into a swarm of legal
and practical challenges. And the practice at that stage, I
submit, would be impossible to police or regulate.
Therefore, if you are serious--anyone who is really serious
about trying to prevent human reproductive cloning must seek to
stop this process at the start.
Now, I believe H.R. 1644 is precisely suited to accomplish
this goal, no more and no less. It explicitly and precisely
defines the specific deed that is outlawed, human somatic cell
nuclear transfer to an egg, and it does not entangle us in
difficult determinations of the perpetrator's intent or
knowledge.
It is extremely carefully drafted and limited in its scope,
and it makes it clear that there is to be no interference with
scientifically and medically useful practices of animal cloning
or equally valuable cloning of human DNA fragments, duplication
of cells, stem cells or somatic cells, in culture.
And if enacted, this bill would bring the United States
into line with the already and soon-to-be-enacted practices of
many other nations. And we should take the lead, rather than be
an outlaw nation in this regard.
People who prefer the other approach, namely a ban only on
the transfer of a human clone to initiate a pregnancy, will
probably look with favor on the other bill before you, H.R.
2172.
But please observe; in my opinion, I think a careful
consideration of the specifics of this bill shows that it does
not effectively provide the ban on reproductive cloning that
everyone wants.
Indeed, it does not explicitly ban reproductive cloning at
all. It prohibits only two things. First, it prohibits the
creation of the embryonic clones by people whose intent it is
to begin a pregnancy; and second, it prevents people from
shipping or transporting the ``cellular product resulting from
this transfer,'' but only if they know that the product is
intended to be used to initiate a pregnancy. Those are the only
two acts that are prohibited.
Put those two prohibitions taken together; they fail to
outlaw a pregnancy initiating transfer of a cloned embryo to a
woman by someone other than its manufacturer. Indeed, nowhere
in this bill, nowhere in this bill, does it specifically ban
the act of reproductive transfer to a woman by anyone.
And if this bill really, seriously intended to outlaw
reproductive cloning, it should have read that, ``It shall be
unlawful to use the cellular product of somatic cell nuclear
transfer to initiate a pregnancy.'' It nowhere says anything
that clear. This bill fails to outlaw the attempts to create a
live, born human-cloned individual.
Consider this possible scenario. It is very clear. I create
the embryos by somatic cell nuclear transfer. You buy them from
me, and you tell me that you want them for research. And I ship
them to you, taking you at your word.
Your company changes management, or you change your mind,
and they decide it is profitable to use the purchased embryos
for reproductive cloning. Under the terms of this bill, I have
done nothing illegal; you have done nothing illegal, and the
cloned child is born.
In brief, with all due respect, as I read the present text
of the Greenwood bill, it seems to be less the Cloning
Prohibition Act of 2001 and more the Human Embryo Cloning
Registry and Industry Protection Act of 2001.
It is not the reproductive cloning ban the American people
are looking for. And I have some other things, some----
Mr. Bilirakis. Please summarize, Dr. Kass.
Mr. Kass. [continuing] details. I will just wind up. It
seems to me, as the composition of this panel of witnesses will
make clear, the issue of human cloning is not an issue of pro-
life or pro-choice. It is not mainly about death and
destruction. It is not about a woman's right to choose. It is
not about stem cell research. It is not even about the basic
freedom of scientists to inquire.
It is most emphatically about baby design and manufacture.
And it is the opening skirmish in a long battle against
eugenics and the post-human future.
Once the embryonic clones are produced in the laboratories,
this eugenic revolution will have begun, and we will have lost
our best chance to do something about it.
[The prepared statement of Leon R. Kass follows:]
Prepared Statement of Leon R. Kass, Addie Clark Harding Professor,
Committee on Social Thought and the College, The University of Chicago
Thank you, Mr. Chairman, for the opportunity to testify before the
subcommittee. I am Leon R. Kass, Addie Clark Harding Professor in the
Committee on Social Thought and the College, The University of Chicago.
I have been professionally concerned, for over 30 years, with the
ethical implications of biomedical advance. Originally trained in both
medicine and biochemistry, I remain enthusiastic about biomedical
research and its promise to cure disease and relieve suffering. Yet, as
has been obvious for some time, new biotechnologies are also providing
powers to intervene in human bodies and minds in ways that go beyond
the traditional goals of healing the sick, to threaten fundamental
changes in human nature and the meaning of our humanity. These
technologies have now brought us to a crucial fork in the road, where
we are compelled to decide whether we wish to travel down the path that
leads to the Brave New World. That, and nothing less, is what is at
stake in your current deliberations about whether we should tolerate
the practice of human cloning.
I am here to testify in favor of a national ban on human cloning
and, in particular, in favor of HR 1644, ``The Human Cloning
Prohibition Act of 2001,'' for two reasons. First, I believe that human
cloning is unethical, both in itself and in what it surely leads to.
Second, I believe that this bill offers us the best--indeed, the only--
reasonable chance at preventing human reproductive cloning from
happening. (The full version of my argument is contained in a recent
essay, ``Preventing a Brave New World: Why We Should Ban Human Cloning
Now,'' written precisely to gain support for such a bill and published
in the May 21, 2001 issue of The New Republic. I submit it as an
appendix to this statement.)
The vast majority of Americans object to human cloning, and on
multiple moral grounds, among them the following. It constitutes
unethical experimentation on the child-to-be, subjecting him or her to
enormous risks of bodily and developmental abnormalities. It threatens
individuality, by deliberately saddling the clone with a genotype that
has already lived and to whose previous life its life will always be
compared. It confuses identity by denying the clone two biological
parents and by making it the twin of its older copy. It represents a
giant step toward turning procreation into manufacture (especially when
understood as the harbinger of non-therapeutic genetic manipulations to
come). And it is a radical form of parental despotism and child abuse--
even when practiced freely and on a small scale. Permitting human
cloning means saying yes to the dangerous principle that we are
entitled to determine and design the genetic make-up of our children.
If we do not wish to travel down this eugenic road, an effective ban on
cloning human beings is needed, and needed now before we are overtaken
by events.
A majority of members of Congress, I believe, are, like most
Americans, opposed to human cloning. But opposition is not enough. For
if Congress does nothing about it, we shall have human cloning, and we
shall have it soon. Congress' failure to try to stop human cloning--and
by the most effective means--will in fact constitute its tacit
approval.
What, then, is the most effective way to stop reproductive human
cloning? Two legislative approaches competed with each other the last
time Congress took up this issue. One bill would have banned only so-
called reproductive cloning by prohibiting the transfer of a cloned
embryo to a woman to initiate a pregnancy. The other bill would have
banned all cloning by prohibiting the creation even of the embryonic
human clones. Both sides opposed reproductive cloning, but because of
the divide over the question of embryo research we got no ban at all.
It would be tragic if we again failed to produce an effective ban on
cloning human beings, especially now that certain people are going
ahead with it and defying us to try to stop them.
A few years ago, I was looking for a middle way between the two
alternatives that failed last time, but I am now convinced that an
effective ban on reproductive cloning requires a ban on all human
cloning, including the creation of the embryonic clones. Anyone truly
serious about preventing human reproductive cloning must seek to stop
the process from the beginning, at the stage where the human somatic
cell nucleus is introduced into the egg. Here is why.
Once cloned human embryos are produced and available in
laboratories and assisted-reproductive centers, it will be virtually
impossible to control what is done with them. Biotechnical procedures
and experiments take place in laboratories, hidden from public view,
and for good commercial reasons these doings are concealed from the
competition and everyone else. Huge stockpiles of cloned human embryos
could thus be produced and bought and sold in the private sector
without anyone knowing it. As we have seen with in vitro embryos
created to treat infertility, embryos produced for one reason can be
used for another reason: today ``spare embryos'' once created to begin
a pregnancy are now used--by someone else--in research, and tomorrow
clones created for research will be used--by someone else--to begin a
pregnancy. Efforts at clonal baby-making (like other forms of assisted-
reproduction) would take place out of sight, within the privacy of a
doctor-patient relationship, making outside scrutiny extremely
difficult. Moreover, the transfer of embryos to begin a pregnancy is a
simple procedure (especially compared with manufacturing the embryo in
the first place), simple enough that its final steps could be self-
administered by the woman, who would thus absolve the doctor of blame
for having ``caused'' the illegal transfer.
Worst of all, a ban on only reproductive cloning will turn out to
be unenforceable. Should the illegal practice be detected, governmental
attempts to enforce the reproductive ban would run into a swarm of
practical and legal challenges, both to efforts aimed at preventing
embryo transfer to the woman and--even worse--to efforts seeking to
prevent birth after the transfer has occurred. Should an ``illicit
clonal pregnancy'' be discovered, no government agency is going to
compel a woman to abort the clone, and there would be an understandable
swarm of protest should she be fined or jailed before or after she
gives birth.
For all these reasons, the only practically effective and legally
sound approach is to block human cloning at the start, at the
production of the embryonic clone. Such a ban is rightly characterized
not as interference with reproductive freedom, nor even as
unprecedented or dangerous interference with scientific inquiry, but as
an attempt to prevent the unhealthy, unsavory, and unwelcome
manufacture of and traffic in human clones. It would do what the
American people want done: stop human cloning before it starts.
H.R. 1644, introduced by Dr. Weldon and joined now by more than 100
cosponsors, is just what the doctor ordered, precisely suited to
accomplish this goal, no more and no less. It explicitly and precisely
describes the specific deed that is outlawed (human somatic cell
nuclear transfer to an egg), and it does not entangle us in difficult
determinations of the perpetrator's intent or knowledge. Its
substantial criminal and monetary penalties will almost certainly shift
the incentives for renegades who are tempted to proceed. Extremely
carefully drafted and limited in its scope, the bill makes very clear
that there is to be no interference with the scientifically and
medically useful practices of animal cloning or the equally valuable
cloning of human DNA fragments, the duplication of somatic cells, or
stem cells in tissue culture. Moreover, if enacted this bill would
bring the United States into line with the already and soon-to-be-
enacted practices of other nations, and, in collaboration with these
efforts, offers us the best and, I think, the only realistic chance we
have of keeping human cloning from happening, or happening much.
People who prefer the other approach to stopping human cloning,
namely, a ban only on transfer of an embryonic clone to initiate a
pregnancy, will oppose H.R. 1644 and will probably look with favor on
the other bill before this Committee, H.R. 2172, introduced last week
by Reps. Greenwood and Deutsch. But, in my opinion, a careful
consideration of the specifics of this bill (as now written) shows that
it does not effectively provide the ban on reproductive cloning that
everyone wants. Indeed, it does not explicitly ban reproductive cloning
at all. This bill permits the use of human somatic cell nuclear
transfer technology (HSCNTT 1), the act that creates an
embryonic human clone. It prohibits (only) two things. First, it
prohibits this act by people whose intent is to begin a pregnancy.
Second, it prohibits people from shipping or transporting ``the
cellular product resulting from HSCNTT,'' but only if they know that
``the product is intended to be used to initiate a pregnancy.'' These
two prohibitions, even taken together, fail to outlaw a pregnancy-
initiating transfer of a cloned embryo to a woman--by someone other
than its manufacturer. (Indeed, nowhere does the bill specifically ban
the act of reproductive transfer to a woman by anyone.2) As
a result, this bill fails to outlaw efforts to create a live-born human
cloned individual.
---------------------------------------------------------------------------
\1\ HSCNTT is defined as the act of ``transferring the nucleus of a
human somatic cell into an egg cell from which the nucleus has been
removed or rendered inert.''
\2\ Readers of the bill may see this for themselves, by
substituting the statutory definition of HSCNTT [provided in SEC. 1001.
(a) (2)] into the first prohibition [SEC. 1001. (a) (1) (A): ``It shall
be unlawful to transfer or to attempt to transfer the nucleus of a
human somatic cell into an egg cell from which the nucleus has been
removed or rendered inert with the intent to initiate a pregnancy.''
That this is the correct meaning of what is prohibited can be confirmed
by the appearance, in the description of the second prohibited act
[SEC. 1001. (a) (1) (B)], of the phrase ``cellular product resulting
from HSCNTT,'' that is, the embryonic human clone. If the bill wanted
explicitly to ban the act of so-called reproductive human cloning, the
first prohibition could and should have read: ``It shall be unlawful to
use the cellular product of HSCNTT to initiate a pregnancy.''
Furthermore, such a proscription would have made the prohibition of
shipping and transporting unnecessary.
---------------------------------------------------------------------------
The Greenwood-Deutsch bill places virtually no restrictions on the
use of licitly produced ``cellular products'' of the technology (i.e.,
the embryonic clones), once they are created. Strikingly, there is no
prohibition on receiving the ``cellular product'' of HSCNTT (i.e., the
embryos) with an intent to initiate a pregnancy; indeed, there is no
restriction whatsoever on what the purchaser of such embryos may do
with them. Consider this possible scenario: I create embryo clones by
HSCNTT. You buy them from me, telling me that you want them for
research, and I ship them to you, taking you at your word. You change
your mind (say, because your company's new management sees the prospect
of gain from reproductive cloning), and you then use the purchased
embryo (that you did not yourself create) to initiate a pregnancy.
Under the terms of this bill, I have done nothing illegal and neither
have you, and in the meantime, the cloned child is born.
There are two further difficulties with this bill. The two banned
acts turn entirely either on intent or on foreknowledge of someone
else's intent--hard matters to discern and verify. Also, because the
cloned embryo is treated like an ordinary drug whose registration with
the FDA is (for obvious reasons) kept confidential, the public will be
completely in the dark even about who is producing the embryo clones,
much less where they are being bought and sold and who is doing what
with them. With all due respect, as I read the present text of this
bill, it seems to me to be less the ``Cloning Prohibition Act of 2001''
and more the ``Human Embryo Cloning Registration and Industry
Protection Act of 2001.'' It is not the reproductive cloning ban the
American people are looking for.
I understand fully that some scientists and biotechnologists hope
that the practice of embryo cloning would someday yield autologous
tissues (and even organs) for transplantation, derivable for each
person from his own embryonic twin clone, tissues useful for the
treatment of serious chronic disease (so-called therapeutic cloning).
Perhaps they are right. But we now have promising alternate routes to
the same therapeutic possibilities--not only non-embryonic (so called
adult) stem cells, but also non-cloned embryonic stem cell lines--that
do not run the risk of opening the door to human clonal reproduction
(and that, it should be added, will not require commodifying women's
reproductive tissues in order to provide the enormous numbers of eggs
that will be needed to create the cloned embryos). Should these other
alternatives fail, and should animal cloning experiments demonstrate
the unique therapeutic potential of stem cells derived from embryo
cloning, Congress could later revisit this issue and consider lifting
the ban on the cloning of embryos. H.R. 1644, in fact, provides for
just such a review of the relevant scientific and therapeutic
possibilities, as does H.R. 2172 (the Greenwood-Deutsch bill).
As the composition of the panel of witnesses before you today makes
clear, the issue of human cloning is most emphatically not an issue of
pro-life versus pro-choice. It is not mainly about death and
destruction, and it is not about a woman's right to choose. It is only
and emphatically about baby design and manufacture, the opening
skirmish of a long battle against eugenics and against the post-human
future. Once embryonic clones are produced in laboratories, the eugenic
revolution will have begun, and we will have lost our best chance to do
anything about it.
The present danger posed by human cloning is, paradoxically, also a
golden opportunity. The prospect of cloning, so repulsive to
contemplate, is the occasion for deciding whether we shall be slaves of
unregulated innovation and, ultimately, its artifacts, or whether we
shall remain free human beings who guide our medical powers toward the
enhancement of human dignity. The preservation of the humanity of the
human future is now in our hands.
Mr. Bilirakis. Thank you very much, sir.
Mr. Guenin--is that correct?
Mr. Guenin. Guenin.
Mr. Bilirakis. Mr. Guenin. Thank you, you may proceed.
STATEMENT OF LOUIS M. GUENIN
Mr. Guenin. Mr. Chairman and members of the subcommittee, I
am Louis Guenin of the Department of Microbiology and Molecular
Genetics at Harvard Medical School where my field of work is
ethics.
In order to assist the subcommittee, the talk that I should
like to set for myself is to unmask the compelling, but
sometimes overlooked grounds for moral approval of non-
reproductive somatic cell nuclear transfer.
I shall emphasize that we should insist for every moral
view on an analysis faithful to that view's fundamental
commitments; and that from such an analysis, we find that moral
views that are sometimes invoked against this research, in
fact, pronounce it not only permissible, but virtuous.
So, I shall be speaking about the instrumental use of
embryos; that is the use of embryos as means, not ends in
themselves. We may distinguish two sets of embryos for this
purpose. The first consists of embryos that are produced by in
vitro fertilization for the purpose of pregnancy. And the
second consists of those produced by in vitro fertilization or
somatic cell nuclear transfer solely for the purpose of medical
treatment or research.
We may say that the elements of that first set are created
by reproductive embryo creation, and that making elements of
the second set is an instance of non-reproductive embryo
creation.
I use that expression instead of the word ``cloning,''
because in this instance, although the genome of the supposed
donor is, in fact, copied, the nuclear donor is not, himself or
herself, copied. There is never an offspring.
So, the question is whether it is moral to use an embryo as
means. Some readers of the philosopher Kant would believe that
that question answers itself because Kant teaches us to ``use
humanity . . . always at the same time as an end, never simply
as a means.''
But for Kant, ``humanity'' includes only rational beings.
And the subject of current scientific interest consists of
microscopic embryos that do not have brains and are not
rational.
What we may do with them, according to Kantian morality,
would follow from the command that we--that we, as universal
beings, act on universal laws, that we can will without
contradicting ourselves.
One such law, holds Kant, states a duty to aid others.
There is no contradiction in willing that scientists should
relieve suffering, and that the rest of us should join in
supporting him by using donated, unenabled embryos.
The developmental potential of an embryo becomes
``enabled,'' as I use that expression, if and only if the
embryo enters a woman's reproductive system. The boundary of
the human body separates enabled from unenabled embryos.
I would like to identify a set of unenabled embryos that is
permissible to use as means. Suppose that Mary wants to help
others by donating--donating to research or therapy an embryo
created in an earlier attempt at pregnancy, or an egg designed
to be used in somatic cell nuclear transfer.
She, thereupon, issues instructions that prohibit the--
prohibit reproduction; that is, she prohibits the embryo be
implanted in a uterus. And she also prohibits nurture of the
embryo for more than 14 days. That period of time is important
because until the 14th day, an embryo can split, forming twins,
and any twins can recombine.
So, in view of that, there is not the individuation of a
person. In the words of the late Harvard philosopher W.V.
Quine, ``No entity without identity.''
Consider also the case of Michael, who suffers from
Parkinson's disease. He contributes a somatic cell for the
purpose of enabling a autologous transplant; that is, a
transplant to him of cells bearing his own genome. And he
imposes the same restrictions as does Mary.
For an unenabled and unindividuated embryo donated by
someone like Mary or Michael, whether from a fertility clinic
or created solely for research or therapy, I use the term
``epidosembryo''. This comes from the Green ``epidosis'' for a
beneficence to the common weal.
The donation of such an embryo is a generous act, but we
have to ask still whether it is permissible for scientists to
use it. Enablement of an embryo, as I have described it, is an
entirely discretionary act.
No woman is obliged to undergo intrauterine transfer of an
embryo. The instructions that are issued by donors of
epidosembryos conclusively foreclose any chance that the
embryos will become babies. They will never be enabled.
The instructions allow research or therapy and nothing
else. And that is a decision that the donors make, not the
recipients. Therefore, there is no possible person that
corresponds to such an embryo.
Moreover, an early stage embryo, so small that it is
invisible to the naked eye, lacks the sensory apparatus to feel
pleasure or pain.
Because the use of such an embryo cannot thwart the
actualization of any possible person, because an embryo cannot
suffer any discomfort, it is permissible to use the embryo in
aid of others.
Some witnesses will be objecting that it is wrong to create
an embryo for some purpose other than procreation. According to
a previously influential teleological view that trances to
Aristotle, in every creature, every cell has a purpose. And we,
today, even think that, in many cases, we know what the purpose
is.
It is a short step, then, to say that this notion of a
mapping of cells to purposes is not purely of human origin, but
perhaps of divine. And thereupon, some would object to
highjacking cells to be used for some purpose other than their
ordained purpose.
But we mortals formerly thought that bone marrow was used
only to nurture bone. And now, we know that it is the factory
for the manufacture of blood.
We used to think that kidneys exist only for benefit of
those that enclose them. And now, we think it virtuous to
donate one's kidney.
We know that oocytes, when they are fertilized, develop
into children, or at least some of them do. But who of us can
say that sexual reproduction is the sole end that an oocyte may
permissibly serve.
Even assuming that the biological function of an oocyte
were singular and known, it does not follow that it is immoral
to deploy it for some other purpose. Nor is it obvious that a
moral wrong occurs if an embryo dies without implanting in the
uterus.
Embryos die in that manner, in vivo, all the time. And we
do not treat their passing as the death of a person.
Now, to take an explicitly religious point of view, suppose
that we could have a conversation with God about this. We tell
him that we have discovered stem cells and, furthermore, we
have discovered somatic cell nuclear therapy.
I suspect his first reaction might be gently to tease us
that it took a few thousand years to get here. But to be
serious about it, I think he would commend us for an attempt to
help others.
In view of what is known as the second greatest of the
Commandments, I suspect he would praise epidosembryo donors. I
doubt that he would stand on metaphysics about early stage
microscopic embryos, but rather wish us----
Mr. Bilirakis. If you could summarize, Mr. Guenin?
Mr. Guenin. Yes, Mr. Chairman--rather wish us to use our
abilities to relieve suffering. The burden of my testimony, I
would therefore conclude, is that it would disserve the cause
of morality, disserve our fulfillment of our duty to aid those
who suffer if any government action were to thwart non-
reproductive somatic cell nuclear transfer.
When I speak of morality, I refer to the intersection of
the leading moral views of our time on this kernel, that it is
virtuous to relieve suffering in actual lives when we may do so
at no cost in potential lives.
In my written statement, I would just mention that I make
the following further points: that Catholicism should be
counted as an ally of this research, not an opponent. This
relates to its fundamental belief in the duty to relieve
suffering.
And the fact that the thesis of zygotic personhood draws
Catholicism into contradiction not only of its 18th Century-
long belief otherwise, but of its fundamental belief in soul, I
suggest that it is misleading to conflate the abortion of an
enabled conceptus with experiment on an unenabled conceptus.
And I make some points of Constitutional and drafting about
the pending legislation. I suggest----
Mr. Bilirakis. In your written statement?
Mr. Guenin. Pardon me?
Mr. Bilirakis. In your written statement, you make----
Mr. Guenin. Yes.
Mr. Bilirakis. [continuing] those points?
Mr. Guenin. Yes. If I may just close with this, final----
Mr. Bilirakis. Please close.
Mr. Guenin. [continuing] sentence, Mr. Chairman? I suggest
there that a sensible prescription would prohibit ``transfer to
a uterus of an embryo created by somatic cell nuclear
transfer.'' That would paint, without using too broad a brush.
Thank you, Mr. Chairman.
[The prepared statement of Louis M. Guenin follows:]
Prepared Statement of Louis M. Guenin, Department of Microbiology and
Molecular Genetics, Harvard Medical School
Mr. Chairman and Members of the Subcommittee, the task that I
should like to set for myself, in order to assist the Subcommittee in
its consideration of legislation against human cloning, is to unmask
the compelling grounds for moral approval of nonreproductive somatic
cell nuclear transfer (``SCNT''). The method leading to the conclusions
that I shall offer is simple to describe though somewhat difficult to
execute. It consists first in probing moral views until we have passed
beyond phrases and aspirations to the most fundamental commitments of
each. It then requires us to construct a moral analysis faithful to
each view. I shall emphasize that if we insist on this regimen, we
shall find that even moral views thus far invoked against
nonreproductive SCNT commend it as not only permissible but virtuous.
1. EMBRYO SUBJECTS
I shall be speaking about the instrumental treatment of embryos,
the use of embryos as means rather than as ends in themselves. An
embryo treated instrumentally is an ``embryo subject.'' We may
distinguish two sets of embryo subjects:
(a) a set A each element of which is an embryo created by in vitro
fertilization (``IVF'') for the purpose of pregnancy, and
(b) a set B each element of which is an embryo created by IVF or
SCNT solely for the purpose of medical treatment or research.
We may say that elements of A are created by ``reproductive embryo
creation,'' and those of B by ``nonreproductive embryo creation,'' the
latter standing for any process of embryo creation for a purpose other
than producing a baby. I do not use the term ``cloning'' for
nonreproductive embryo creation by SCNT (``nonreproductive SCNT'')
because in that process, no copy of the nucleus donor ever develops. No
infant is born. Only the donor's nuclear genome is copied.
Nonreproductive embryo creation does not risk deformed or socially
anomalous offspring or like problems that may trouble us about
reproductive use of SCNT in humans (``reproductive cloning'').
2. KANT'S MORALITY AS PROPONENT, NOT OPPONENT, OF EMBRYO USE
In considering elements of A or B as research subjects, we
encounter a different problem. Is it moral to use an embryo as a means?
Some readers of Kant have thought that this question answers itself.
The second form of Kant's categorical imperative, embraced by many
religious traditions, bids us to ``use humanity . . . always at the
same time as an end, never simply as a means.'' But as I have explained
elsewhere (``Morals and Primordials,'' Science 292: 1659-1660 [2001],
copy attached), by ``humanity'' Kant understands only rational beings.
The early stage embryo subjects of current scientific interest are
microscopic. They do not have brains, they are not rational. For
Kantian guidance on how we must act with respect to any nonrational
being, we must look to a more general principle. That is the command
that we as rational beings act only on those maxims that, without
contradicting ourselves, we can will as universal laws. One such law,
Kant holds, states a duty of mutual aid. When we imagine that we stand
seriatim in the shoes of our fellows who suffer from diseases that we
might cure, we do not contradict ourselves in willing that we
collectively support biomedical scientists in the relief of suffering
by use of donated unenabled embryos.
3. THE EPIDOSEMBRYO SUBJECT, AN UNENABLED UNINDIVIDUATED EMBRYO TO
WHICH NO POSSIBLE PERSON CORRESPONDS
Let me explain enablement, the key concept that I have introduced
here. I say that the developmental potential of an embryo becomes
enabled if and only if the embryo enters a woman's reproductive system
(either fallopian tubes or uterus). The boundary of the human body
separates enabled embryos from unenabled embryos. I shall describe, if
I may, a set of unenabled embryos that one may permissibly use as
means. Suppose that Mary wants to help others by donating to research
or therapy (a) an embryo produced from one of her eggs in an earlier
fertility procedure or (b) an unfertilized egg for use in SCNT. In her
donative instructions, given to the physician who recovered the egg
from her, she prohibits reproduction. She forbids intrauterine embryo
transfer and she also prohibits ex utero embryo nurture for more than
fourteen days. The fourteen day constraint assures that neither
research nor therapy will use a person as means. How is that so? Until
day 14, any embryo can split, forming twins, and until day 14, twins
can recombine, neither mother nor physician being the wiser. Thus until
the end of the first fortnight, identity of an individual is not
established, and hence it does not make sense to say that there exists
a new person. ``No entity,'' said the late philosopher W.V. Quine,
``without identity.''
Consider also the case of Michael, a victim of Parkinson's disease.
Michael arranges with his physician for a somatic cell to be removed
from Michael's body so that via SCNT, that cell's nucleus may be used
to generate embryonic stem cells of Michael's own genome, thereby
enabling an autologous transplant. Michael imposes the same embryo
restrictions as does Mary.
For an unenabled unindividuated embryo donated by someone like Mary
or Michael, I use the term epidosembryo. I derive this word from the
Greek epidosis for a beneficence to the common weal. In the relief of
suffering, epidosembryos enable the bounteous possibilities of stem
cell research and cellular reprogramming. (Here I describe the general
concept of an epidosembryo, whether of set A or B. The discussion in
``Morals and Primordials'' principally concerns epidosembryos from A.)
For the following reasons, it is morally permissible to use an
epidosembryo. Enablement is an entirely discretionary act. No woman is
obligated to undergo intrauterine transfer of an embryo. Instructions
issued by epidosembryo donors conclusively foreclose any chance of
enabling the embryos. The instructions specify research or therapy, and
nothing else. Hence there exists no chance that an epidosembryo will
become an infant. Therefore no possible person corresponds to such an
embryo. To this we add that any early stage embryo--each so small as to
be invisible to the naked eye--lacks the sensory apparatus to feel
pleasure or pain. Because use of an epidosembryo cannot thwart the
actualization of any possible person--no possible person corresponds to
the embryo--and because the embryo cannot experience frustration or
discomfort, it is permissible to use an epidosembryo in aid of others.
Because we owe profound respect to any human life form, especially
embryos, we cannot use embryos for frivolous means. But the hopes of
scientists for embryo research are far from frivolous. First, from work
on stem cells science may be able to overcome juvenile-onset diabetes,
Parkinson's, Alzheimer's, muscular dystrophy, and other diseases, and
to accelerate drug development by supplying for testing normal human
cells in lieu of abnormal and animal tissues. Second, in SCNT we
anticipate a stem cell possibility that embryos donated from fertility
clinics cannot provide. In SCNT we have an ingenious means for
obtaining transplantable cells of the patient's own nuclear genome.
Such an autologous, histocompatible transplant is the holy grail of
cell replacement therapy. For efficiency's sake, instead of creating
cells of each patient's genome whenever needed, SCNT might be used in
the project of creating a bank of embryonic stem cell lines. Scientists
would culture one line for each of the more common alleles of the major
histocompatibility complex (the set of genes that code for antigens,
the structures that signal whether a cell is self or nonself). Or into
cells from an embryonic stem cell line, scientists might by
transgenesis insert a given patient's own version of the complex. Each
of these strategies in principle could issue in transplantable cells
that surmount the vexing problem that a patient's immune system rejects
anything that it does not recognize as self. Third, SCNT also
constitutes our hope for knowledge of how a cell's reprogramming can
occur. If we can find out how reprogramming occurs in an egg following
SCNT--we know that it does occur, but do not know the details--
clinicians might learn how to induce reprogramming of adult patients'
cells. In such case we have the exciting prospect of inducing
specialized cells in the adult to differentiate into developmentally
much earlier cells that patients desperately need. Even neurons might
be regenerated.
4. REPLY TO OBJECTIONS CONCERNING USE OF EPIDOSEMBRYOS
Let me address two likely objections to what I have said about
unenabled embryos.
(a) It might be argued that an embryo outside the body possesses a
potential to become an infant and that we just happen to observe it at
a preimplantation stage, a stage through which passes every embryo that
becomes a neonate. But embryos passing through that stage inside a
woman's body have a nontrivial chance of implanting in the uterus.
Epidosembryos have no such chance. That is to say that they have less
chance of becoming babies than do the gametes of a man and woman who
have never met. Most of us would approve experiments on gametes--even
though each contains half the genome of a possible person. For moral
purposes, some cells and cell masses are possible persons, others are
not.
(b) Still it will be objected that the reason that embryos created
by SCNT have a zero chance of becoming babies is that someone created
them with precisely that fate in mind, and that it is wrong to create
an embryo with no thought of procreation. (This is the moral objection
peculiar to nonreproductive embryo creation in contrast with use of
epidosembryos from fertility clinics.) Here I think that one can put
one's finger on the view that may explain much of the reluctance
understandably voiced concerning the challenged use of embryos.
According to a previously influential teleology originating with
Aristotle, some purpose obtains for every cell type, every structure.
At various times in history, it has been thought that for many a cell
and structure in the human, we humans know what the purpose is. It is a
short step from there to the notion that the mapping of cells to
purposes is not an accident but a divine design. Whereupon some would
object to hijacking cells for purposes other than those ordained.
Who can know the mind of God on this? We mortals formerly thought
that the sole purpose of bone marrow is to nurture bone. Now we look
upon the marrow as the factory where blood cells are manufactured. We
used to think that kidneys exist solely for benefit of those enclosing
them, and now we recognize the virtuousness of donating one's kidney to
another. We know that oocytes when fertilized develop into children,
but who is to say that sexual reproduction is the sole end that oocytes
may permissibly serve? Even assuming that the natural function of a
cell were both singular and known, it does not follow that it would be
immoral to deploy it for another purpose. Nor it is obvious that a
moral wrong occurs if embryos die without implanting in a uterus. The
majority of embryos do die in such manner. We do not treat their
passing as the deaths of persons.
Let me take up a religious point of view. If we could have a
conversation with God, is it plausible that He would tell us never to
fertilize an egg except for purposes of creating a baby? If we informed
Him that we had discovered stem cells, and had invented SCNT, He might
first gently tease us that it took us a few thousand years to discover
these things. As for what we should make of them, we may recall what
Christianity teaches as the second greatest of the commandments, and
the Golden Rule as embraced by virtually all religions. I suspect that
God would commend epidosembryo donors. I suspect that He would not
stand on metaphysics about microscopic embryos, but would wish us to
use our humble abilities to relieve suffering--an effort that expresses
esteem for life--when we have happened upon a way to do so in which we
do not prevent the existence of any possible person who would otherwise
become actual. He would know that children will not result from the use
of epidosembryos as sources of stem cells or subjects of study.
From a religious perspective, SCNT may even be said to offer one
advantage over the use of embryos created with pregnancy in view.
Nonreproductive embryo creation does not bring to an end any divine-
human procreative collaboration.
5. BREADTH OF MORAL SUPPORT FOR NONREPRODUCTIVE EMBRYO CREATION
The use of unenabled embryos as means for helping others, even as
we are reminded of how carefully we must proceed, enjoys the support of
a wide range of religious traditions. That support is even broader than
commonly supposed. To see this, let us consider what is ostensibly the
principal opposition. I refer to the view of the Congregation for the
Doctrine of the Faith of the Roman Catholic Church, as joined by
fundamentalist Christians, which asserts two doctrines: (a) that human
life is a sacred gift of God that we must respect, and (b) zygotic
personhood, the thesis that fertilization suffices to create a new
person.
[a] We Respect Life by Relieving Suffering at No Cost in Potential
Lives
The Congregation has declared that IVF, cloning, and other
technological innovations in reproduction are inconsistent with the
sanctity of human life. The reason that the Congregation rejects these
procedures is twofold: it categorizes the procedures as nonconjugal
reproduction, and thus as a departure from God's manner of giving life,
and it expresses fear that they might lead to eugenics. But note that
these two objections do not apply to procedures, such as
nonreproductive embryo creation, that do not produce babies. What
respect for life requires therefore remains an open question. I
suggest, with ample support in religious traditions, including
Catholicism, that relieving widespread human suffering when one may do
so at no cost in potential lives--this in fulfillment of the wishes of
generous cell donors--virtuously affirms respect for human life.
[b] Zygotic Personhood Untenable
I have explained in my recent paper in Science that (i) zygotic
personhood contradicts the Catholic church's more plausible teaching,
maintained during the church's first nineteen centuries, that at
fertilization a conceptus cannot, for lack of structures corresponding
to the intellectual faculty that makes us human, constitute a person,
and that (ii) zygotic personhood is refuted by the fact that embryos do
not individuate until day 14, as Catholic theologians have recognized.
The church, having recently conceded that personhood is a philosophical
question, offers only one argument for zygotic personhood. That
argument consists in identifying a new person with the genome formed at
each conception. But the church cannot maintain this embrace of genetic
reductionism. To do so contradicts the church's fundamental belief in
mind and soul.
We must first plumb the depths of any moral view before we can
ascertain its verdict on a question at hand. When we include in our
analysis of Catholicism its bedrock--including the second greatest of
the commandments and the consequence that we are obliged to come to the
aid of our neighbors and to answer the call to charity--we find a
compelling case for epidosembryo research and therapy.
It would be misleading to conflate the use of unenabled embryos
with abortion. An abortion kills a conceptus developing in the womb, an
enabled conceptus. An enabled conceptus will follow a course of
gestation requiring only that the mother stay healthy. Whereas absent a
voluntary act to which no one is obliged, an unenabled embryo will
never implant, will never mature even to the fetal stage. Fewer
abortions mean more babies. Were society to refrain from
nonreproductive embryo creation, not one more baby would likely be
born.
6. WISHFUL THINKING ABOUT ADULT CELLS WILL NOT OBVIATE STUDY OF
EMBRYONIC
Opponents of embryo use have recently urged that we forego use of
embryos and instead use cells that they characterize as functionally
equivalent and less morally problematic, namely, adult cells. This line
of wishful thinking, embraced in H. R. 1644, Sec. 2, finding (7),
begins with the notion that we might confine stem cell research to
adult stem cells. Clinging to this idea, some nonscientist opponents of
embryo research are wont to trumpet every report about the plasticity
of adult stem cells. Meanwhile these advocates will exaggerate every
qualification or condition that they hear mentioned by cautious
scientists careful not to overstate present knowledge about embryonic
stem cells. The refutation of this wishful thinking is immediate.
Embryonic stem cells are pluripotent, which is to say that they are
capable of issuing in every cell type save for the placenta. Adult stem
cells are only multipotent, each capable of issuing in no more than a
few cell types. When pluripotency is the goal, the earlier the better.
For some cell types, among them cardiac and pancreatic islet, no adult
stem cells have been found. Where adult stem cells are known to exist,
often they can be found only in small quantities and obtained only by
intrusive means. For instance, to obtain adult stem cells useful in the
brain, as one would wish to do for Parkinson's disease, one must drill
a hole in the cranium. Adult stem cells may also embody the effects of
aging and contain genetic abnormalities accumulated over the course of
a life. If, painlessly for both donor and recipient, one could
rejuvenate one's skin with a transplant from a family member, who would
prefer their grandmother's skin to that of a newborn niece? We must
also recognize that stems cell vary in the extent to which clinicians
will be able to direct differentiation. Embryonic stem cells may prove
easier to direct. For all these reasons, it is simply implausible that
adult stem cells are functional substitutes for embryonic stem cells.
Nor can one assume that embryonic germ cells, derived from abortuses
five or more weeks old, are functionally equivalent to embryonic stem
cells.
It does not advance understanding to interject, as have opponents
of embryo research, that no therapies by means of embryonic stem cells
have yet been confirmed. For both adult and embryonic stem cells, the
present agenda is basic research. In the U. S. there has been scant
little research on embryonic stem cells and SCNT. Both lines of inquiry
are stymied by law. No funds dispensed by the National Institutes of
Health may be used for research in which embryos are destroyed (Pub. L.
106-554, Title V, Sec. 510). It is unrealistic to expect confirmed
therapies from research not yet performed.
Frequently in the history of science when the prospect has appeared
of beneficial results from several alternative avenues of inquiry, and
when it has not been known which avenue would be the most productive,
the practice has been to follow all paths simultaneously. Sundry
mathematicians traveled down numerous paths, developing whole new
fields of mathematics in the process, before Andrew Wiles combined
insights from multiple fields into the proof of Fermat's Last Theorem.
And then there is serendipity. Often great advances occur in one
direction while scientists believe that they are working in another.
Roentgen discovered x-rays without looking for them. Sometimes multiple
avenues all bear fruit. Biomedical research could reveal a clinical
need for all varieties of stem cells, one type for one disease, another
type for another disease. When delay and inefficiency are measured in
lives lost, it would be a shame to bet everything on one horse.
The overwhelming majority of biomedical scientists prize embryonic
stem cell research as one of the most promising frontiers for the
relief of human suffering in our lifetime. The ability to generate
specialized cells of all types renders the use of embryonic stem cells,
through SCNT and otherwise, that rare strategy that can yield therapies
in virtually all fields of medicine. If biomedical scientists imagined
that adult cells would suffice instead, they would be the first to tell
us so. Research on adult cells does offer some promise, should be
pursued, and is being pursued. But the overwhelming majority of
biomedical scientists urge that embryonic research possesses singular
advantages and is yet more promising. On the question of which avenues
of investigation are relatively more promising, the judgment of these
scientists should serve as our guide, just as it does in budgetary
decisions. We have learned from encounters with such ventures as
``creation science,'' which purportedly refutes the theory of
evolution, that we must be sceptical when nonscientist advocates offer
purported analyses of scientific data to reinforce conclusions that
they have already reached on nonscientific grounds. The current
incarnation of data advocacy would have us believe that we have little
to gain scientifically from the alternative that the advocates disfavor
on moral grounds. To object to embryo research explicitly on moral
grounds is of course quintessentially pertinent here. (Though,
according to my analysis, morality bids us support, not oppose, that
research.) But whatever our moral theory, if we think that the moral
permissibility of an action depends on that action's probable success
in achieving a scientific result, we ought to take counsel about that
probability from science's mainstream. The voice of science's
mainstream is resounding. We could fail to apprehend the scientific
consensus on the singular promise of embryonic stem cell research only
by putting our heads in the sand.
The rationale for SCNT is even more compelling than that for
embryonic stem cells in general, this by virtue of two advantages to
which I have alluded--and perhaps others not yet glimpsed. First, SCNT
affords a means of producing stem cells that are (a) ample in quantity
and pluripotent and (b) of the patient's own genome. Adult cells do not
allow us to achieve (a); an unrelated embryo from a fertility clinic
will not achieve (b). Second, eggs developing after SCNT furnish the
optimal opportunity for observing the full scale reprogramming of gene
expression and the cell's other regulatory mechanisms, the likes of
which either does not naturally occur in specialized cells of the
adult, or occurs on a scale too small to allow us to learn much if we
could observe it. By studying reprogramming in embryos, scientists hope
to learn what steps to take in order to induce reprogramming in
specialized cells of adult patients, which in turn could obviate the
need to obtain embryonic stem cells for therapy. Scientists would not
urge this research, would not predict the loss of useful therapies if
we forgo it, if they could gain that knowledge without using embryos
created by SCNT.
In short, if Congress defies the advice of science's mainstream and
excludes unenabled unindividuated embryos from research, it will
handcuff research for no moral gain.
7. PRESERVING THE LEGALITY OF NONREPRODUCTIVE SCNT
As the Members well know, there obtains a scientific and, if I may
say, a public consensus that because reproductive cloning in animals so
often issues in deformed offspring, and because cloning in homo sapiens
poses further technical challenges and questions that have not been
met, we ought not presently to attempt the cloning of a human. That is
not the whole of the moral discussion, since we can imagine a day when
present problems have been overcome to the extent that the procedure
has become relatively reliable. Thereupon we would return to the
morality of ``replacing'' a lost child with a clone and of using SCNT
to conceive a child who could be available as a histocompatible donor
to a sick child. Consider again a religious perspective. We, none of
us, can confidently say that, if we could have a conversation with God,
He would tell us to shun reproductive cloning in all instances. But
insofar as reproductive cloning is not presently reliable, and I
therefore cannot defend it on moral grounds, I confine myself here to
the case for preserving nonreproductive embryo creation. We may further
narrow the discussion to nonreproductive SCNT rather than
nonreproductive embryo creation in general. For the proposed
legislation would forbid SCNT but not restrain the use of IVF in
research.
Thus far I have discussed morality, the only cited rationale for
making nonreproductive SCNT a crime. I have argued that a close
analysis of leading moral views reveals moral approval and praise for
nonreproductive SCNT. This issues even from quarters that might be
thought settled otherwise. I now turn to two pragmatic arguments. These
have been advanced for the proposition that, even if nonreproductive
SCNT is moral for the reasons that I have offered, the procedure should
be prohibited anyway. The first of these arguments emanates from
concern for enforceability of a ban on cloning, the second from fear of
a slippery slope. I shall show that neither argument sustains the
prohibition of nonreproductive SCNT.
[a] Difficulty of Enforcement: Inherent for Any Proscription of
Reproductive Conduct, Not Grounds for an Overly Broad
Proscription
The first argument is broached in H. R. 1644, Sec. 2, finding (8),
which asserts that ``it will be nearly impossible to prevent attempts
at `reproductive cloning' once cloned human embryos are available in
the laboratory.'' Fully stated, the argument starts with the premise
that for satisfactory enforcement of a statute that prohibits x, law
enforcement officials must be able to detect most instances of x. Next
it is asserted that officials will not reliably be able to detect
reproductive cloning if and when it is perpetrated by someone legally
permitted to perform SCNT for research and therapy. It is then
concluded that, by dint of such undetected violations, a statute
prohibiting only reproductive cloning cannot be enforced to a
satisfactory extent.
I contend that the enforcement problem envisioned here is a red
herring. As the foregoing argument itself implies, the question that we
must ask, when urged to forbid all SCNT so as to tighten the noose
around reproductive cloning, is as follows. If SCNT in research and
therapy were permitted, what would be the probable incidence of
surreptitious reproductive cloning by persons performing SCNT in
research and therapy? The probable incidence, so I shall suggest, is
negligible. The foregoing argument leaps from the observation that
undetected violations can occur to the conclusion that significantly
many undetected violations will occur.
We must understand the laboratory environment. Cell biology
laboratories--where studies of stem cells and cellular reprogramming
would occur--do not serve patients. Such laboratories contain no
examining rooms, no surgical suites, no equipment for the invasive
procedures of removing an egg from an ovary or transferring an embryo
to a uterus. Most of the scientists who work in such laboratories are
Ph.D.s, not physicians. Eggs and somatic cells used by such
laboratories in research will have been shipped there as donations. If
cell donors impose the condition by which I earlier defined an
epidosembryo, the laboratories will have use of the cells on condition
that any resultant embryo not be transferred to a uterus. A federal law
forbidding reproductive cloning would effectively impose this condition
in all cases. So if a rogue scientist seeks to clone a human, that
scientist must be surreptitious indeed. The rogue must remove an embryo
from a laboratory's inventory and arrange an intrauterine embryo
transfer in such fashion that the rogue and the woman receiving the
embryo manage to keep the whole thing secret. Where can the rogue
arrange an intrauterine transfer? He cannot engage a reputable
physician, hospital, or clinical laboratory. If reproductive cloning is
a federal crime, reputable providers will not perform the procedure--
just as, comporting with a nonpenal statute (Pub. L. 106-554), NIH-
supported scientists now abstain from SCNT for any purpose. Hence the
rogue must collaborate with a woman willing to undergo an assisted
reproduction procedure without the usual circumstances of medical care.
And she must be willing to risk punishment by a minimum fine of
$1,000,000 and up to ten years'' imprisonment. By proposed 18 U.S.C.
Sec. 302(a)(2) of H. R. 1644, she and the rogue would both be guilty of
the crime.
A step earlier in the analysis, consider also what it would take
for a woman to want an embryo produced in a research laboratory. As a
solution to infertility, SCNT is inferior to IVF: IVF produces
offspring that combine the genomes of the parents, and does not, like
cloning, make a deformed neonate more probable than not. Therefore a
woman interested in a baby by SCNT--if we can imagine that desire amid
public awareness of how likely is a deformed child--will most likely
not be infertile but instead someone seeking a clone of a previously or
presently living human identified by her. That is the imagined primary
motivation for cloning. Only by a highly improbable accident would an
embryo created in a research or clinical laboratory serve a cloning
purpose of someone other than the person who chose the somatic cell
donor. A woman considering cloning will not want any of a laboratory's
already extant embryos. She will want only an embryo created to order,
an embryo bearing a genome chosen by her. We observe what follows from
this. For the vast majority of embryos produced by SCNT in research and
for therapy--in a reputable laboratory, for all of the embryos--there
will be no women wishing to bear them. And in the ordinary course, the
embryos will be consumed in research and therapy.
So regardless how many embryos are produced by SCNT in laboratories
across the country, for a rogue to produce an embryo acceptable to a
given woman, the rogue must arrange yet another surreptitious
procedure, namely, removal of a somatic cell from a corpse or living
human chosen by her. She would also likely prefer that any embryo
transferred to her be made of one of her eggs so that the clone will
bear her mitochondrial DNA, not a stranger's. In order to furnish one
of her eggs to the rogue scientist, she would have to undergo an oocyte
recovery procedure that punctures her ovarian wall. For this she would
need to seek out a fertility clinician, and, after the procedure, ask
the physician to give her an egg to take home. That would immediately
seem suspicious to the clinician because in the usual practice of IVF,
all recovered eggs are fertilized in hopes of obtaining a few
transferable embryos.
From these circumstances we can see why the risk of surreptitious
cloning via research and medical care is negligible. Talk of large
numbers of embryos sitting around ready to make clones makes for good
rhetoric, but we must insist on analysis. Consider further that penal
legislation against reproductive cloning will thwart any large scale
efforts to attempt the procedure, and in consequence its success rate
on transferred embryos--i.e., the ratio of healthy infants to embryos
transferred--will doubtless remain dismal. As proponents of a ban on
reproductive cloning have observed, the public keenly understands the
high risk of deformities through reproductive cloning and strongly
opposes the practice. Opposition may harden if we learn that, in
addition to the high incidence of deformities at birth, ostensibly
healthy infant clones are found to develop serious health problems
later in life. We do not yet know how even Dolly's life will go. All of
which suggests that scant few women would be willing to tackle both the
high risk of a deformed offspring and a jail sentence, fewer still if
only a rogue will assist. Despite recent announcements by a handful of
providers who say that they intend to produce clones, conspicuous by
its absence is any sign that a significant number of women are willing
to enlist. Even if, by virtue of research in other countries, the day
arrives at which cloning has so greatly improved that the risk of
deformities is deemed tolerable, a woman would do better to procure the
procedure legally in a foreign country--assisted reproduction already
serves the affluent--than to commit a crime without benefit of
customary medical care.
In view of all these circumstances, the notion that SCNT in
research and therapy will to any significant extent form a conduit to
illegal reproductive cloning seems manifestly improbable.
Of course I do not purport to say that never will it happen that a
researcher or provider attempts illegal reproductive cloning. Some
illegal reproductive cloning may occur, without detection, even if
federal law forbids all SCNT. Not only might a rare disreputable health
care provider stray, but in theory women and cooperating cell donors
who do not care whose eggs were used could, acting without medical
assistance, buy oocytes through advertisements in campus newspapers,
learn somatic cell nuclear transfer from the literature, and perform
intrauterine embryo transfers entirely in private. A person who is
clever and determined enough can violate any law. That does not alter
my fundamental point. By virtue of the circumstances that I have
described, research and clinical laboratories are not a probable back
door route to illegal cloning.
Upon recognizing that airtight enforcement of any law seems
unattainable, we ought not lash out and broaden a cloning prohibition
to sweep nonreproductive SCNT within its maw. Instead we should
understand that enforceability depends on the chosen territory. The
territory chosen here should give us pause. Within the penumbra of the
Bill of Rights, as interpreted in the Supreme Court's decision in
Griswold v. Connecticut (1965), the right of privacy extends to
reproduction. The Court has also made clear that each person's zone of
privacy encompasses reproduction under the care of a physician. Hence
if H. R. 1644 declared it a crime to perform or attempt contraception,
or in vitro fertilization, it would be said that such prohibition
unconstitutionally infringes the right of privacy. Can the conclusion
be different when the proscribed act is reproductive cloning? H. R.
1644 itself states in Sec. 2, finding (8)(A), that ``cloning would take
place within the privacy of the doctor-patient relationship.'' A
measure of the intrusiveness of an anticloning statute is what would be
adduced as evidence of the crime. When a mother as defendant denies
bearing a clone, a prosecutor may seek a ``genetic audit'' comparing
her child's DNA to that of the person allegedly cloned. In facilitating
patents on DNA sequences, as in the Biotechnology Patent Protection Act
of 1995, Congress has already opened the door to legal claims
predicated on DNA audits. But now we are talking about incarceration of
parents on the basis of such evidence. The fate of a criminal statute
about reproduction lies in the courts. We ought not worsen its chances
by overbreadth. Apart from this constitutional problem, as a matter of
policy overbreadth here would foreclose such a negligible increment in
illegal cloning as to make unreasonable an opportunity cost measured in
relief of human suffering.
What can wisely be done to tighten enforceability of an anticloning
statute includes four provisions that I shall mention in a moment.
First I must discuss the second argument for making nonreproductive
SCNT illegal.
[b] Nonreproductive SCNT Not a Slippery Slope to Reproductive Cloning
That argument begins with the prediction that use of
nonreproductive SCNT in research and therapy will add to scientific
knowledge about reproductive cloning, and that this will hasten the day
when reproductive cloning becomes so reliable as to tempt us.
Thereupon, it is suggested. we might repeal any statute forbidding it
and bring upon ourselves its detrimental effects. Hence we are urged to
forbid nonreproductive SCNT now.
The slippery slope is an overworked metaphor. Not every
decisionmaking surface is slippery. As the philosopher Richard M. Hare
once observed, we decided to allow right turns from red traffic lights,
and have not seen significantly more traffic accidents of right-turning
vehicles. Now we discuss whether to allow reproductive cloning. For
purposes of this discussion, we routinely abstract from the problem of
defective clones, for we know that such a technical problem is solvable
in principle. Even so, the public, so we are reliably informed, easily
summons the collective will to prohibit cloning. That tells us that
strong objections lie against even a perfectly reliable cloning
procedure. Indeed it is argued that cloning may in various ways
diminish respect for human life. Other objections to cloning gain
expression in H. R. 1644, Sec. 2, findings [3]-[5]. If the day arrives
when cloning's already anticipated reliability becomes actual, those
objections will survive with undiminished force. It is not a foregone
conclusion that if cloning becomes reliable, we shall approve it.
On the other hand, we must be realistic in anticipating that even
if reproductive cloning is declared illegal within various
jurisdictions, someone may someday clone humans so as to gain, in the
eyes of others, some advantage. In that event, competitors may follow
suit. (This scenario has been broached concerning germ line genetic
intervention in general. See my ``Norms for Patents Concerning Human
and Other Life Forms,'' Theoretical Medicine 17: 279-314 [1996].)
Competitors might migrate to jurisdictions where cloning is legal.
Sovereign countries might themselves behave in the same way, rushing to
follow the first rival who legalizes cloning, this for fear of being
dominated by genetic superiors. The salient defect in the slippery
slope argument against nonreproductive SCNT does not lie in the
prediction that mercurial mankind will find reliable cloning
irresistible, for that outcome is possible.
Rather the slippery slope argument falls by virtue of its mistaken
assumption that we can somehow attenuate or delay reproductive cloning
if we preclude nonreproductive SCNT in the U. S. To state the obvious,
what must happen to make reproductive cloning alluring is the
successful performance of reproductive cloning. For such success, there
must occur experiments and cloning attempts. This is a tough row to
hoe, since it doubtless begins with a spate of deformed offspring. To
produce healthy clones will require surmounting many challenges, among
them the shorter interval before gene activation in humans than in
sheep, the effects of aging and mutation on donated somatic cells, and
cloning's failure to produce normal genetic imprinting. If progress
against birth defects or later health problems of clones requires
studies of development in utero, or even of development ex utero beyond
fourteen days, the work of scientists using nonreproductive SCNT will
not provide the solution. Scientists working on embryonic stem cells
and cellular reprogramming culture embryos for only a matter of days.
(In fact when an embryo reaches about day 10, if it does not implant in
a uterus, it will so badly deform that it can no longer properly be
called an embryo.) Suppose nonetheless that as mainstream scientists
come to understand and publish accounts of how cellular reprogramming
works, they inevitably issue knowledge dividends that can be cashed by
those trying to perfect cloning. We are powerless to prevent such
dividends. For instance, under authority of recent approval by
Parliament, outstanding scientists in Oxford, Cambridge, and other
British universities and research institutions will be using SCNT in
research generally and in the study of cellular reprogramming in
particular. So too will scientists elsewhere in the world. Their
results will be reported in leading journals. New scientific knowledge
disseminates rapidly. We cannot forestall improvements in cloning by
any ban on SCNT in the U. S. A ban on nonreproductive SCNT can only
strike a blow against those who suffer. Viewed from the perspective of
years hence, the measure of damage wrought by a ban on use of SCNT in
research would be the amount of suffering that could have been relieved
if our extensive research enterprise had joined the worldwide effort to
benefit from embryonic stem cells and cellular reprogramming.
8. TIGHTENING A BAN ON REPRODUCTIVE CLONING WITHOUT OVERBREADTH
The prohibition of proposed 18 U.S.C. Sec. 302(a) set forth in H.
R. 1644 extends to SCNT that produces an embryo ``at any stage of
development.'' This would bar all presently envisioned research use of
SCNT, which produces and grows embryos to the blastocyst stage (day 5
of development). The prohibition would bar SCNT even for therapy. Thus
if scientists learn how to use eggs to accomplish autologous
transplants, the clinical implementation of this boon for sick patients
would be a crime. No comfort can be taken from mention in H. R. 1644
(in Sec. 2, clause [9] and proposed 18 U.S.C. Sec. 302[d]) of research
that the bill would not prohibit. We are told that the prohibition does
not extend to ``nuclear transfer or other cloning techniques'' to
produce, inter alia, ``cells other than human embryos.'' But the sundry
methods other than SCNT for producing copies of various life forms--
methods that vary by life form even though some commentators (and the
bill) lump them all under the name ``cloning''--are not within the
scope of the prohibition in the first place.
For the moral reasons that I have now recounted, if Congress were
to thwart nonreproductive SCNT, that move would disserve morality. It
would thwart our ability to fulfill our duty to aid those in need. If
Congress chooses to legislate against reproductive cloning, I recommend
the following four statutory features to preserve the availability of
nonreproductive SCNT while tightening the proscription of reproductive
cloning.
(1) The offense may be defined as
``intentional transfer to a uterus of an embryo created by
somatic cell nuclear transfer.''
This would paint without using too broad a brush. ``Intentional''
assures that, as is appropriate in defining a crime, accidental conduct
is not punished. Congress could consider making reckless transfer a
lesser offense.
(2) It may also be provided that
``A physician shall not effect intrauterine transfer of an
embryo unless the embryo was (i) created in a laboratory under
the physician's control or (ii) received from a licensed
physician accompanied by a certificate that the embryo was
created, without use of SCNT, in a laboratory under the latter
physician's control.''
This provision assures that fertility clinicians will know the means by
which any embryos that they transfer to a uterus were created. It
blocks the possibility of a woman inveigling an unwitting fertility
clinician into a transfer into her of an SCNT-created embryo carried
into the clinic by her. The transferability provision of (ii) allows a
scenario such as the following. A woman engages an IVF procedure in
Connecticut, then later moves to Oregon. By virtue of (ii), her frozen
embryos may be sent to an Oregon fertility clinician for intrauterine
transfer. She will not have to return to Connecticut for that
procedure.
(3) In the preamble of H. R. 1644 appears language about what
``many'' think concerning morality. There exist many who believe many
things. Rather than legislate morality, Congress could declare that it
is prohibiting a procedure that would effectively constitute a clinical
experiment with a probable success rate that is unacceptably low. This
is consistent with H. R. 2172 in that the enactment becomes part of the
federal scheme of regulation of drugs and medical devices.
(4) Within the several states have already been enacted a potpourri
of interdictions pertinent to this technological genre. We can expect
more such statutes. Only preemptive federal legislation can assure a
uniform norm, at least within the U. S. It behooves us, for the sake of
the public health, to foster a reliable basis of expectations for those
making decisions about where to direct research efforts. This
especially applies to young scientists who wisely shun fields of work
whose regulatory environment is unstable. (Here it may be added that we
should be grateful for the commendable caution of senior scientists
who, upon discovering the techniques of nonreproductive embryo
creation, have evoked an open moral discussion. This follows a pattern
in the recent history of science, of which the introduction of
recombinant DNA technology is another example, in which the bright
light of public exposure shines early on morally sensitive innovations
by virtue of their discoverers' candor and alertness to moral
questions.) For preemptive legislation, precedent obtains. We look to
the Food and Drug Administration, not to the several states, for a
national system of regulating drugs and medical devices.
9. CONCLUSION
The burden of my testimony today is that it would disserve the
cause of morality, disserve fulfillment of our duty to come to the aid
of those who suffer, if any government action, whether a proscription
of conduct or a constraint on the public purse, were to thwart
nonreproductive SCNT. When I speak of morality, I refer to the
intersection of the leading moral views of our time--including
especially those sometimes imagined to hold otherwise--whose common
kernel holds it virtuous to relieve suffering in actual lives when we
can do so at no cost in potential lives.
Mr. Bilirakis. Thank you very much, sir. And I apologize
for cutting you off, but, you know, we have got to try to stay
on point here.
Dr. Newman?
STATEMENT OF STUART A. NEWMAN
Mr. Newman. I thank the chairman for giving me the
opportunity to testify today on this historical issue. My name
is Stuart Newman. I have been a Professor of Cell Biology and
Anatomy at New York Medical College since 1979 where I teach
medical and graduate students, and direct a laboratory in
developmental biology.
This is a scientific field that studies embryo development,
cloning, regeneration, and stem cells. My work on the
development of the skeletal system in animals embryos has been
supported over the past 25 years by grants from the National
Science Foundation and the National Institutes of Health. I am
currently the recipient of two Federal grants in this area.
Since my student days, I have also been concerned with the
uses to which scientific research is put. Having become
convinced that scientists, who are beneficiaries of public
resources, have a deep responsibility to anticipate what lies
down the road in their own fields, and to themselves act as a
resource for the public on the complex issues around
applications of scientific research, I joined with other
scientists, social-scientists, feminists, and progressive
community advocates to found the Council for Responsible
Genetics in the late 1970's.
The Council is now the Nation's oldest organization
scrutinizing and interpreting the new genetic technologies, and
has worked for protecting genetic privacy, ending genetic
discrimination, exercising caution in the development and
dissemination of genetically engineered crops, banning
biological weapons, and banning the introduction of inheritable
genetic modifications into humans.
This last issue relates to my own field of expertise. Over
the past quarter century, I have seen laboratory findings, such
as virus-based gene therapies and implantation of fetal tissues
employed prematurely or inappropriately in humans through a
process that, while often having noble motivations, has also
been mixed with appreciable amounts of wishful thinking, hype,
and greed.
Last year, the Council issued the Genetic Bill of Rights,
which is appended to my written testimony, which touches on all
the above issues.
The last of the 10 listed Rights states, ``All people have
the right to have been conceived, gestated, and born without
genetic manipulation.''
This position arose, in part, from scientific consideration
of the inherent uncertainties in performing such manipulations,
which include cloning. Reviewing the animal studies in this
area led Professor Rudolf Jaenisch, of the Massachusetts
Institute of Technology, to state, ``I believe there probably
isn't a normal clone around.''
Our position also emanated from the fact that any person
engineered in this fashion will be an experiment subject to the
kinds of disappointments associated with experiments failing to
meet expectations.
A grim aspect of this experimental approach to producing
people would be the devaluation of unfavorable outcomes if, as
in cloning, the same procedure could be performed repeatedly
until a desired outcome was reached.
In addition, while the Council for Responsible Genetics is
unequivocally committed to a woman's right not to proceed with
a pregnancy, if that is her choice, we, along with many
feminists and others who affirm this right, are concerned that
reproductive choice is increasingly being taken to include the
right to genetically improve the next generation.
If this is allowed, it may soon lead to baby design and
reproductive boutiques. Eugenics, defining humans as
genetically superior or inferior, and implementing those
definitions, has a horrific history that we dare not repeat.
In line with the Genetic Bills of Rights, and in light of
new experimental results and proposals to generate and modify
human embryos, the Council for Responsible Genetics issued a
policy statement on human embryo research earlier this month.
The statement is appended, and I will summarize it here.
The Council for Responsible Genetics opposes the utilization of
human eggs and embryos for experimental manipulations and as
items of commerce.
We, therefore, call for a ban on the buying or selling of
human eggs or embryos, and the manipulation of any and all
human eggs or embryos by transfer of cells, nuclei, cytoplasm,
mitochondria, chromosomes, or isolated DNA or RNA molecules of
human or non-human origin.
These bans are to apply whether or not the embryos are to
be implanted and gestated. No human embryo is to be produced
solely for purposes of research. These bans are to apply,
irrespective of the sources of funding, whether public or
private.
It is essential that the United States join the many other
nations that have banned reproductive cloning. But note that we
call for a ban not just on reproductive cloning, but on so-call
therapeutic cloning as well.
That is, even if a cloned embryo is not intended for
gestation, we are opposed to its manufacture. We have become
convinced that if a construction of modified or cloned human
embryos is permitted, there will be little standing in the way
of using them for reproductive purposes.
At that point, gestation of cloned embryos would easily
become defined as a matter of individual choice.
The bans that we call for would not--would, in no way,
curtail the option to employ in vitro fertilization for
reproductive purposes. Moreover, while we do not explicitly
reject the production of embryo stem cells from excess embryos
produced by in vitro fertilization, my own view is that other
scientific avenues, specifically adult stem cell research, have
greater promise.
A group of my colleagues at New York Medical College
recently published on the repair of damaged mouse hears with
adult mouse stem cells. I know of no comparable successes with
embryo stem cells in the mouse, even though such cells have
been available and researched for more than a decade.
Any objective view of the relevant animal research would
conclude that adult stem cells are the better bet.
As recently as a year or 2 ago, advocates of human cloning
were careful to state that an embryo produced by cloning had no
less dignity as a potential human than an embryo produced by
fertilization.
Now that some technical advance is seen in making donor-
matched stem cells from cloned embryos, distinctions are being
made by interested parties between producing embryos for
research by fertilization still not acceptable, and doing so by
cloning, now acceptable.
If we let purely technical and utilitarian considerations
determine what is acceptable in human reproduction and
production, in a few brief years, human error will assuredly
lead to production of humans with avoidable errors.
As a scientist, I am personally concerned that the products
of our research not be used for dangerous and divisive
purposes, which would bring disrepute to science and undermine
our ability to do beneficial work.
As these new technologies proliferate, the question
continually arises as to where to draw the line. I am convinced
that the bio-technology industry does not want any line to be
drawn that would curtail any of their activities.
The Greenwood bill, with its limited moratorium on
reproductive cloning, will just be an opportunity to soften up
public opinion, even on this issue. I say----
Mr. Bilirakis. Please summarize, Doctor. I would appreciate
it.
Mr. Newman. I say this with regret, as a life-long
progressive and a democratic voter. Because embryo cloning
will, with virtual certainty, lead to the production of
experimental human beings, both as a scientist and a citizen, I
urge you to draw the line here.
[The prepared statement of Stuart A. Newman follows:]
Prepared Statement of Stuart A. Newman, Professor of Cell Biology and
Anatomy, New York Medical College
My name is Stuart Newman. I have been a professor of Cell Biology
and Anatomy at New York Medical College since 1979, where I teach
medical and graduate students and direct a laboratory in developmental
biology. This is the scientific field that studies embryo development,
cloning, regeneration, and stem cells. My work on the development of
the skeletal system in animal embryos has been supported over the past
25 years by grants from the National Science Foundation and the
National Institutes of Health. I am currently the recipient of two
Federal grants.
Since my student days I have also been concerned with the uses to
which scientific research is put. My doctoral research in chemistry at
the University of Chicago was conducted at the James Franck Institute.
Professor James Franck was a Nobel prize winning atomic physicist who
was the principal author of the May 1945 Franck Report. This document
anticipated the horrors of nuclear weapons and was the first call by
scientists for international controls over these weapons. The Franck
report was a landmark in scientific responsibility and its message
ultimately prevailed.
Having become convinced that scientists, who are beneficiaries of
public resources, have a deep responsibility to anticipate what lies
down the road in their own fields and to themselves act as a resource
for the public on the complex issues around applications of scientific
research, I joined with other scientists, social scientists, feminists
and community advocates to found the Council for Responsible Genetics
in the late 1970s. The Council is now the Nation's oldest organization
scrutinizing and interpreting the new genetic technologies, and has
worked for protecting genetic privacy, ending genetic discrimination,
exercising caution on the development and dissemination of genetically
engineered crops, banning biological weapons, and banning the
introduction of inheritable genetic modifications into humans. This
last issue relates to my own field of expertise. Over the past quarter
century I have seen laboratory findings such as virus-based gene
therapies and implantation of fetal tissues employed prematurely or
inappropriately in humans through a process that while often having
noble motivations has also been mixed with appreciable amounts of
wishful thinking, hype and greed.
Last year the Council issued the Genetic Bill of Rights (appended)
which touches on all the above issues. The last of the ten listed
Rights states:
All people have the right to have been conceived, gestated, and
born without genetic manipulation.
This position arose, in part, from scientific consideration of the
inherent uncertainties in performing such manipulations, which include
cloning. Reviewing the animal studies in this area led Professor Rudolf
Jaenisch of the Massachusetts Institute of Technology to state ``I
believe there probably isn't a normal clone around.'' Our postion also
emanated from the fact that any person engineered in this fashion will
be an experiment, subject to the kinds of disappointments associated
with experiments failing to meet expectations. A grim aspect of this
experimental approach to producing people would the devaluation of
``unfavorable'' outcomes if, as in cloning, the same procedure could be
performed repeatedly until a desired outcome was reached. In addition,
while the Council for Responsible Genetics is unequivocally committed
to women's right not to proceed with a pregnancy if that is her choice,
we, along with many feminists and others who affirm this right, are
concerned that ``reproductive choice'' is increasingly taken to include
the right to genetically improve the next generation. If this is
allowed it may soon lead to baby design and reproductive boutiques.
Eugenics, defining humans as genetically superior or inferior and
implementing those definitions, has a horrific history that we dare not
repeat.
In line with the Genetic Bill of Rights, and in light of new
experimental results and proposals to generate and modify human
embryos, the Council for Responsible Genetics issued a policy statement
on human embryo research earlier this month. The statement is appended
and I will summarize it here:
The Council for Responsible Genetics opposes the utilization
of human eggs and embryos for experimental manipulations and as
items of commerce.
We therefore call for a ban on the buying or selling of human
eggs or embryos, and the manipulation of any and all human eggs
or embryos by transfer of cells, nuclei, cytoplasm,
mitochondria, chromosomes, or isolated DNA or RNA molecules of
human or non-human origin.
These bans are to apply whether or not the embryos are to be
implanted and gestated.
No human embryo is to be produced solely for purposes of
research.
These bans are to apply irrespective of the sources of
funding, whether public or private.
It is essential that the United States join the many other nations
that have banned reproductive cloning. But note that we call for a ban
not just on reproductive cloning but on so-called ``therapeutic
cloning'' as well. That is, even if a cloned embryo is not intended for
gestation we are opposed to its manufacture. We have become convinced
that if the construction of modified or cloned embryos is permitted
there will be little standing in the way of using them for reproductive
purposes. At that point gestation of cloned embryos would easily become
defined as a matter of individual choice.
The bans that we call for would in no way curtail the option to
employ in vitro fertilization for reproductive purposes. Moreover,
while we do not explicitly reject the production of embryo stem cells
from excess embryos produced by in vitro fertilization, my own view is
that other scientific avenues, specifically adult stem cell research,
have greater promise. A group of my colleagues at New York Medical
College recently published on the repair of damaged mouse hearts with
adult mouse stem cells. I know of no comparable successes with embryo
stems cells in the mouse, even though such cells have been available
and researched for more than a decade. Any objective view of the
relevant animal research would conclude that adult stem cells are the
better bet.
As recently as a year or two ago advocates of human cloning were
careful to state that an embryo produced by cloning had no less dignity
as a potential human than an embryo produced by fertilization. Now that
some technical advantage is seen in making donor-matched stem cells
from cloned embryos, distinctions are being made by interested parties
between producing embryos for research by fertilization (still not
acceptable) and doing so by cloning (now acceptable). If we let purely
technical and utilitarian considerations determine what is acceptable
in human reproduction and production, in a few brief years human error
will assuredly lead to the production of humans with avoidable errors.
As a scientist, I am personally concerned that the products of our
research not be used for dangerous and divisive purposes, which would
bring disrepute to science and undermine our ability to do beneficial
work. As these new technologies proliferate the question continually
arises as to ``where to draw the line.'' Because embryo cloning will,
with virtual certainty, lead to the production of ``experimental''
human beings, both as a scientist and a citizen I urge you to draw the
line here.
Appendix I
COUNCIL FOR RESPONSIBLE GENETICS STATEMENT ON EMBRYO RESEARCH
JUNE 2001
The Council for Responsible Genetics unequivocally supports a
woman's right to make her own reproductive decisions. However, we
oppose the utilization of human eggs and embryos for experimental
manipulations and as items of commerce because of the potential for
eugenic applications and health risks to women and their offspring.
The Council for Responsible Genetics therefore calls for a ban on
the buying or selling of human eggs or embryos, and the manipulation of
any and all human eggs or embryos by transfer of cells, nuclei,
cytoplasm, mitochondria, chromosomes, or isolated DNA or RNA molecules
of human or non-human origin.
This ban would apply whether or not the embryos are to be implanted
and gestated and irrespective of the sources of funding, whether public
or private.
No human embryo is to be produced solely for purposes of research.
Appendix II
THE GENETIC BILL OF RIGHTS
Preamble
Our life and health depend on an intricate web of relationships
within the biological and social worlds. Protection of these
relationships must inform all public policy.
Commercial, governmental, scientific and medical institutions
promote manipulation of genes despite profound ignorance of how such
changes may affect the web of life. Once they enter the environment,
organisms with modified genes cannot be recalled and pose novel risks
to humanity and the entire biosphere.
Manipulation of human genes creates new threats to the health of
individuals and their offspring, and endangers human rights, privacy
and dignity.
Genes, other constituents of life, and genetically modified
organisms themselves are rapidly being patented and turned into objects
of commerce. This commercialization of life is veiled behind promises
to cure disease and feed the hungry.
People everywhere have the right to participate in evaluating the
social and biological implications of the genetic revolution and in
democratically guiding its applications.
To protect our human rights and integrity and the biological
integrity of the earth, we, therefore, propose this Genetic Bill of
Rights.
THE GENETIC BILL OF RIGHTS
1. All people have the right to preservation of the earth's
biological and genetic diversity.
2. All people have the right to a world in which living organisms
cannot be patented, including human beings, animals, plants,
microorganisms and all their parts.
3. All people have the right to a food supply that has not been
genetically engineered.
4. All indigenous peoples have the right to manage their own
biological resources, to preserve their traditional knowledge, and to
protect these from expropriation and biopiracy by scientific, corporate
or government interests.
5. All people have the right to protection from toxins, other
contaminants, or actions that can harm their genetic makeup and that of
their offspring.
6. All people have the right to protection against eugenic measures
such as forced sterilization or mandatory screening aimed at aborting
or manipulating selected embryos or fetuses.
7. All people have the right to genetic privacy including the right
to prevent the taking or storing of bodily samples for genetic
information without their voluntary informed consent.
8. All people have the right to be free from genetic
discrimination.
9. All people have the right to DNA tests to defend themselves in
criminal proceedings.
10. All people have the right to have been conceived, gestated, and
born without genetic manipulation.
[Spring, 2000--Copyright, The Council for Responsible Genetics]
Mr. Bilirakis. Thank you very much, Doctor.
Mr. Perry?
STATEMENT OF DANIEL PERRY
Mr. Perry. Chairman Bilirakis and members of the committee,
I very much appreciate the opportunity to come before this
committee today to address the promise and the peril
surrounding cloning technologies.
My name is Daniel Perry, and I am the Executive Director of
the Alliance for Aging Research. And as the head of a not-for-
profit group eager to find cures, preventions and overall
better health and vitality for the elderly, my views on
research reflect the medical needs of the growing population of
older Americans.
The Alliance for Aging Research works to stimulate
academic, governmental, and private sector research into the
chronic diseases of human aging.
Our organization also takes up the cause of the vast
majority of Americans who fervently wish to benefit from
scientific discoveries that improve the human experience with
aging.
Our survey research tells us that most Americans believe
the Federal Government has a critical role to play to prepare
the way for new medical breakthroughs and to hurry applications
of science in health care in order to relieve human suffering
and improve the quality of life for their family members and
for themselves.
On behalf of a growing American constituency for healthy
aging, powered by the aging of the Baby Boom generation, I am
here to express a concern to this committee.
The Alliance for Aging Research believes that broadly
drafted legislation intended to prevent the cloning of a human
being could have the effect of derailing promising lines of
health research, which could ultimately benefit older
Americans, their families, and the Nation as a whole.
Every day in America, another 6,000 people celebrate their
65th birthday. And just behind them, the Baby Boomers are
cruising into their 50's in even greater numbers.
In just 10 years, the post-World War babies will begin
swelling the Medicare rolls. In less than 30 years, the whole
of our largest generation will be old enough to receive health
care paid by Medicare.
If, during these years just ahead, we fail to reduce the
threat of age-related diseases, the U.S. will encounter
staggeringly high economic costs, as well as we will face a
toll on human lives due to mounting debts and disabilities from
cancer, stroke, macular degeneration, joint and bone diseases,
Alzheimers and Parkinson's disease.
If we stifle future medical breakthroughs and must end up
managing the aging of 75 million Baby Boomers with today's
halfway technologies, we risk economic and social catastrophe
within a generation.
Fortunately, we can choose a wiser, more humane, and
ultimately less costly alternative. That alternative is to
encourage rapid advances and applications from medical and
behavioral research to prevent much of the declining health
status we now associate with old age.
There is good reason to hope that scientific understanding
of the mechanisms of aging within the--within our own cells,
genes, and proteins may ultimately permit a significant delay
in disabilities caused by diseases of aging.
Regenerative medicine is the concept of harnessing powers
of growth and healing within our own bodies at a fundamental
level of human biology.
We can look forward to future health technologies that use
stem cells, engineered tissues, grown factors, and other tools
of regenerative medicine. It is a growing possibility that
physicians 1 day will be able to replace damaged tissues using
a person's own cells to treat blindness, spinal cord injury,
coronary artery disease, diabetes, and other diseases that
result from injured, malfunctioning, or aged cells.
Scientists involved in this research say that human somatic
cell nuclear transfer is an enabling technology that can be
used to generate healthy cells and tissues for repair or
replacement in a vast variety--in a vast array of medical
applications.
To deny our aging population the opportunity to benefit
from this research would be a tragic reversal of our recent
biomedical progress toward permanent cure of diseases that
compromise quality of life, and which account for so much of
our Nation's health care expenditures.
A prominent member of the Alliance's Science Advisory Board
is Dr. George M. Martin of the University of Washington in
Seattle. Dr. Martin writes, ``Those of us in the Alzheimers
Disease Research Center are using cell cultures in attempts to
discover the fundamental molecular mechanisms that lead to
differing rates of neuronal damage in dementias of the
Alzheimers type. For obvious reasons, we cannot work with
samples of brain tissues from living subjects.''
``We are forced to utilize surrogate cells, typically
fibroblasts that can be grown from tiny skin biopsies. The
ability to reprogram such cells so that they can exhibit the
properties of the donor's neural cells would represent an
enormous advance.''
I want to make it abundantly clear that the Alliance for
Aging Research is strongly opposed to cloning of a human being.
To my knowledge, that position is supported by virtually every
responsible scientific and health advocacy organization in the
United States.
The Alliance does support responsible and sound biomedical
research, including emerging cellular therapies which could
lead to the development of treatments for cures for scores of
age-related diseases.
We urge this committee to lead the way by drawing a clear
distinction between cloning for human reproductive purposes,
which we oppose, and cloning cells for human therapeutic
purposes.
Millions of patients and families, organizations, and
advocates for health and scientific research across the land
would applaud that kind of leadership.
Some measures before this committee propose to avoid the
cloning of a human being by bringing into the laboratory the
full police powers of the Federal Government.
These intended anti-cloning proposals would criminalize
laboratory techniques that otherwise might help us find cures
for diseases such as cancer and Alzheimers. To threaten
university scientists with massive fines and prison sentences
would constitute a massive and unprecedented assault on
research.
Mr. Bilirakis. Please summarize, Mr. Perry.
Mr. Perry. I will, Mr. Chairman. I would cast a pall over
the conduct of academic science, and it would diminish and
contradict the accomplishments of a U.S. Congress that, even
now, is working nobly to double research funding to through the
National Institutes of Health.
Mr. Chairman, it is likely that we will continue to be
confronted with scientific advances that pose difficult social
and ethical questions. Congress is at its best when its actions
are informed and enriched by slow and careful debate, by advice
from expert sources, and when taken in respect for minority
opinion.
On behalf of the Alliance for Aging Research, I think the
committee again for its deliberation and the opportunity to
speak to this issue.
[The prepared statement of Daniel Perry follows:]
Prepared Statement of Daniel Perry, Executive Director, Alliance for
Aging Research
Chairman Bilirakis, and Members of the Committee: Thank you for the
opportunity to come before this committee today to address the promise
and perils surrounding cloning technologies.
As the head of a not-for-profit group eager to find cures,
preventions and overall better health and vitality for the elderly, my
views on research reflect the medical needs of the growing population
of older Americans.
The Alliance for Aging Research works to stimulate academic,
governmental and private sector research into the chronic diseases of
human aging. Our organization takes up the cause of the vast majority
of Americans who fervently wish to benefit from scientific discoveries
that improve the human experience with aging. Our survey research tells
us that most Americans believe the federal government has a critical
role to play to prepare the way for new medical breakthroughs and to
hurry applications of science in health care in order to relieve human
suffering and improve the quality of life for their family members and
for themselves.
On behalf of a growing American constituency for healthy aging--
powered by the aging of the Baby Boom generation--I am here to express
a concern to the committee. The Alliance for Aging Research believes
that broadly drafted legislation, intended to prevent the cloning of a
human being, could have the effect of derailing promising lines of
health research which could ultimately benefit older Americans, their
families and the nation as a whole.
Every day in America another 6,000 people celebrate a 65th
birthday. Just behind them, the Baby Boomers are cruising into their
50s in even greater numbers. In just 10 years the post World War babies
will begin swelling the Medicare roles.
In less than 30 years, the whole of our largest generation will be
old enough to receive health care paid by Medicare. If, during these
years just ahead, we fail to reduce the threat of age-related diseases,
the U.S. will encounter staggeringly high economic costs, as well as we
will face a toll on human lives due to mounting deaths and disabilities
from cancer, stroke, macular degeneration, joint and bone diseases,
Alzheimer's and Parkinson's diseases.
If we stifle future medical breakthroughs, and must manage the
aging of 75 million Baby Boomers with today's halfway health
technologies, we risk economic and social catastrophe within a
generation.
Fortunately, we can choose a wiser, more humane, and ultimately
less costly alternative. That alternative is to encourage rapid
advances and applications from medical and behavioral research to
prevent much of the declining health status we now associate with old
age.
There is good reason to hope that scientific understanding of the
mechanisms of aging within our own cells, genes and proteins may
ultimately permit a significant delay in disabilities caused by
diseases of aging.
Regenerative medicine is the concept of harnessing powers of growth
and healing within our own bodies at a fundamental level of human
biology. We can look forward to future health technologies that use
stem cells, engineered tissues, growth factors and other tools of
regenerative medicine. It's a growing possibility that physicians one
day will be able to replace damaged tissues, using a person's own cells
to treat blindness, spinal cord injury, coronary artery damage,
diabetes and other diseases that result from injured, malfunctioning or
aged cells.
Scientists involved in this research say that human somatic cell
nuclear transfer is an enabling technology that can be used to generate
healthy cells and tissues for repair or replacement in a vast array of
medical applications. To deny our aging population the opportunity to
benefit from this research would be a tragic reversal of recent
biomedical progress toward permanent cure of diseases that compromise
quality of life, and which account for so much of our nation's health
care expenditures.
A prominent member of the Alliance's Science Advisory Board is Dr.
George M. Martin of the University of Washington in Seattle. Dr. Martin
has written: ``those of us in the Alzheimer's Disease Research Center
are using cell cultures in attempts to discover the fundamental
molecular mechanisms that lead to differing rates of neuronal damage in
dementias of the Alzheimer type and related disorders. For obvious
reasons, we cannot work with samples of brain tissue from living
subjects. We are forced to utilize surrogate cells, typically
fibroblasts that can be grown from tiny skin biopsies. The ability to
reprogram such cells so that they can exhibit the properties of the
donor's neural cells would represent an enormous advance.''
I want to make it abundantly clear that the Alliance for Aging
Research is strongly opposed to the cloning of a human being. To my
knowledge that position is supported by virtually every responsible
scientific and health advocacy organization in the U.S. The Alliance
does support responsible and sound biomedical research, including
emerging cellular therapies, which could lead to the development of
treatments or cures for scores of age-related diseases and
disabilities.
We urge this committee to lead the way by drawing a clear
distinction between cloning for human reproductive purposes--which we
oppose--and cloning cells for human therapeutic purposes. Millions of
patients and families, organizations and advocates for health and
scientific research across the land would applaud that kind of
leadership.
Some measures before this committee propose to avoid the cloning of
a human being by bringing into the laboratory the full police powers of
the federal government. These intended anti-cloning proposals would
criminalize laboratory techniques that otherwise might help us find
cures for diseases such as cancer and Alzheimer's.
To threaten university scientists with massive fines and prison
sentences would constitute a massive and unprecedented assault on
research. It would cast a pall over the conduct of academic science.
And it would diminish and contradict the accomplishments of a U.S.
Congress that even now is working nobly to double research funding
through the National Institutes of Health.
At this very moment, tens of millions of older Americans are
suffering from Alzheimer's, Parkinson's, cancer, diabetes and chronic
health problems of aging. Not only are they suffering, but their
families and caregivers are suffering too, and they are hoping that
scientists will find cures for these devastating diseases and
conditions while there is still time. They are in a hurry for answers,
and they look to leaders like you to be their advocates and protectors.
Mr. Chairman, it is likely that we will continue to be confronted
with scientific advances that pose difficult social and ethical
questions. The present momentum in the life sciences, and the profound
implications of what we are learning, will inevitably raise public
concerns.
There is ample time for policymakers, ethicists, scientists, and
patient groups to discuss options that would prevent human cloning, but
which would preserve promising health research. Congress is at its best
when its actions are informed and enriched by slow and careful debate,
by advice from expert sources, and when taken in respect for minority
opinion.
In the case of proposals to limit any of the tools for scientific
and medical research, the need for prudence is especially important,
due to the technical complexity of the issues and the consequences for
public health and well being.
On behalf of the Alliance for Aging Research, I thank the committee
again for its deliberations and for the opportunity to speak to this
issue.
Mr. Bilirakis. Thank you so much, Mr. Perry.
Ms. Norsigian?
STATEMENT OF JUDY NORSIGIAN
Ms. Norsigian. Thank you, Chairman Bilirakis and members of
the committee for the opportunity to speak. My name is Judy
Norsigian. I am Executive Director of the Boston Women's Health
Book Collective, which is best known for the landmark women's
health and sexuality book entitled, ``Our Bodies, Ourselves,''
published first in 1970.
There are now 4.5 million copies in print in 20 languages
around the world, with 10 on the way. The most recent edition
is entitled, ``Our Bodies, Ourselves for the New Century.'' And
there is a new Spanish language cultural adaptation that
appeared last year.
Our organization has a long track record in the area of
women's health and reproductive rights. And I personally serve
on the Board of Directors of a public interest organization
devoted to medical research issues.
And I also have served in the capacity of advisor and on
some planning committees for the Office of Research on Women's
Health at the National Institutes of Health.
I am deeply interested in many avenues of research. I would
like to endorse the comments by Drs. Kass and Newman, so I will
try not to repeat them again.
Our organization joins many other national and
international organizations in calling for a universal ban on
human reproductive cloning. As we said, allowing for cloning
would open the door to treating our children like manufactured
objects. It would pave the way for an unprecedented new form of
eugenics. And it really would serve no justifiable purpose.
Supporters of women's health and reproductive rights have
particular reasons to oppose human cloning. Those who would
encourage human cloning appear oblivious to the enormous risks
to women and children's health that cloning would pose. And
there is no way that human cloning could be developed without,
in effect, mass experimentation on human beings, women and
children, of a sort that has been outlawed since the
formulation of the Nuremburg Principles following World War II.
For these reasons, we call for a permanent ban on the
creation of cloned human beings. And our opposition to human
cloning in no way diminishes our support for a woman's right to
safe, legal, and accessible contraception and abortion
services.
Some medical researchers support the creation of clonal
human embryos for experimental purposes leading to potential
therapeutic applications.
While many women's health advocates may not, in principle,
oppose the use of human embryos for valid medical research,
including their use to generate embryonic stem cells, they do
oppose the creation of clonal human embryos.
To allow this procedure would make it all but impossible to
enforce the ban on the creation of fully formed human clones. I
think that point has been made. There is no such thing as an
enforceable ban, and I won't repeat that.
Further, it would open the door to other, more profound
forms of human genetic manipulation. And for these reasons, we
call for a moratorium on the creation of clonal human embryos
for research purposes.
During such a period, the many non-controversial
alternatives for these purposes could be explored.
I also want to point out that we, along with many others,
have never taken the position that a woman or a man has a right
to biological parenthood and, the corollary position that would
follow, an unlimited right to pursue any type of reproductive
technology that may lead to biological parenthood.
There are many reasons why such a position would be
untenable from the basic view of health and safety alone. More
than 30 countries worldwide already have banned the creation of
human clones and/or imposed constraints on the creation of
clonal embryos.
It is time for the United States to do likewise. The
majority of women's health and reproductive advocates want this
to happen as the future of our common humanity is at stake.
And I do want to say that my interpretation of the Weldon-
Stupak bill is that it goes just the right distance. It will
prevent the things we don't want to have happened from
happening, and it will allow appropriate clonal techniques to
proceed ahead with somatic cells.
And a good deal of the therapeutic benefits that we would
like to see developed can be developed while we oppose the
development of clonal human embryos. Thank you very much.
[The prepared statement of Judy Norsigian follows:]
Prepared Statement of Judy Norsigian, Executive Director, Boston
Women's Health Book Collective
I am Judy Norsigian, the Executive Director of the Boston Women's
Health Book Collective (BWHBC), co-authors of Our Bodies, Ourselves,
the most widely read book about women's health and sexuality since it
was first published in 1970. There are now 4\1/2\ million copies in
print in 20 languages around the world, with 10 more editions on the
way. The 7th and latest English language edition in the United States
is entitled Our Bodies, Ourselves for the New Century. The Spanish
language cultural adaptation--Nuestros Cuerpos, Nuestras Vidas--was
published last year. Our organization has also produced similar books
for teenagers and for older women and sustains a variety of advocacy
and activist efforts related to the health of women, families and
communities. We have a long track record in the field of reproductive
rights and reproductive health.
The BWHBC joins many other national and international organizations
in calling for a universal ban on human reproductive cloning. To allow
the creation of human clones would open the door to treating our
children like manufactured objects. It would violate deeply and widely
held values concerning human individuality and dignity. It would pave
the way for unprecedented new forms of eugenics. And it would serve no
justifiable purpose.
Supporters of women's health and reproductive rights have
particular reasons to oppose human cloning. Those who encourage human
cloning appear oblivious to the enormous risks to women and children's
health that human cloning would pose. There is no way that human
cloning could be developed without, in effect, mass experimentation on
human beings--women and children--of a sort that has been outlawed
since the formulation of the Nuremberg Principles following World War
II.
Further, cloning advocates are seeking to appropriate the language
of reproductive rights to support their case. This is a travesty. There
is an immense difference between seeking to end an unwanted pregnancy
and seeking to create a genetic duplicate human being. Our opposition
to human cloning in no way diminishes our support for a woman's right
to safe, legal, and accessible contraception and abortion services.
For these reasons, we call for a permanent ban on the creation of
cloned human beings.
Some medical researchers support the creation of clonal human
embryos for experimental purposes leading to potential therapeutic
applications. While we do not in principle oppose the use of human
embryos for valid medical research, including their use to generate
embryonic stem cells, we do oppose the creation of clonal human
embryos. To allow this procedure would make it all but impossible to
enforce the ban on the creation of fully formed human clones. Further,
it would open the door to other, more profound forms of human genetic
manipulation. For these reasons, we call for at least a moratorium on
the creation of clonal human embryos for research purposes. During such
a period the many non-controversial alternatives to using clonal
embryos for these purposes could be explored.
More than thirty countries worldwide have already banned the
creation of human clones and/or imposed constraints on the creation of
clonal embryos. It is time for the United States to do likewise. The
vast majority of women's health and reproductive rights advocates want
this to happen. The future of our common humanity is at stake.
Mr. Bilirakis. Thank you very much, Ms. Norsigian.
Mr. Doerflinger?
STATEMENT OF RICHARD M. DOERFLINGER
Mr. Doerflinger. Thank you. I will forego the opportunity
to debate Dr. Guenin on what Catholicism means unless someone
raises it in a question.
The only Catholic quote I will use is this statement from
the Pontifical Academy of Life, which advises the Holy See,
``In the cloning process, the basic relationships of the human
person are perverted; filiation, consanguinity, kinship,
parenthood. A woman can be the twin sister of her mother, lack
a biological father, and be the daughter of her grandmother. In
in vitro fertilization''--I am sorry, ``In vitro fertilization
has already led to the confusion of parentage, but cloning will
mean the radical rupture of these bonds.''
By reducing human reproduction to simple manufacture in the
laboratory, cloning reduces the new human being to a product
and then to a commodity, and obviously opens the door to these
human beings, at any age, being treated as mere research
fodder, as second-class human beings.
We all agree that in the present state of science, it would
be irresponsible to try to produce a live-born child by
cloning, as evidenced by the 95 to 99 percent death rate of
cloned embryos in animal trials.
I would note, though, that if people think that the human
embryo has no status, is chopped liver, then I don't know why
even my pro-choice colleagues agree that that 95 to 99 percent
death rate, most of which happens at the embryonic and fetal
stage, is a problem.
I think the abortion issue and its politics have really
confused the fact that biologically, we are speaking about a
being that is a member of the family with us, and is a member
of the human species.
And the fact that in our current legal situation, there are
other considerations involving competing rights of a pregnant
woman that have been found to override those interests, does
not make the human embryo into a goldfish, as the International
Chairman of the Juvenile Diabetes Foundation has been known to
say.
Now, I want to go into the problem that some people want to
solve the problem of 95 to 99 percent death rate by simply
jacking the death rate up to 100 percent for research purposes.
I don't think that is the right direction.
I think that if you are--if you are going to make new human
beings in such a way that the death rate is anywhere between 95
and 100 percent, it would be a very good idea to decide not to
create those human beings.
But I would like to cite particularly the Greenwood bill. I
agree with Dr. Kass about what the Greenwood bill does, except
I think he has been too kind. I think the Greenwood bill
doesn't ban anything at all in the area of reproductive
cloning.
And Dr. Kass has set forth a number of scenarios in which
one person would make the embryo and another transfer it, or
ship it, and so on. And those are all true.
But let us take the very simplest, most straightforward
case of outright reproductive cloning with one researcher. Now,
that researcher is authorized by this bill, and gets a
registered laboratory, to do research in cloning, presumably
including research to see how efficient the cloning process can
be made in the laboratory to prepare for the day, 10 years
hence, when all bans drop away, and the safety record is
sufficient to argue that we should do reproductive cloning.
Now, on that basis alone, I would call this bill the
Railian agenda with a speed bump. But let us see what happens
in the meantime.
He makes these embryos in the laboratory to test the
efficiency of the process. This time, the embryos look really
good; they look a lot more viable than in the past. So, he now
intends to initiate a pregnancy with them. That is the way this
would happen.
You would never know in advance which embryos are going to
be good enough to try a pregnancy with. And when he initiates
that pregnancy, he is acting fully in accord with this bill.
He is not evading the law. He is obeying the law because
his intent to implant happened after he made the embryos.
So, if this bill does nothing to stop reproductive cloning,
what does it do? It does two things. First, it bans any State
from trying to ban reproductive or research cloning by saying
that the only thing a new State law may do is exactly what this
bill does, which is nothing to stop cloning.
The second thing it does is to actually inject the Federal
Government in a much more active way into the licensing, the
registration, of laboratories to do that process which Mr.
Greenwood quoted me a moment ago, as ``morally abhorrent and
medically questionable,'' except that he was stating that as
the position of the Catholic Church. And actually, I was
paraphrasing President Clinton, Senator Specter, the NIH, and
The Washington Post and The Chicago Sun Times.
This is not something that has been a dividing matter
between pro-life and pro-choice people. Just to cite The
Washington Post, ``The creation of human embryos specifically
for research that will destroy them is unconscionable . . .
[I]t is not necessary to be against abortion rights, or to
believe human life literally begins at conception, to be deeply
alarmed by the notion of scientists purposely causing
conceptions in a context entirely divorced from even the
potential of reproduction.''
Likewise, The Chicago Sun Times has editorialized that
creating research embryos solely for research that will kill
them is an idea that is ``grotesque, at best.''
This is an ethical principle that has united us in the
past. The NIH guidelines forbid creation of embryos for this
stem cell research.
The Specter bill forbids this. And he recently said twice
on the Charlie Rose Show that he continues to hold firmly
against any special creation of embryos for research purposes.
Even among those who support other forms of embryo
research, this has been seen as a moral step too far to the
totally utilitarian demoting of human life into a research
entity.
In short, I think we can support research and support
useful medical progress, but also we should be serious. Do we
want to ban human cloning?
The Greenwood bill does not do it, and we believe the
Weldon bill does, and does so in a way that is very carefully
crafted and effective. Thank you.
[The prepared statement of Richard M. Doerflinger follows:]
Prepared Statement of Richard M. Doerflinger on Behalf of the Committee
for Pro-Life Activities, National Conference of Catholic Bishops
I am Richard M. Doerflinger, Associate Director for Policy
Development at the Secretariat for Pro-Life Activities, National
Conference of Catholic Bishops. I am grateful for this opportunity to
testify on human cloning, and to express our Conference's support for a
federal ban on the practice as proposed in Congressman Weldon's ``Human
Cloning Prohibition Act of 2001'' (H.R. 1644).
The sanctity and dignity of human life is a cornerstone of Catholic
moral and social teaching. We believe a society can be judged by the
respect it shows for human life, especially in its most vulnerable
stages and conditions.
At first glance, human cloning may not seem to threaten respect for
life because it is presented as a means for creating life, not
destroying it. Yet it shows disrespect for life in the very act of
generating it. Here human life does not arise from an act of love, but
is manufactured in the laboratory to preset specifications determined
by the desires of others. Developing human beings are treated as
objects, not as individuals with their own identity and rights. Because
cloning completely divorces human reproduction from the context of a
loving union between man and woman, such children have no ``parents''
in the usual sense. As a group of experts advising the Holy See has
written:
In the cloning process the basic relationships of the human
person are perverted: filiation, consanguinity, kinship,
parenthood. A woman can be the twin sister of her mother, lack
a biological father and be the daughter of her grandmother. In
vitro fertilization has already led to the confusion of
parentage, but cloning will mean the radical rupture of these
bonds.1
---------------------------------------------------------------------------
\1\ Reflections from the Pontifical Academy for Life, ``Human
Cloning Is Immoral'' (July 9, 1997), in The Pope Speaks, vol. 43, no. 1
(January/February 1998), p. 29. Also see: Congregation for the Doctrine
of the Faith, Donum Vitae (Instruction on Respect for Human Life in its
Origin and on the Dignity of Procreation)(March 10, 1987), I.6 and
II.B.
---------------------------------------------------------------------------
From the dehumanizing nature of this technique flow many disturbing
consequences. Because human clones would be produced by a means that
involves no loving relationship, no personal investment or
responsibility for a new life, but only laboratory technique, they
would be uniquely at risk of being treated as ``second-class'' human
beings.
In the present state of science, attempts to produce a liveborn
child by cloning would require taking a callous attitude toward human
life. Animal trials show that 95 to 99% of cloned embryos die. Of those
which survive, many are stillborn or die shortly after birth. The rest
may face unpredictable but potentially devastating health problems.
Those problems are not detectable before birth, because they do not
come from genetic defects as such--they arise from the disorganized
expression of genes, because cloning plays havoc with the usual process
of genetic reorganization in the embryo.2
---------------------------------------------------------------------------
\2\ See Testimony before the House Energy and Commerce Subcommittee
on Oversight and Investigations, March 28, 2001, presented by Dr. Mark
E. Westhusin and Dr. Rudolf Jaenishch (http://energycommerce.house.gov/
107/hearings/03282001Hearing141/hearing.htm).
---------------------------------------------------------------------------
Scenarios often cited as justifications for human cloning are
actually symptoms of the disordered view of human life that it reflects
and promotes. It is said that cloning could be used to create
``copies'' of illustrious people, or to replace a deceased loved one,
or even to provide genetically matched tissues or organs for the person
whose genetic material was used for the procedure. Each such proposal
is indicative of a utilitarian view of human life, in which a fellow
human is treated as a means to someone else's ends--instead of as a
person with his or her own inherent dignity. This same attitude lies at
the root of human slavery.
Let me be perfectly clear. In objective reality a cloned human
being would not be an ``object'' or a substandard human being. Whatever
the circumstances of his or her origin, he or she would deserve to be
treated as a human person with an individual identity. But the
depersonalized technique of manufacture known as cloning disregards
this dignity and sets the stage for further exploitation. Cloning is
not wrong because cloned human beings would lack human dignity--it is
wrong because they have human dignity, and are being brought into the
world in a way that fails to respect that dignity.
Ironically, startling evidence of the dehumanizing aspects of
cloning is found in some proposals ostensibly aimed at preventing human
cloning. These initiatives would not ban human cloning at all--but
would simply ban any effort to allow cloned human embryos to survive.
In these proposals, researchers are allowed to use cloning for the
unlimited mass production of human embryos for experimentation--and are
then required by law to destroy them, instead of allowing them to
implant in a woman's womb.
In other words: Faced with a 99% death rate from cloning, such
proposals would ``solve'' the problem by ensuring that the death rate
rises to 100%. No live clones, therefore no evidence that anyone
performed cloning. This is reassuring for researchers and biotechnology
companies who may wish the freedom to make countless identical human
guinea pigs for lethal experiments. It is no great comfort to the dead
human clones; nor is it a solution worthy of us as a nation.
Congressman Greenwood's ``Cloning Prohibition Act of 2001'' (H.R.
2172) is even worse than previous bills of this kind. It would actually
have the Department of Health and Human Services authorize and license
the practice of destructive cloning. In a new way, our government would
be actively involved in human cloning--but only to ensure that no
cloned embryos get out of the laboratory alive. Under the guise of a
ban on cloning, the government would assist researchers in refining
their procedure; then, ten years after the date of enactment, it would
obligingly drop all penalties for using cloning to initiate a
pregnancy, so they could use their newly honed skills to manufacture
babies. This bill would even invalidate any future state law seeking to
establish a genuine ban on cloning, by preempting any such law that
does not take the same irresponsible approach.
Sometimes it is said that such proposals would ban ``reproductive
cloning'' or ``live birth cloning,'' while allowing ``therapeutic
cloning'' or ``embryo cloning.'' This may sound superficially
reasonable. If banning all cloning is too difficult a task, perhaps we
could ban half of it--and the half that is ``therapeutic'' sounds like
the half we'd like to keep.
But this description relies on a fundamental confusion as to what
cloning is. I can sum up the real situation in a few propositions.
1. All human cloning is embryo cloning. Some accounts of cloning
seem to imagine that cloning for research purposes produces an embryo,
while cloning for reproductive purposes produces a baby or even a fully
grown adult--like new copies of Michael Keaton or Arnold Schwarzenegger
springing full-grown from a laboratory. This is, of course, nonsense.
In the words of Professor Lee Silver of Princeton University, a leading
advocate of human cloning: ``Real biological cloning can only take
place at the level of the cell.'' 3
---------------------------------------------------------------------------
\3\ Lee M. Silver, Remaking Eden: How Genetic Engineering and
Cloning Will Transform the American Family (Avon Books 1998) at 124.
---------------------------------------------------------------------------
Cloning technology can also be used to produce other kinds of
cells; these are not the subject of this hearing, and they are
explicitly excluded from the scope of Congressman Weldon's legislation.
But when somatic cell nuclear transfer is used to replace the nucleus
of an egg with the nucleus of a human body cell and the resulting cell
is stimulated, a human embryo results, whatever one's ultimate plans on
what to do next.4
---------------------------------------------------------------------------
\4\ See the Fact Sheet, ``Does Human Cloning Produce an Embryo?'',
Secretariat for Pro-Life Activities, National Conference of Catholic
Bishops, March 31, 1998 (www.nccbuscc.org/prolife/issues/bioethic/
fact398.htm).
---------------------------------------------------------------------------
2. In an important sense, all human cloning is reproductive
cloning. Once one creates a live human embryo by cloning, one has
engaged in reproduction--albeit a very strange form of asexual
reproduction. All subsequent stages of development--gestation, birth,
infancy, etc.--are simply those which normally occur in the development
of any human being (though reaching them may be far more precarious for
the cloned human, due to the damage inflicted by the cloning
procedure).
To say this is not to make a controversial moral claim about
personhood or legal rights.5 It is to state a biological
fact: Once one produces an embryo by cloning, a new living being has
arrived and the key event in reproduction has taken place. The complete
human genome that once belonged to one member of the human species now
also belongs to another. Anything that now happens to this being will
be ``environmental'' influence upon a being already in existence--
transfer to a womb and live birth, for example, are chiefly simple
changes in location.
---------------------------------------------------------------------------
\5\ Professor Silver, for example, agrees that cloning is
accomplished at the embryonic level, while also claiming that the
cloned embryo (and all other embryos) lack full moral significance
until later in development. To his Princeton colleague Peter Singer and
some other bioethicists, humans do not acquire the rights of persons
until some time after birth. See P. Singer, ``Justifying Infanticide,''
in Writings on an Ethical Life (HarperCollins 2000), 186-193.
---------------------------------------------------------------------------
Moreover, even government study commissions favoring harmful human
embryo experiments concede that with the generation of a new embryo, a
new life has come into the world. They describe the early embryo as ``a
developing form of human life'' which ``warrants serious moral
consideration.'' 6
---------------------------------------------------------------------------
\6\ Final Report of the Human Embryo Research Panel (National
Institutes of Health: September 27, 1994) at 2. The National Bioethics
Advisory Commission, which defined the embryo as ``the beginning of any
organism in the early stages of development,'' likewise said that ``the
embryo merits respect as a form of human life'' (though not, the
Commission thought, the level of respect owed to persons). See Ethical
Issues in Human Stem Cell Research (National Bioethics Advisory
Commission: September 1999) at 85, 50. Also see the sources cited in
the Fact Sheet, ``What is an Embryo?'', Secretariat for Pro-Life
Activities, National Conference of Catholic Bishops, Feb. 26, 1998
(www.nccbuscc.org/prolife/issues/bioethic/fact298.htm).
---------------------------------------------------------------------------
Thus generating this new human life in the laboratory confronts us
with new moral questions: Not ``Should we clone?'' but ``What do we do
with this living human we have produced by cloning?'' If all the
available answers are lethal to the cloned human 95% to 100% of the
time, we should not allow cloning.
3. All human cloning, at present, is experimental cloning. The line
between ``reproductive'' and ``experimental'' cloning is especially
porous at present, because any attempt to move toward bringing a cloned
child to live birth would first require many thousands of trials using
embryos not intended for live birth. Years of destructive research of
this kind may be necessary before anyone could bring a cloned human
through the entire gestational process with any reasonable expectation
of a healthy child. Therefore legislation which seeks to bar creation
of a cloned embryo for purposes of live birth, while allowing unlimited
experimental cloning, would actually facilitate efforts to refine the
cloning procedure and prepare for the production of liveborn children.
This would be irresponsible in light of the compelling principled
objections to producing liveborn humans by cloning.
4. No human cloning is ``therapeutic'' cloning. The attempt to
label cloning for purposes of destructive experiments as ``therapeutic
cloning'' is a stroke of marketing genius by supporters of human embryo
research. But it does serious damage to the English language and common
sense, for two reasons.
First, the experiments contemplated here are universally called
``nontherapeutic experimentation'' in law and medical ethics--that is,
the experiments harm or kill the research subject (in this case the
cloned human embryo) without any prospect of benefitting that subject.
This standard meaning of ``nontherapeutic'' research is found, for
example, in various state laws forbidding such research on human
embryos as a crime.7 Experiments performed on one subject
solely for possible benefit to others are never called ``therapeutic
research'' in any other context, and there is no reason to change that
in this context.
---------------------------------------------------------------------------
\7\ For example, see La. Rev. Stat. tit. 14 Sec. 87.2 (a crime to
conduct any experiment or study on a human embryo except to preserve
the health of that embryo) and tit. 40 Sec. 1299.35.13 (prohibiting
experimentation on an unborn child unless it is therapeutic to that
child); Mich. Comp. Laws Sec. 333.2685 (prohibiting use of a live human
embryo for nontherapeutic research that will harm the embryo); Pa.
Cons. Stat. tit. 18 Sec. 3216(a) (nontherapeutic experimentation on an
unborn child at any stage is a felony; defining ``nontherapeutic'');
S.D. Codified Laws Sec. Sec. 34-14-16 through 34-14-20 (prohibiting
nontherapeutic research that harms or destroys a human embryo; defining
``nontherapeutic research'').
---------------------------------------------------------------------------
Second, the ``therapeutic'' need for human cloning has always been
highly speculative; it now seems more doubtful than ever in light of
recent advances in adult stem cell research and other noncontroversial
alternatives. In the stem cell research debate, as one recent news
report observes, ``There is one thing everyone agrees on: Adult stem
cells are proving to be far more versatile than originally thought.''
8 Adult stem cells have shown they can be ``pluripotent''--
producing a wide array of different cells and tissues.9 They
can also be multiplied in culture to produce an ample supply of tissue
for transplantation.10 Best of all, using a patient's own
cells solves all problems of tissue rejection, the chief advantage
cited until now for use of cloning.11
---------------------------------------------------------------------------
\8\ A. Zitner, ``Diabetes Study Fuels Stem Cell Funding War,'' Los
Angeles Times, April 27, 2001 (www.latimes.com/news/nation/updates2/
lat--stemwar010427.htm).
\9\ Citing eleven other studies, a study funded by the National
Institutes of Health (NIH) and the Christopher Reeve Paralysis
Foundation states: ``Pluripotent stem cells have been detected in
multiple tissues in the adult, participating in normal replacement and
repair, while undergoing self-renewal.'' D. Woodbury et al., ``Adult
Rat and Human Bone Marrow Stromal Cells Differentiate Into Neurons,''
61 Journal of Neuroscience Research 364-370 (August 15, 2000) at 364.
\10\ See: D. Colter et al., ``Rapid expansion of recycling stem
cells in cultures of plastic-adherent cells from human bone marrow,''
97 Proc. Natl. Acad. Sci. USA 3213-8 (March 28, 2000)(adult stem cells
amplified a billion-fold in six weeks, retaining their
multipotentiality for differentiation); E. Rosler et al.,
``Cocultivation of umbilical cord blood cells with endothelial cells
leads to extensive amplification of competent CD34+CD38-cells,'' 28
Exp. Hematol. 841-52 (July 2000).
\11\ A recent report on use of adult stem cells to form new
muscles, nerves, liver cells and blood vessels observes: ``None of
these approaches use embryonic stem cells, which some oppose on ethical
grounds. Another advantage is that they use tissue taken from the
patient's own body, so there is no risk of rejection or need for drugs
to suppress immune system defenses.'' See ``Approach may renew worn
hearts,'' Associated Press, November 12, 2000.
---------------------------------------------------------------------------
In 1997 the National Bioethics Advisory Commission reviewed the
idea of cloning human embryos to create ``customized stem cell lines''
but described this as ``a rather expensive and far-fetched scenario''--
and added that a moral assessment is necessary as well:
Because of ethical and moral concerns raised by the use of
embryos for research purposes it would be far more desirable to
explore the direct use of human cells of adult origin to
produce specialized cells or tissues for transplantation into
patients.12
---------------------------------------------------------------------------
\12\ Cloning Human Beings: Report and Recommendations of the
National Bioethics Advisory Commission (Rockville, MD: June 1997) at
30-31. The Commission outlined three alternative avenues of stem cell
research, two of which seemed not to involve creating human embryos at
all.
---------------------------------------------------------------------------
Now PPL Therapeutics, the Scottish firm involved in creating
``Dolly'' the sheep, says it has indeed found a way to reprogram
ordinary adult cells to become stem cells capable of being directed to
form almost any kind of cell or tissue--without creating or destroying
any embryos.13
---------------------------------------------------------------------------
\13\ ``PPL follows Dolly with cell breakthrough,'' Financial Times,
February 23, 2001.
---------------------------------------------------------------------------
Even in the field of embryonic stem cell research, new developments
have called into question the need for cloning. The problem of tissue
rejection may not be as serious as once thought when cells from early
human development are used, and there are other ways of solving the
problem--for example, by genetically modifying cells to become a closer
match to a patient.14
---------------------------------------------------------------------------
\14\ P. Aldhous, ``Can they rebuild us?'', 410 Nature 622-5 (5
April 2001) at 623.
---------------------------------------------------------------------------
For all these reasons, a recent overview of the field concludes
that human ``therapeutic cloning'' is ``falling from favour,'' that
``many experts do not now expect therapeutic cloning to have a large
clinical impact.'' Even James Thomson of the University of Wisconsin, a
leading practitioner and advocate of embryonic stem cell research
generally, calls this approach ``astronomically expensive''; in light
of the enormous wastefulness of the cloning process and the damage it
does to gene expression, ``many researchers have come to doubt whether
therapeutic cloning will ever be efficient enough to be commercially
viable'' even if one could set aside the grave moral issues
involved.15
---------------------------------------------------------------------------
\15\ Id. at 622.
---------------------------------------------------------------------------
We should clearly understand what would be entailed by any effort
to implement a ``therapeutic cloning'' regimen for stem cell
transplants. This would not be a case in which human embryos are
destroyed once to form a permanent cell line for future use. For each
individual patient, countless human embryos--the patient's genetic twin
brothers or sisters--would have to be created in the laboratory and
then destroyed for their stem cells, in the hope of producing
genetically matched tissue for transplantation. Thus the creation and
destruction of human life in the laboratory would become an ongoing
aspect not only of medical research but of everyday medical practice.
And what would become of those who have profound moral objections to
cloning, and to having new lives created and destroyed for our benefit?
Would we be told that we must choose between our life and our
conscience?
In short, the ``therapeutic'' case for cloning is as morally
abhorrent as it is medically questionable. Which brings me to a final
proposition on how to assess proposals for preventing human cloning.
5. Because cloned humans are humans, any proposal to prevent human
cloning must not do to cloned humans anything that would be universally
condemned if done to other humans at the same stage of development.
This proposition can be universally endorsed by people on both
sides of the cloning issue, and on both sides of the abortion issue. To
quote Lee Silver once more: ``Cloned children will be full-fledged
human beings, indistinguishable in biological terms from all other
members of the human species.'' 16 Thus, for example, cloned
embryos deserve as much respect as other human embryos of the same
stage--whatever that level of respect may be.
---------------------------------------------------------------------------
\16\ Silver at 125.
---------------------------------------------------------------------------
Silver's point about cloned humans being ``indistinguishable'' from
others raises a major practical problem for efforts to allow creation
of cloned embryos while forbidding their transfer to a womb. Once the
embryo is created in a fertility clinic's research lab (as such a law
would permit) and is available for transfer, how could the government
tell that this embryo was or was not created by cloning? And if it
cannot do so, how can it enforce a prohibition on transferring cloned
embryos (but not IVF embryos) to a woman's womb?
However, an even more serious moral and legal issue arises at this
point. If the government allows use of cloning to produce human embryos
for research but prohibits initiating a pregnancy, what will it be
requiring people to do? If pregnancy has already begun, the only remedy
would seem to be government-mandated abortion--or at least, jailing or
otherwise punishing women for remaining pregnant and giving birth. We
need not dwell on the abhorrence such a solution would rightly provoke
among people on all sides of the abortion issue. It would be as ``anti-
choice'' as it is ``anti-life.''
However, even if the law could act before transfer actually occurs,
the problem is equally intractable. For the law would have to require
that these embryos be killed--defining for the first time in U.S.
history a class of human embryos that it is a crime not to destroy. It
is impossible to reconcile such a law with the profound ``respect'' and
``serious moral consideration'' that even supporters of human embryo
research say should be accorded to all human embryos.
If the law permitted (or, even worse, licensed) creation of cloned
embryos for research, while prohibiting their creation for any other
purpose (or prohibiting any other use of them once created), the
government would be approving the one practice in human embryo research
that is widely condemned even by supporters of abortion rights:
specially creating human embryos solely for the purpose of research
that will kill them.
In 1994 the National Institutes of Health did propose funding such
abuses, as part of a larger proposal for funding human embryo research
generally. The moral outcry against this aspect of the proposal,
however, was almost universal. Opinion polls showed massive opposition,
and the NIH panel making the recommendation was inundated with over
50,000 letters of protest. The Washington Post, while reaffirming its
support for legalized abortion, attacked the Panel's recommendation:
The creation of human embryos specifically for research that
will destroy them is unconscionable . . . [I]t is not necessary
to be against abortion rights, or to believe human life
literally begins at conception, to be deeply alarmed by the
notion of scientists' purposely causing conceptions in a
context entirely divorced from even the potential of
reproduction.17
---------------------------------------------------------------------------
\17\ Editorial, ``Embryos: Drawing the Line,'' The Washington Post,
October 2, 1994 at C6.
---------------------------------------------------------------------------
The Chicago Sun-Times likewise editorialized:
We can debate all day whether an embryo is or isn't a person.
But it is unquestionably human life, complete with its own
unique set of human genes that inform and drive its own
development. The idea of the manufacture of such a magnificent
thing as a human life purely for the purpose of conducting
research is grotesque, at best. Whether or not it is federally
funded.18
---------------------------------------------------------------------------
\18\ Editorial, ``Embryo Research Is Inhuman,'' Chicago Sun-Times,
October 10, 1994 at 25.
---------------------------------------------------------------------------
In the end, President Clinton set aside the recommendation for creation
of ``research embryos.''
Every year since then, Congress has prohibited funding for all
harmful embryo research at the National Institutes of Health, through
the Dickey amendment to the annual Labor/HHS appropriations
bills.19 However, even members of Congress who have led the
opposition to the Dickey amendment agree with its rejection of special
creation of human embryos for research. On the only occasion when an
amendment was offered on the House floor to weaken the Dickey
amendment, the sponsors emphasized that it would leave intact the
clause rejecting the creation of embryos for research.20
Similarly, the recent NIH guidelines for embryonic stem cell research,
as well as Senator Specter's ``Stem Cell Research Act of 2001,''
explicitly reject the idea of using embryos specially created for
research purposes.21
---------------------------------------------------------------------------
\19\ The current version is Section 510 of the Labor/HHS
appropriations bill for Fiscal Year 2001, H.R. 5656 (enacted through
Section 1(a)(1) of H.R. 4577, the FY '01 Consolidated Appropriations
Act, Public Law 106-554). It bans funding any creation of human embryos
(by cloning or other means) for research purposes, and any research in
which human embryos are harmed or destroyed.
\20\ ``Let me say that I agree with our colleagues who say that we
should not be involved in the creation of embryos for research. I
completely agree with my colleagues on that score,'' said Rep. Nancy
Pelosi, arguing in favor of research on ``spare'' embryos originally
created for fertility treatment. The sponsor of the weakening
amendment, Rep. Nita Lowey, said: ``I want to make it very clear: We
are not talking about creating embryos . . . President Clinton again
has made it very clear that early-stage embryo research may be
permitted but that the use of Federal funds to create embryos solely
for research purposes would be prohibited. We can all be assured that
the research at the National Institutes of Health will be conducted
with the highest level of integrity. No embryos will be created for
research purposes . . .'' 142 Cong. Record at H7343 (July 11,
1996)(emphasis added). The weakening amendment failed nonetheless, 167
to 256. Id. at H7364. While this debate concerned federal funding,
supporters of the Lowey amendment said it was ``very hard to
understand'' why standards for ethical research should be different for
publicly funded and privately funded research. See remarks of Rep.
Fazio at H7341-2.
\21\ The NIH guidelines deny funding for ``research utilizing
pluripotent stem cells that were derived from human embryos created for
research purposes,'' and ``research in which human pluripotent stem
cells are derived using somatic cell nuclear transfer, i.e., the
transfer of a human somatic cell nucleus into a human or animal egg.''
National Institutes of Health Guidelines for Research Using Human
Pluripotent Stem Cells, 65 Fed. Reg. 51976-81 (August 25, 2000) at
51981. Senator Specter's bill supports embryonic stem cell research but
insists that ``the research involved shall not result in the creation
of human embryos.'' 107th Congress, S. 723, Sec. 2.
---------------------------------------------------------------------------
As mentioned above, at least nine states generally prohibit harmful
experiments on human embryos living outside a woman's body. A federal
law that facilitates such experimentation, by approving it as the only
accepted use for human embryo cloning, would mark a radical departure
from state precedents on respect for nascent human life.22
In short, human embryos produced by cloning would be created
specifically, and solely, for destructive embryo experiments that are a
crime in some states.
---------------------------------------------------------------------------
\22\ In Louisiana, for example, a human embryo fertilized in the
laboratory may generally be used only for efforts at a live birth, not
for research. La. Rev. Stat. tit. 9 Sec. 122. What would happen if a
new federal law turned this on its head, and banned creating embryos
for live birth while allowing their creation for destructive research--
keeping in mind that cloned embryos may be biologically
indistinguishable from IVF embryos once created?
---------------------------------------------------------------------------
Ironically, it seems the cloning procedure is so demeaning and
dehumanizing that people somehow assume that a brief life as an object
of research, followed by destruction, is ``good enough'' for any human
produced by this technique. The fact that the procedure invites such
morally irresponsible policies is another reason to ban it. For if an
embryo produced by cloning cannot even garner the respect that we all
agree should be accorded to all other human embryos, but is treated as
a dangerous entity that must not be allowed to survive, how will we
view any human clone who is ultimately born alive? As a mere ``organ
farm'' for others? Or could we compartmentalize our thinking, so that
an embryo created solely for destructive research will be greeted as a
new individual with full human rights if someone does bring him or her
to full term? In light of some uses proposed even now for born human
clones, it would be foolish to assume that our society will shift gears
so easily.
We must remember that it is morally wrong and irresponsible to make
human clones, not to be a human clone. The innocent victim of cloning
should not receive a government-sanctioned death penalty simply for the
crime of existing. Therefore the approach taken by the Weldon bill,
prohibiting the use of cloning to initiate the development of a new
human organism, is the only morally responsible approach as well as the
clearest and most effective one in practical terms.
The Weldon bill even incorporates key distinctions and
recommendations made by the Biotechnology Industry Organization (BIO)
and its leading spokesperson on cloning. It bans the specific act of
using cloning to make a new human organism, but does not ban
``therapeutic cloning'' as defined in Dr. Okarma's recent House
testimony on behalf of BIO: ``cloning specific human cells, genes and
other tissues that do not and cannot lead to a cloned human being.''
23 This bill clearly exempts from its scope the use of
cloning to make any cells other than human embryos. And the Weldon
bill's distinction between human embryos, which are complete human
organisms, and other cells such as pluripotent stem cells, which are
not, was strongly affirmed by BIO's chief spokesperson on cloning in
December 1998 as a basis for federal policy on embryo
research.24
---------------------------------------------------------------------------
\23\ Testimony of Dr. Thomas Okarma on behalf of the Biotechnology
Industry Organization (BIO) before the House Energy and Commerce
Subcommittee on Oversight and Investigations, March 28, 2001.
\24\ In his December 2, 1998 testimony before the Senate
Appropriations Subcommittee on Labor, Health and Human Services and
Education, Dr. Okarma joined other scientists and ethicists in agreeing
that a stem cell is not a human ``organism'' as a human embryo is, and
therefore is not covered by the statutory ban on federal funding for
human embryo research. HHS General Counsel Harriet Rabb also relied
heavily on this distinction (and this testimony) in finding that the
federal government may fund embryonic stem cell research. If this
distinction between human embryos and all other cells were problematic,
unclear or unenforceable, the current NIH guidelines for stem cell
research would clearly be illegal. (As I pointed out to the same Senate
subcommittee in my January 26, 1999 testimony, the NIH guidelines are
in fact illegal but on other grounds. See www.nccbuscc.org/prolife/
issues/bioethic/test99.htm.)
---------------------------------------------------------------------------
By contrast, the Greenwood bill is not only morally unacceptable
because of the encouragement it gives to experimental human cloning--it
also contains features which BIO has said are unacceptable in any
cloning ban. For example, instead of prohibiting the specific act of
cloning a human being, it relies heavily on the ``intent'' of
researchers in an attempt to define good and bad uses for human
cloning. BIO has declared that such a subjective standard ``could grant
undue discretion to enforcers, create uncertainty for researchers, and
consequently have a broad chilling effect among researchers.''
25 Moreover, unlike the Weldon bill, the Greenwood proposal
has a forfeiture clause calling for the confiscation of all a
violator's assets, which BIO has said will have ``a definite chilling
effect of investor interest in funding research.'' 26
---------------------------------------------------------------------------
\25\ Actually the bill's ``intent'' standard makes its
enforceability doubtful. A researcher's ``intent'' for future use of a
cloned embryo is inherently changeable and unknowable, so it will be
extremely difficult to prove until he or she acts on that intent by
using the embryo to initiate a pregnancy--at which point it is too late
for any morally defensible or constitutionally sound way to prevent the
birth of cloned humans. If BIO's charges about a chilling effect on
legitimate research are also correct, the Greenwood bill will be an
unusual achievement--a bill that would never lead to a conviction
against its supposed targets, but in the meantime would harass and
frighten those who conduct research the bill ostensibly seeks to
protect.
\26\ See BIO's criteria for cloning legislation, posted on the
organization's Web site at www.bio.org/laws/cloning__paper2.html.
---------------------------------------------------------------------------
Contrary to what the biotechnology industry may now claim in a
clumsy attempt to block any real ban on cloning, then, BIO's own
standards suggest that the Greenwood bill is a far greater threat to
legitimate medical research than the Weldon bill could be. In addition,
the Greenwood bill is singularly ineffectual at doing what it was
supposedly designed to do--that is, preventing the live birth of human
clones. While it seeks to ban the creation of cloned embryos with the
``intent'' to initiate a pregnancy, it freely allows the unlimited
creation of these embryos in the laboratory--and then freely allows
anyone (except the person who first created them) to use them to
initiate a pregnancy, since the act of doing so is not itself
prohibited. The only way to prevent the live birth of cloned humans
once this is allowed to occur, of course, would be the odious and
unacceptable solution of coercing an abortion.
In any event, the Greenwood bill's ``rule of construction''
vitiates any ban in two ways. First, it exempts from the ban any use of
cloning to create ``cells'' regardless of one's further intent on how
to use them--and a new human embryo is, of course, a cell of a very
special type. Second, it exempts ``[t]he use of in vitro fertilization,
the administration of fertility-enhancing drugs, or the use of other
medical procedures to assist a woman in becoming or remaining
pregnant''--and of course, the transfer of an embryo (whether produced
by cloning or not) to a woman's womb is a medical procedure which could
assist her in becoming pregnant.
This is a cloning ban that only a supporter of cloning could
love.27 It combines the moral defect of establishing a
regimen for the government-mandated destruction of human lives, and the
practical defect of massive loopholes that will ensure the arrival of
live-birth cloning as well.
---------------------------------------------------------------------------
\27\ Indeed BIO, which now supports the Greenwood bill, previously
announced on several occasions that it favors no new legislation
against human cloning. BIO recommended to the National Bioethics
Advisory Commission that a ``voluntary moratorium'' on cloning (which
is to say, no moratorium at all) be continued ``in lieu of any new
federal law or regulation regarding the cloning of an entire human
being.'' See www.bio.org/bioethics/nbac.html. In its recent March 28
testimony BIO reaffirmed its opposition to any new federal ban on human
cloning. The Greenwood bill is exempt from this policy because it is no
ban at all. It would even preempt and thus invalidate any effective
future ban a state may enact, creating a situation better for the most
irresponsible researchers (and far
---------------------------------------------------------------------------
In short: Some would reject the most straightforward and effective
legislation against human cloning, solely to protect the use of cloning
for a practice (creating human embryos solely for research) which is of
highly questionable use and has been rejected by policy makers on both
sides of the abortion and stem cell debates. Such advocacy should not
prevent Congress from taking the right course on this issue.
Research in the cloning of animals, plants, and even human genes,
tissues and cells (other than embryos) can be beneficial and presents
no intrinsic moral problem. However, when research turns its attention
to human subjects, we must be sure not to undermine human dignity in
the pursuit of human progress. Human experimentation divorced from
moral considerations might progress more quickly on a technical level--
but at the loss of our humanity.
A ban on human cloning will help direct the scientific enterprise
toward research that benefits human beings without producing,
exploiting and destroying fellow human beings to gain those benefits.
Creating human life solely to cannibalize and destroy it is the most
unconscionable use of human cloning--not its highest justification.
Mr. Bilirakis. Thank you very much, Mr. Doerflinger.
Mr. Fukuyama?
STATEMENT OF FRANCIS FUKUYAMA
Mr. Fukuyama. Thank you, Mr. Chairman, for the opportunity
to testify before this subcommittee on the subject of human
cloning. I am Dr. Francis Fukuyama. For another 10 days, I will
be a professor at George Mason University, at which point I
become Bernard Schwartz Professor of International Political
Economy at the Paul H. Nitze School of Advanced International
Studies, John Hopkins University.
And I have been working very intensively over the past few
years on the implications of modern biology for politics, and
particularly for issues--on issues of international governance
related to biotechnology.
Now, one advantage of being the last speaker is that I have
found that most of my points have already been made by other
panelists, so I skip over a number of sections.
I am opposed to cloning for the reasons I think that have
been, particularly by Dr. Kass, articulated, by other speakers
as well articulated, very well. And I think that it is
extremely important, in light of the consensus on reproductive
cloning that is evident in this room, that the Congress act
quickly on this to establish the principle that it is not
scientists who are sovereign, but the political community, the
Democratic political community as such, that is sovereign and
has the power to control the pace and scope of such
technological developments.
There is another reason I think for Congress to act
quickly, which is related to our American political system. In
the past, it has been the case that the Courts have stepped
into controversial areas of social policy when the Legislature
has failed to negotiate acceptable political rules. This was
the case in abortion and bussing, among other things.
In the absence of Congressional action on cloning, it is
conceivable that the Courts, at some later point, may be
tempted or compelled to step into the breach and discover, for
example, that human cloning, or research on cloning, is a
Constitutionally protected right.
I think this would be an absurd outcome. It would certainly
be a very poor approach to the formulation of law and public
policy.
So, the American people, therefore, need to express their
will on human cloning at the first opportunity through their
democratically elected representatives.
Of the two bills, H.R. 1644 and H.R. 2172, I support the
former, the Weldon bill again, primarily because of the non--
what I regard as the non-enforceability of the ban on
reproductive cloning, which has, again, been articulated by
earlier speakers.
I would make one further point. I believe that creation of
embryos for research purposes, in itself, is morally
questionable. I am fairly agnostic on the question of abortion.
But it does seem to me that there is an intermediate position.
You do not have to believe that a one-cell embryo is a
human being, a full human being, to believe also that it is not
just another cell, because it has the potential to develop into
a full human being.
One of the earlier speakers said that Kant would have said,
well, the rule about treating people as ends, not as means
applies only to rational human beings. If that were the case,
you could experiment on infants because I have never met an
infant that was particularly rational in my conversation with
them.
The issue I would like to raise before this committee
concerns the international dimensions of any effort to regulate
a medical technology like human cloning. Opponents of a
legislative ban frequently argue that such a ban would be
rendered ineffective by the fact that we live in a globalized
world, and any attempt to regulate a medical technology by
sovereign nation states can easily be side-stepped by moving
the research to another jurisdiction.
There are other advanced countries in Europe and Asia that
are eager to move ahead in biotechnology, it is said, and the
U.S. will risk falling behind technologically if we hobble
ourselves by restricting either research into or the actual
practice of cloning.
In the absence of comprehensive international regulation,
no national regulation will work. This is part of a widespread,
larger belief that technological advance should not and cannot
be stopped.
I believe that this line of reasoning is fundamentally
flawed. In the first place, it is simply not the case that the
pace and scope of technological advance cannot be controlled
politically.
There are many dangerous and controversial technologies,
including nuclear weapons and nuclear power, ballistic
missiles, biological and chemical warfare agents, replacement
of human body parts, neuropharmacological drugs, and, indeed,
genetically engineered crops and the like, which cannot be
freely developed or traded internationally.
We have successfully regulated experimentation in human
subjects internationally for many decades. And the fact that
none of these regulator regimes has ever been leak-proof or the
regulations fully implemented is not an excuse for not trying
to put them in place in the first instance.
And second, I think that to argue that any national ban or
regulation cannot precede an international agreement on the
subject is to put the cart before the horse. Regulation never
starts at an international level.
Nation states have to set up enforceable rules for their
own societies before they can even think about international
ones.
The United States is economically, politically, and
culturally a dominant force in the world and will have an
enormous impact on other societies.
Council on Europe has already passed a ban on cloning. To
date, 24 countries have enacted national bans on cloning. And
in regard to the difference between the two bills, I should
point out although it is mentioned that England has passed a
very permissive legislation on research cloning, that France,
Germany, Austria, Switzerland, Norway, Brazil and Peru have
already passed explicit legislation prohibiting it.
And laws in Ireland, Hungary, Poland, Costa Rica and
Ecuador implicitly ban this procedure. So, there is an open
question whether England will be an outlier in this regard, or
whether it is the tip of an iceberg. It is hard to predict that
in advance, but we can't know that unless we try to do the
legislation.
I finally believe that international competition in
biomedical research is an important problem. But we cannot
answer it by simply agreeing to join in a technological arms
race.
My final point is that human cloning is the first of many
political decisions and battles that will occur over
biotechnology. I think in the future total bans on research and
technology development of the sort envisioned by H.R. 1644 will
not be the right model.
We will soon need a regulatory structure that will permit
us, on a routine basis, to make decisions that distinguish
between technologies that we regard as positive, and helpful
advances for human wellbeing, and those that raise troubling
moral and political questions.
However, that is not the case with the issue of human
cloning where there is a large consensus that it is not
acceptable and very few interests in its favor. Thank you very
much for your attention.
[The prepared statement of Francis Fukuyama follows:]
Prepared Statement of Francis Fukuyama, Omer L. and Nancy Hirst
Professor of Public Policy, George Mason University
Thank you, Mr. Chairman, for the opportunity to testify before this
subcommittee on the subject of human cloning. I am Dr. Francis
Fukuyama, and as of July 1 of this year I will be Bernard Schwartz
Professor of International Political Economy at the Paul H. Nitze
School of Advanced International Studies, Johns Hopkins University. I
have been working intensively for the past several years on the
implications of modern biology for politics, and particularly on issues
of international governance related to biotechnology.
I am opposed to human cloning for two reasons. The first is that
human reproductive cloning, if and when it becomes possible, will
constitute a highly unnatural form of reproduction, one that interferes
with the normal process of conception and establishes a very abnormal
relationship between parent and child. I believe that human nature is a
valid standard for establishing human rights, and that technological
procedures that interfere egregiously with normal human functioning
should be viewed very skeptically in the absence of very powerful
reasons to do so. I do not have time today to defend this position at
greater length, but would be happy to provide the subcommittee with
further materials at a later time.
The second reason that I am opposed to human cloning, and in
support of legislation to curtail it, is that cloning represents the
opening wedge for a series of future technologies that will permit us
to alter the human germline and ultimately to design people
genetically. I believe that we must proceed extremely cautiously in
this direction because such a capability of altering human nature has
extremely grave political, social, and moral implications. It is
therefore extremely important that Congress act legislatively at this
point to establish the principle that our democratic political
community is sovereign and has the power to control the pace and scope
of such technological developments.
There is another reason for Congress to act quickly, one that is
related to our American political system. In the past, it has been the
case that the courts have stepped into controversial areas of social
policy when the legislature failed to act to negotiate acceptable
political rules. This was the case, for example, with both abortion and
busing. In the absence of Congressional action on cloning, it is
conceivable that the courts at some later point may be tempted or
compelled to step into the breech and discover, for example, that human
cloning or research on cloning is a constitutionally protected right.
This has been and will be a very poor approach to the formulation of
law and public policy. The American people must therefore express their
will on human cloning at the first opportunity through their
democratically elected representatives, a will that I believe the
courts will be predisposed to respect.
Of the two bills before this committee, H.R. 1644, ``The Human
Cloning Prohibition Act of 2001,'' and H.R. 2172, ``The Cloning
Prohibition Act of 2001,'' I would strongly urge Congress to pass the
former. The reason for this is that while both bills ban reproductive
cloning, the latter in effect legalizes non-reproductive cloning and
the deliberate creation of embryos for research purposes. I believe
that this would legitimate the first step toward the manufacture of
human beings, and I do not believe that it will be possible to enforce
a ban on reproductive cloning once embryos can be easily produced for
research purposes.
The issue that I would like to raise before this committee concerns
the international dimensions of any effort to regulate a medical
technology like human cloning. Opponents of a legislative ban
frequently argue that such a ban would be rendered ineffective by the
fact that we live in a globalized world in which any attempt to
regulate technology by sovereign nation-states can easily be
sidestepped by moving to another jurisdiction. There are other advanced
countries in Europe and Asia eager to move ahead in biotechnology, it
is said, and the United States will risk falling behind technologically
if we hobble ourselves by restricting either research into or the
actual procedure of cloning. In the absence of comprehensive
international regulation, no national regulation will work. This is
part of a larger widespread belief that technological advance should
not and cannot be stopped.
I believe that this is a fundamentally flawed argument. In the
first place, it is simply not the case that the pace and scope of
technological advance cannot be controlled politically. There are many
dangerous or controversial technologies, including nuclear weapons and
nuclear power, ballistic missiles, biological and chemical warfare
agents, replacement human body parts, neuropharmacological drugs, and
the like which cannot be freely developed or traded internationally. We
have successfully regulated experimentation in human subjects
internationally for many decades. The fact that none of the regulatory
regimes controlling these technologies has ever been leakproof or
regulations fully implemented has never been a valid reason not to try
to put them in place in the first instance.
Second, to argue that no national ban or regulation can precede an
international agreement on the subject is to put the cart before the
horse. Regulation never starts at an international level: nation-states
have to set up enforceable rules for their own societies before they
can even begin to think about international rules. The United States,
as an economically, politically, and culturally dominant force in the
world will have an enormous impact on other societies. The Council on
Europe has already passed a ban on cloning; to date, twenty-four
countries (including Germany, France, Italy, and Japan) have already
enacted national bans on cloning, while sixteen have banned creation of
embryos for research purposes. The United States can do a great deal to
either reinforce (or else undermine) an emerging international
consensus that human cloning is an unacceptable use of medical
technology.
I do believe that international competition in biomedical research
creates problems for any nation that wants to limit or control new
technology. There are a number of countries that will try to exploit a
human cloning ban or any other constraints the United States places on
the development of future biotechnologies. We should not be prematurely
defeatist, however, in thinking that we have no choice but to join in
this technological arms race. If we can establish a general consensus
among civilized nations that human cloning is unacceptable, we will
then have a range of traditional diplomatic and economic instruments at
our disposal to persuade or pressure countries outside that consensus
to join. If human cloning ends up being a procedure that can be
performed, but only in states regarded as renegade or pariahs, then so
much the better. But none of this will be possible unless we first
begin by establishing laws on this subject for the United States.
Let me close by saying that human cloning is the first of many
political decisions and battles that will occur over biotechnology. In
the future, total bans on research and technology development of the
sort envisioned by H. R. 1644 will not be the right model. What we will
soon need is a broader regulatory structure that will permit us, on a
routine basis, to make decisions that distinguish between those
technologies that represent positive and helpful advances for human
well-being, and those that raise troubling moral and political
questions. Ultimately, this regulation will have to become
international in scope if it is to be more effective. We will need to
think carefully about the institutional form that such a regulatory
structure must take. A blanket ban on human cloning is appropriate at
this time, however, because it is necessary at an early point to
establish the principle that the political community has the
legitimacy, authority, and power to control the direction of future
biomedical research, on an issue where it is difficult to come up with
compelling arguments about why there is a legitimate need for human
cloning.
Thank you very much for your attention.
Mr. Bilirakis. Thank you, Mr. Fukuyama.
Well, are we all agreed that the Weldon bill, the former of
the two bills as it has been referred to here, does not ban or
preclude the cloning of human tissue that does not give rise to
an embryo? We are all agreed there, Mr. Okarma? We are agreed?
Because you made comments about the Weldon bill would----
Mr. Okarma. (No audible response, nodded.)
Mr. Bilirakis. Okay. Dr. Newman, can we take stem cells
from our own bodies to be used for an affliction in another
part of our body, bone marrow I suppose?
Mr. Newman. Well, these are called adult stem cells.
Mr. Bilirakis. Yeah.
Mr. Newman. And adult stem cells can be taken from the bone
marrow, from fat, from muscle, from the brains of recently
deceased people. And----
Mr. Bilirakis. Can take it from my body, for instance,
for--to help an affliction that I have?
Mr. Newman. Yes, you could take your own bone marrow----
Mr. Bilirakis. Right.
Mr. Newman. [continuing] and stem cells can be isolated
from your own bone marrow, from your own fat tissue, yes.
Mr. Bilirakis. Thank you, sir. You referred to the ultimate
adult stem cell, which appears to have been discovered in the
bone marrow that can transform itself into almost any organ in
the body. And this is according to the study published in the
May 4 issue of New York University School of Medicine. You
mention Yale University School of Medicine----
Mr. Newman. The publication of Cell.
Mr. Bilirakis. Issue of Cell by New York, published in an
issue of Cell by NYU School of Medicine, Yale University School
of Medicine, and Johns Hopkins School of Medicine and
Researchers.
There is a comment made by Dr. Tice, ``There is a cell in
the bone marrow that can serve as the stem cell for most, if
not all, of the organs in the body.'' And then, ``This is an
exciting study,'' etcetera, etcetera. I know at the University
of Florida, one of my alma maters, they have announced that
they have reversed diabetes in mice using adult stem cells.
I might add that to--for the benefit of Ms. DeGette, that
JDF was invited to come here to testify, and they for some
reason or other----
Ms. DeGette. If the gentleman would----
Mr. Bilirakis. [continuing] were not able to do so----
Ms. DeGette. [continuing] yield.
Mr. Bilirakis. [continuing] which is unfortunate.
Ms. DeGette. Mr. Chairman, if the gentleman would yield one
moment? The Juvenile Diabetes Foundation would have liked to
have testified. This weekend is their big Children's Congress.
Mr. Bilirakis. I see.
Ms. DeGette. They are bringing children from all around the
country to lobby Congress on Type-1 diabetes. So, I am sorry
they couldn't come.
Mr. Bilirakis. Okay. No, and I appreciate that explanation
because they are really one of my favorite groups. I feel very
strongly about them, and I am glad to hear that explanation.
In any case, there has been some research done in that
regard. And we also know that Americans presently destroy some
4 million placentas and umbilical cords every year, which could
be an abundant supply of stem cells.
I guess I raise the question, there is this controversial
issue of the use of the embryo. If we can help the people who
need help--and we have all had members of families--I lost my
youngest brother to Parkinson's.
If we can help the people that need to be helped through
the adult stem cells which appear to have been discovered
through the use of placentas and umbilical cords, which are
just thrown away, why is it that we have got to insist on
this--this controversial, very controversial, area of using an
embryo, cloning an embryo, and using that?
Does that make too sense, Mr. Doerflinger?
Mr. Doerflinger. Well, obviously, Mr. Chairman, I would ask
that question too. I wanted to respond to what Ms. DeGette said
about--about diabetes research. I think the Canadian trial----
Mr. Bilirakis. Do it real quickly, but I would like to have
a response----
Mr. Doerflinger. Yes.
Mr. Bilirakis. [continuing] a few responses to my question.
Mr. Doerflinger. Yes, I think--absolutely. President
Clinton's National BioEthics Advisory Commission said that it
would be ethically unjustified even to use spare embryos from
IVF clinics if there are less morally controversial
alternatives available. And I think it has been proved again,
and again, and again those alternatives are there.
The Canadian study, I think we are talking about the
University of Ottawa trials? Yes. Those were adult islet cell
transplants. Those had nothing to do with embryonic stem cells.
They were taken from cadavers.
And the reason why these trials worked and had several
patients walking around without any further need for insulin
injections were two advances in the transplant technique.
One was that they used two cadavers for each transplant
instead of one to get a bigger volume of the islet cells, and
the other was a new immuno-suppressive drug that greatly
reduced the tissue rejection problem, the very problem that we
are now being told human cloning is essential for. And that is
just not true.
Mr. Bilirakis. Any other comments? Dr. Newman? ---- 1 Mr.
Newman. These problems of tissue repair, the repair of the
heart wall after a mild cardio infarction, the repair of
damaged skin and so---- all of these can be addressed by cells
that have the potential to repair those tissues.
A study that I briefly alluded to, but it was published
recently in Nature by some colleagues of mine at New York
Medical College and at the NIH, took bone marrow cells from the
mouse and isolated adult stem cells from those bone marrows,
and implanted them into the heart walls of mice whose hearts
had been damaged by a heart attack, an induced heart attack.
And those bone marrow stem cells were able to repair the
damage in the wall of those damaged hearts. So, it seems to me
that there is a tremendous amount of promise in therapeutics
using adult stem cells.
I don't--I mean, as I said, the Council for Responsible
Genetics isn't, in principle, against using embryo stem cells
from non-cloned embryos. But I see much more promise in the
adult stem cells, actually.
Mr. Bilirakis. How close are we to their being available in
a way that we would be confident that they would be helpful?
Mr. Newman. Well, adult stem cells are already available. I
guess approval needs to be done based on good animal
experiments, which are coming out now. But I think it is just a
regulatory issue now because I think that there are adult stem
cells that have shown promise. Human adult stem cells have
shown promise in culture, in vitro, and animal adult stem cells
have shown promise in vivo.
So, I think that it is just a few steps now to get the
adult human stem cells to be used in humans.
Mr. Bilirakis. I would like to hear from all of you, but my
time has expired. And I just want to be fair to the rest of the
members of the committee. Mr. Brown?
Mr. Brown. Thank you, Mr. Chairman, and you always are.
Thank you. This morning--and this is a question for the
scientists on the panel, and then I would like an answer as
scientific as possible. This morning's edition of The Hill, Dr.
Doris Platika of Curesis, Inc., a firm that works in adult stem
cells, is quoted as arguing, ``that embryonic stem cells work
as a prerequisite for research in adult stem cells.''
Dr. Michael Bishop, a Nobel laureate, who is now at the
University of California's Biomedical Complex, a chancellor
there in San Francisco, said also, ``What scientists need to
learn is how to direct the cells to develop in one direction or
another. Once you have that, you have the makings of tissue
replacement.''
Would the scientists on the panel comment on the validity
of these two statements, which seem to suggest that without
research involving human embryos, the promising treatments for
diabetes, or spinal injury, or a whole host of medical problems
might never come to fruition?
Mr. Newman. Well, without seeing the context, I can just
say that from what you have said, I have to disagree with those
statements. The problem of getting an embryo cell or an embryo
stem cell to become directed toward a differentiated cell type
is an interesting scientific problem.
But it is a different problem from getting an adult stem
cell to be directed toward a particular differentiated cell
type. And there is no way that studying the embryo stem cells
is a prerequisite for studying that process in the adult stem
cells. They are two, distinct scientific issues.
Mr. Brown. Others? Mr. Okarma, or whoever else wants to
answer? Mr. Okarma, if you----
Mr. Okarma. Thank you. Well, first of all, it is true that
there is recent and exciting, with major medical potential,
work coming out of the adult stem cell field, a field in which
I had personally worked for about 12 years in my first company.
And in no way are any of my comments to be construed as
being arguing against continuing to work on adult stem cells.
There are, however, some major issues which provide immense
advantages for the embryonic stem cell technology, first and
foremost which is the scalability of the production of
replacement cells from embryonic stem cells.
These cells are immortal. We have had them growing in
culture continuously for over 2 years. They have undergone 450
population doublings without any change in their ability to be
turned into functioning neurons, functioning liver cells,
functioning cardiomyocytes.
And that transformation process can be scaled so that the
cells we make can be characterized and experimented upon with
the same rigor as a drug or a biological. The issue is
scalability. And inherent in that is the cost of goods.
The cost of extracting a rare adult stem cell, which grows
slowly and must be manipulated to grow into a different cell
from--than what it is programmed to do, will be prohibitive and
will make the cost of goods of the therapy so high as to
prevent its commercialization.
Those are the advantages of the embryonic stem cell, which
are scalability, rapid growth, and the ability to grow into
literally all cells of the human body.
Mr. Brown. Other--yes, Ms.----
Ms. Norsigian. I just want to say that I believe that some
reproductive rights advocates would agree that embryonic stem
cell research should continue. Others would disagree. And the
issue of scalability and mass production, I think comes into
play when you think about the development of clonal embryos.
And although you might argue that we will not know what we
could have developed or learned by not going down the path of
allowing clonal embryos, you can also argue that the risks that
we would take are just simply not worth it.
I think that is where the vast majority of reproductive
health advocates I have spoken with are at right now. And even
though we disagree about the subject of embryo--of embryonic
stem cell research, the Weldon bill doesn't really address
that. It only addresses clonal embryos, so that you get away
from that disagreement.
You will, in fact, impede mass production in some ways. I
think that is a given. But I think, given what is at stake, we
have to say we are going to say no to that, and acknowledge
that there are some things that we have to bypass.
Mr. Brown. Dr. Kass?
Mr. Kass. Yes, your question to Dr. Okarma was answered
and, I think, made a case for the great benefits of using
embryonic stem cells as a scale--a scalable source. But he
didn't yet speak to why they have to be from embryonic clones.
And if I read his testimony right, I think he argues that
this would be a great benefit for eventual adult stem cell
research because you would learn how to reprogram the adult
nucleus to get adult stem cells in quantity.
But that technique, as I understand it, has not yet been
worked out in animals, this kind of reprogramming process. That
could be done in animal research.
And if it should turn out 5 years from now that the adult
stem cells and the non-cloned embryonic stem cells don't
produce the kind of therapeutic benefits we want, under the
Weldon bill, there is an opportunity to come back and say,
``Look, we absolutely--we absolutely have to have cloned
embryos in order to do this therapeutic work.''
I think the burden of proof has to be placed there, given
the great risks that we have all argued for before. And so----
Mr. Okarma. May I just respond to that specifically?
Mr. Brown. Sure.
Mr. Okarma. The burden of proof we accept fully and, in
fact, has been satisfied. A group in Australia has used nuclear
transfer in mice to produce blastocysts from which mouse
embryonic stem cells have been successfully derived, and those
nuclear transfer derived stem cells have exactly the same
properties of immortality and pluri-potentiality as embryonic
stem cells derived from embryos produced sexually in mice.
So, the data are here, presented and published in peer
review literature, that the cells produced in that way are, in
fact, fully functional.
Mr. Bilirakis. I thank the gentleman. Mr. Greenwood?
Mr. Greenwood. Thank you, Mr. Chairman. I think we are at a
very critical point here. Everyone agrees, no reproductive
cloning. Everyone agrees we want to take advantage of the
amazing potentiality for curing things that harm, and hurt, and
kill children and adults in terms of these terrible diseases
and injuries that inflict us.
I think--I don't know if maybe--you are shaking your head;
maybe you don't agree we want to--we want----
Ms. Norsigian. Not all of the potentiality----
Mr. Greenwood. Okay, but the point that I am making is it
seems that there is widespread agreement that if we could find
ways to cure spinal injury, and Parkinson's, and so on, that we
would do it.
What seems to separate us is a question of whether you need
clonal embryonic research in order to get there. And we have
heard questions about can't we use placentas? Can't we use
umbilical cords? Can't we use cadavers? Can't we use adult stem
cells from bone marrow?
And that is the critical question? We either get to this
great potentiality to relieve human suffering in all of those
other ways, in which case we don't need clonal embryonic
research, or we can't.
And I think that is the critical question. And I would like
Dr. Okarma--I know that you addressed this, to some degree, in
response to Mr. Brown's question. But this question of
scalability seems to be critical. It seems to me that if you
are going to help thousands or hundreds of thousands or
millions of people, you need to have this issue of scalability
dealt with. And I wonder if you would address that?
Mr. Okarma. Well, that is true actually in two contexts.
The first, as you correctly say, it is relevant for the
embryonic stem cell technology, itself. It is equally
important, however, on the point that we are debating here
today, the use of cloning techniques to arrive at a scalable
way to produce hysto-compatible cells.
But let me emphasize once again, the objective of the work
is not to produce a process that would consume human oocytes or
which would generate embryos on a case-by-case basis. That
could never be commercialized for practical----
Mr. Greenwood. Let me just interrupt you. I always do this
when you say ``oocytes'' because I am not----
Mr. Okarma. Egg cells.
Mr. Greenwood. Egg cells, okay. So, this is not a
question--it is not the question that in order to meet this
potential, we need to continually harvest human eggs. This is
a--this is a bridge technology or bridge research. Is that
correct?
Mr. Okarma. Precisely. The objective of the exercise is to
identify the factors in the eggs that achieve reprogramming so
that we could use those factors outside of any egg to directly
transform a skin cell into a heart cell, or a skin cell into a
brain cell, precisely the challenge Mr. Stupak enunciated in
his opening statements.
That is where this work is going. We could never, ethically
or practically, scale nuclear transfer the way it is currently
performed, for human therapy.
The objective of the research is to understand the biology,
the magic behind the oocyte's ability to take a differentiated
cell all the way back to development, and allow the gene
expression pattern to be changed, which is precisely what we
are trying to learn how to do in order to scalably produce the
process, allow it to happen, reproducably, in a regulated way,
and with sufficiently low cost of goods that it can, in fact,
be widely commercialized.
Mr. Greenwood. My concern is, I am afraid that people on
this subcommittee, people on the committee, people in the
Congress, this administration, are going to take the position
that although they do want all of these people to be relieved
of their suffering through these wonderful therapeutic
opportunities coming up, but they can vote for a Weldon-style
bill to ban clonal embryonic somatic cell research and feel
that they haven't--that those two are not in conflict.
And is it possible that--for members of this committee to
feel that they can vote for a Weldon research--a Weldon bill
and still hold out the promise that, in our lifetimes, we are
going to see the kind of results that you have envisioned?
Mr. Okarma. In my view, no. No other cell, other than an
egg cell, has ever been demonstrated to possess the
reprogramming biology that we are seeking through the research.
Mr. Greenwood. Mr. Newman, you are----
Mr. Newman. Yeah, I have something to say about this.
People may not recognize that embryo stem cells and cloning
have been available in frogs--well, cloning in frogs for 25 or
30 years, and embryo stem cells in mice for more than 10 years.
And this research about what it takes for an egg to
reprogram a nucleus, well, it is progressing. It is progressing
slowly. And there is absolutely no reason to do this research
in humans. It is----
Mr. Greenwood. Well, Mr. Okarma, is that--do you have a
difference of opinion? Can we do these with other species,
mammals and other species, and learn just as much?
Mr. Okarma. Well, we are certainly doing that, as we speak.
We are working very diligently in sheep, and in mice, and in
cow models of nuclear transfer to understand--get hints at the
animal way that that process is performed.
But these are only models. And in point of fact, the early
embryology, as I am sure Dr. Newman will agree, of these
species versus humans are enormously different. We now have the
human genome project, right? So, we know what these genes could
be if we would simply identify the factors in the egg that
perform this biology.
We don't have that data base from these animals. The
animals are only a distant approximation to the condition in
humans.
Mr. Greenwood. Thank you. Thank you, Mr. Chairman.
Mr. Bilirakis. Mr. Deutsch?
Mr. Deutsch. Thank you, Mr. Chairman. Dr. Kass, you
testified that once human embryos are produced and available in
laboratories, it will be virtually impossible to control what
is done to them. How will the ban you support, the Weldon-
Stupak ban, prevent the actual creation of these cloned
embryos?
Mr. Kass. How will it prevent it?
Mr. Deutsch. Correct.
Mr. Kass. If you are saying it will not prevent some rascal
who wants to disobey the law from doing it, I would have to say
that it won't prevent that, just as the law against incest
doesn't prevent cases of incest from cropping up.
But it will deter--it will deter all reputable scientists
from going down this road. It will give them the opportunity 5
years down the road to have a report that makes the case that
we now actually have to have this kind of therapeutic cloning.
Mr. Deutsch. Let me just follow up.
Mr. Kass. Please.
Mr. Deutsch. Why would you believe that the criminal and
civil penalties contained in the Greenwood-Deutsch bill, which
are virtually identical to the Weldon-Stupak bill, also do not
act as effective deterrents to the prohibited acts?
Mr. Kass. As I say in my testimony, with all due respect,
the Greenwood-Deutsch bill does not ban the implantation of a
cloned embryo to initiate a pregnancy. It simply prohibits the
creation of that embryo with the intent to do so.
But once the embryo is there, there is no governing
language on what shall subsequently be done with it.
Mr. Deutsch. All right, well----
Mr. Kass. That is partly why----
Mr. Deutsch. [continuing] let me just follow up. If you
were to make the changes that you note, specifically
prohibiting the act of transferring the embryo to a uterus and
making it a crime to also receive cloned embryo products with
the intent to initiate a pregnancy, would you then say that the
Greenwood-Deutsch bill would, in fact, do what you want?
Mr. Kass. It would be better. It would be better, but it
wouldn't be good enough. And that is partly because we now know
that there is a market for reproductive cloning. And I don't
think, at that particular stage, we are going to have the
requisite enforceability.
I would much rather--and if people who--well, I would much
rather say, given the grave seriousness, not just of curing
disease, but of going down this road to the brave, new world in
the post-human future, given the grave seriousness of that,
that we make every effort to find morally, unproblematic means
of finding these therapies that we need----
Mr. Deutsch. But----
Mr. Kass. [continuing] and not producing this kind of clear
and present danger at this time.
Mr. Deutsch. Let me follow up directly to that point
because in your comments, and actually in Mr. Stupak's
legislation specifically--and you have said this actually
several times in your testimony and in answers to questions,
that if alternatives to therapeutic cloning fail, and animal
studies demonstrate that embryonic cloning has therapeutic
potential, and I am going to quote, ``Congress could later
revisit this issue and consider lifting the ban on cloning of
embryos.''
All right, is your position then that the morality of
cloning embryos is a relative, not absolute, concept?
Mr. Kass. It is a complicated question for me, and I do not
have a right-to-life position on this matter. But I think that
whatever you think about the moral status of the embryo--and
Professor Fukuyama, I think spoke very movingly about this.
The human embryo is at least potentially one of us. It is
not nothing, and it is different from other cells. The attempt
to call it cell cloning or blastocyst cloning, whatever we do,
we should call things by their right name. This is nascent
human life. And it seems to me you create that and treat it as
mere cellular tissue to be experimented with at our peril.
One of the things--one of the dehumanizing effects in this
area already seen is that people can stand and talk about
creating new human life that is potentially you or potentially
me--I am not saying it is already a person. I am not saying it
has rights.
But it has some kind of standing. And to create that----
Mr. Deutsch. Well, let me----
Mr. Kass. [continuing] sort of indifference, it seems to
me, is already worrisome.
Mr. Deutsch. Dr. Kass, thank you. Let me--you know, for Mr.
Okarma, you are in the field doing this research. And I think,
in some ways, the strongest argument that you have made is your
actual experiential research, saying that all of the
alternatives are already secondary alternatives, that what--Dr.
Kass' comments have already been made in the real world; that
everything else is not as good; that it is less likely to bring
successful research outcomes.
And to me, you know, that--you know, for literally the
hundreds of thousands, if not millions, of Americans who
potentially can benefit from this research--I mean, to hear
that issue I think is the real issue. So, if you can, you know,
comment to that?
Mr. Okarma. Well, you are correct in that in our
professional judgment, the application of nuclear transfer
research to get to the process we have spoken about, not the
nuclear transfer process itself, but the use of that biology,
is the perfect solution to enable regenerative medicine.
And all others fail in a variety of technical respects. We
are pursuing other ways to achieve this. So, for example, would
it be possible to genetically engineer the embryonic stem cell
to render it immunologically null? It would not, for example,
potentially evoke an immune response.
That is theoretically possible. We are working on that. But
we are asking genetic engineering to do a lot to enable that
engineered trait to be passed through the manufacturing
process, all the way down to the differentiated cell that
would, in fact, be the product.
And we worry about the durability of that nullness. So if,
for example, we use that process to repair your heart or mine,
it is very possible that a year or 2 after the implantation of
the cell, that nullness is lost, and you suddenly reject that
tissue, and you are back to where we started from.
So, the point is well-taken, Mr. Deutsch, that the use of
nuclear transfer research could lead to a perfect and permanent
solution to that set of problems.
Mr. Bilirakis. Dr. Ganske to inquire?
Mr. Ganske. Mr. Chairman, I am just going to ask one
question, but I will ask all members of the panel to answer it.
I apologize because I have had to be gone for part of this. And
so, you may have spoken to this. I thought the administration
was quite clear with its statement today that, ``As we
interpret the bill, it prohibits not only the use of human
somatic cell nuclear transfer to initiate a pregnancy, but also
all other applications of somatic cell nuclear transfer with
human somatic cells, such as cloning to produce cell or tissue-
based therapies. That is consistent with Secretary Thompson's
and the President's views.''
I also asked the question, is it the administration's
position that it should be illegal for anyone to do somatic
cell nuclear transfer? And the answer was yes. So, I guess my
question to all of you is, what is your response to that, if we
could start on my left?
Mr. Okarma. Well, I----
Mr. Ganske. And if you could keep your--since there is--
what do we have--eight respondents, maybe to 30 seconds?
Mr. Okarma. Two points; first, I think it will--it is a
giant step toward rendering the American biomedical research
community a second-rate resource. And second, it will clearly
encourage the exportation of this research to countries that
are bit more enlightened.
Mr. Kass. I don't agree. I think the international
community, for the most part, supports this position. I think
we could take the lead to achieve--since what I am mostly
interested in is preventing human cloning and the road that it
leads to, we need to take a lead in the international
community, and I think we can do so.
And if I might just say one word on a question you asked
the Deputy Secretary before about the importing business and
stuff that goes elsewhere, as I read the Weldon bill, that
product of somatic cell nuclear transplantation, the
trafficking in which is prohibited, are not the drugs that
might come somewhere else, but simply on the cloned embryonic
product.
I think if you look at that language, it is quite clear on
that.
Mr. Ganske. But you are--you say you don't agree with their
position; is that right?
Mr. Kass. Well, I thought the question was what the
language--the language of the bill about importing the
products. I am sorry, I do not agree with Dr.--with Dr. Okarma.
Mr. Ganske. Okay, next?
Mr. Kass. Thank you.
Mr. Guenin. I can imagine only one rationale for the
administration's position this morning, and that is that the
administration believes that it is immoral to use an embryo as
means. And if--there was otherwise no rationale stated. If that
is the case, then we can surmise that the President will
announce its opposition to embryonic stem cell research.
In such a case, I think we will have stymied the most
promising frontier of biomedical research that has faced us in
our lifetime for the relief of suffering.
I think, therefore, it falls to the Congress to consider
those two issues together, because they are the same problem.
May an embryo be used as means?
I would point out that under the so-called rider to the NIH
appropriations bill that has been discussed with respect to
embryonic stem cell research, the creation of an embryo for
research purposes is already prohibited. But here we are today
still discussing whether it should be.
So, it seems to me, in all committees of the Congress,
those two issues will be discussed in the future. And I hope
the resolution will be an explicit authorization of this line
of research, rather than placing us in the circumstance of
statutory gymnastics.
Mr. Ganske. Mr. Newman?
Mr. Newman. Insofar as the administration has come out
against embryo cloning, I would agree with that. On the issue
of stem cell research using embryos that haven't been produced
experimentally, I would disagree with the administration's
position on that.
I have questions about it, but I wouldn't call for a
legislative ban on it.
Mr. Perry. The vast community of patient support groups and
research advocacy organizations have been waiting on tenter-
hooks for months to hear the administration's position on the
use of embryonic stem cells for research.
Today's announcement, I think, presages a negative response
on that, and it presupposes that we now know enough as
political leaders to decide which areas of research are going
to produce the breakthroughs that we all want so much.
The reality is that in the scientific community, there is
considerable uncertainty as to the viability long-term of stem
cells from adult sources.
There seems to be a lot more power in embryonic stem cells,
and the cloning technologies, or the cell replication
technologies, open up yet another avenue that has great
promise.
And the decision from the Bush Administration seems to be
closing one door after another, leaving us with fewer options,
even as we face an explosion of chronic diseases related to the
aging of the population.
Ms. Norsigian. I don't agree with the administration's
position, but I think there was some confusion this morning as
I read Claude Allen's statement, which interpreted the Weldon
bill as prohibiting all applications of somatic cell nuclear
transfer with human somatic cells.
He didn't--this didn't say ``human egg cells.'' And then
under questioning from you, Representative DeGette, I heard
something different. So, I think there is a little confusion
about what the administration really is saying right now.
But I agree with the statements that were made earlier by
Dr. Kass and Dr. Newman. And I don't read the bill, the Weldon-
Stupak bill, as others have read it, as being much more
restrictive than it is.
Mr. Doerflinger. Congressman Ganske, I don't know whether
you were here for the colloquy between Congressman Stupak and
Deputy Secretary Allen because he clarified that awkward phrase
in the testimony and said what the administration is against is
any use of this technology to make human embryos for cell and
tissue-based therapy. And we certainly agree with that stance.
I am rather surprised at the scientific witnesses who are
now moving over into the debate on the NIH stem cell guidelines
for embryonic stem cell research because given their new
testimony, the President would have to be a fool to endorse the
NIH stem cell guidelines. They have just announced they are
useless.
Those guidelines forbid the special creation of embryos for
research. Dr. Okarma testified that use--that moving on to
cloning is essential to making these therapies work.
Apparently, the stem cell guidelines were a bait-and-
switch. As soon as you got to human use, they were going to
tell us, we forgot to tell you; you had to go to this further
step that everybody, including the supporters of stem cell
research, had said was ethically off the table.
They have now raised the stakes, but they have called into
serious question their earlier claims about the usefulness of
these spare embryos.
Mr. Fukuyama. Well, this whole discussion, I think, has
conflated embryonic--this embryonic stem cell research with the
issue before us, which is cloning for research purposes. And I
think you can support the former and oppose the latter
perfectly consistently.
Again, just to repeat myself on the international thing, if
this research, as the result of the Weldon bill, moves to less
enlightened countries overseas, so be it. It may be that this
is the kind of research that will only be done in places like
China, you know, or Singapore. But I think that is something we
can live with.
Mr. Bilirakis. Thank you. The gentleman's time is expired.
Mr. Stupak?
Mr. Stupak. Thank you. Dr. Okarma, in your testimony, you
cite there are two cloning--cloning specific human eggs or,
excuse me, cloning specific cells, genes, and other tissues
that do not and cannot lead to a cloned human being.
Since a live human embryo, by its nature, can lead to a
cloned human being, you seem to be drawing a line or a
distinction between therapeutic cloning and human embryo
cloning. Is that correct?
Mr. Okarma. Thank you for the opportunity to clarify. It is
really crucial to understand that what we are supporting is
research in somatic cell nuclear transfer for the sole purpose
of understanding its mechanism so that those factors that
perform--that achieve----
Mr. Stupak. But----
Mr. Okarma. [continuing] reprogramming can be isolated and
used in a scalable way.
Mr. Stupak. But you were really--no, yes or no, are you
drawing a distinction then between therapeutic cloning and
human embryo cloning?
Mr. Okarma. No.
Mr. Stupak. Are you saying we need human embryo cloning in
order to further our therapeutic?
Mr. Okarma. Yes, I am.
Mr. Stupak. Okay. Then, our bill bans only the use of
cloning to create new human embryos. How can you say that we
would be banning therapeutic cloning?
Mr. Okarma. I am sorry, I don't understand it.
Mr. Stupak. All right. So, if our bill bans human embryo--
and you really need human embryo to do your research, right?
Mr. Okarma. Yes.
Mr. Stupak. Okay, then let me take this step. Then, how do
you--as Dr. Kass and others have indicated, where do you draw
the line then between manipulating that research for hair
color, for eye color, for intelligence? Once you create that
human embryo, where do you draw the line?
How do you do it with either our bill or--well, our bill,
you just don't do it--or the other bill, the Greenwood bill?
Mr. Okarma. By intent and by restrictions on the purposes
to which such a cloned embryo could be placed.
Mr. Stupak. But see, by ``intent''--then I am really
confused because on your web-page, the BIO web-page, you say,
``Some bills do not prohibit the act of cloning a human being
and focus on the intent or purpose of the researchers. The
terms intent and purpose used in some bills are criminal law
concepts which could grant undue discretions to enforcers,
create uncertainty for researchers, and consequently have a
broad-chilling effect among researchers.''
``Using a specific act as the trigger for violation makes
it clear that, to all scientists and enforcers, what activities
are not acceptable.''
Mr. Okarma. On my web-page?
Mr. Stupak. On your web-page.
Mr. Okarma. I am sorry, sir, that is----
Mr. Stupak. I just pulled it down.
Mr. Okarma. [continuing] that is not correct.
Mr. Stupak. On your BIO----
Mr. Bilirakis. The BIO web-page.
Mr. Stupak. The web-page from BIO.
Mr. Okarma. Oh, that is not my----
Mr. Stupak. I am sorry, but that is the organization you
represent, isn't it?
Mr. Okarma. I am representing--I am testifying on behalf of
BIO. I represent my own company, sir.
Mr. Stupak. Okay. Well, I am sorry to have the misnomer. I
thought your--BIO was your company. All right, so I guess that
would be sort of in conflict to what you are testifying? The
BIO web-page would be in conflict, then, as to the intent?
Mr. Okarma. I would have to read it and study it, sir, to
give you an honest answer.
Mr. Stupak. All right. The blastocysts that you speak of on
page 4 of your testimony, isn't that really another term for an
early, living human embryo?
Mr. Okarma. Yes, sir, it is, absolutely. And do we not mean
to obviscate the intent or the actuality of what we are talking
about here. And we do, as our Ethics Advisory Board constantly
reminds us, recognize that these early embryos do, in fact,
have moral status, and they are special cells, which is why we
are so adamant about their utility for very special
circumstances, treating these diseases which we view have no
other alternative.
Mr. Stupak. Well, would----
Mr. Okarma. We would also draw the line between the degree
of moral status that these undifferentiated, unindividuated,
and unenabled embryos have compared to embryos later in
gestation.
Mr. Stupak. But how do you really draw the line? If
blastocysts are early human embryo, then what--aren't you
really saying is that reproductive cloning and research cloning
proceed exactly through the same initial stages, and they
really aren't separated?
Mr. Okarma. No, the reason we draw the distinction, the----
Mr. Stupak. Where and when do you draw the distinction?
Mr. Okarma. It has to do with the biology. The stage of
these blastocysts that we use to derive our ES cells, or that
we would use in the cloning debate we are engaged in----
Mr. Stupak. Which are the same as living human embryos?
Mr. Okarma. They are living, human embryos.
Mr. Stupak. Okay.
Mr. Okarma. But they are completely unindividuated, which
means that they have the capability after we would use them to
divide into two human beings.
Mr. Stupak. But----
Mr. Okarma. So, they are not individuated.
Mr. Stupak. [continuing] how can they----
Mr. Okarma. They are not----
Mr. Stupak. [continuing] not be individuated----
Mr. Okarma. Let me finish, sir.
Mr. Stupak. Go ahead.
Mr. Okarma. They are completely undifferentiated in that
every single cell in that early embryo is exactly like every
other one. And we know that from doing genetic work on in vitro
fertilized embryos.
Those cells can be removed, identified as being--as
containing or not containing that genetic defect, and those
which do not, are implanted successfully.
Mr. Stupak. But we also know, and maybe it is more from our
side of the aisle here, that frozen embryos in the lab have
parental rights associated with them. So, how are they, then,
unidentifiable? And aren't you really creating the issue of
peril rights and conflicts with privacy rights?
Mr. Okarma. Well, sir, that is a legal question that I am
really not competent to answer.
Mr. Stupak. But you said they were unidentifiable. If we
already attach, as a country, legal rights to these embryos in
these stages, which are the same, you said, at the early
stages, and there are parental rights, then how are they
unidentifiable?
Mr. Okarma. Well, I----
Mr. Stupak. It is no different than the example of Dr.
Guenin there when he talked about Mary giving her cells to
research or whatever. What if Mary changes her mind? Does she
then have parental rights that can be enforced in the courts?
What if she changed her mind?
Mr. Guenin. Let me distinguish here. There isn't any
problem about keeping track of which parents own these. What we
are discussing is individuation, which is the question of moral
importance, as to whether we have one embryo, or whether we
have 2, or 3, or 4.
Mr. Stupak. Did you say ``more'' or ``moral''?
Mr. Guenin. Moral.
Mr. Stupak. Oh, moral.
Mr. Guenin. So, the individuation idea reflects on the
possibility of twinning. But so far as tracking who they belong
to, that is not a problem.
Mr. Stupak. Dr. Kass?
Mr. Kass. Just one small point on this argument of non-
individuation; yes, the embryo, as a blastocyst, is not yet
differentiated. But each one of those blastocysts is different
from every other one. That is the whole purpose of making the
argument that you need the identical clone.
Mr. Stupak. Right.
Mr. Kass. They are genetically different from one another,
even if they can subsequently split.
Mr. Stupak. Even in the early stages?
Mr. Kass. And they came from specific sources, so they have
that kind of individual origin.
Mr. Stupak. Mr. Chairman, are we doing a second round
later?
Mr. Bilirakis. I am not disposed on doing that. I suppose
we could. I don't know that we should go another 5 minutes.
Mr. Stupak. So, we could follow-up then, at least with
written questions?
Mr. Bilirakis. I would say so. You raised the question of
the support by the bio-tech industry of the Greenwood bill,
which seems to be in conflict----
Mr. Stupak. Right.
Mr. Bilirakis. [continuing] with their web-page.
Mr. Stupak. Right.
Mr. Bilirakis. You never did really--did you get an answer
for that?
Mr. Stupak. Yeah, I did. It was--I don't think it is fair
to Dr. Okarma. It is not his--it is his organization, but it is
not his company, and I asked ``company''. And----
Mr. Bilirakis. But he----
Mr. Stupak. [continuing] he is not--you are not here to
speak on behalf----
Mr. Bilirakis. But you are representing the biotech
industry here today?
Mr. Okarma. Sir, I am not in a position to respond.
Mr. Bilirakis. You don't know.
Mr. Stupak. I would just ask the unanimous consent to put
the biotech webpage----
Mr. Bilirakis. Without objection, that is the case. I want
to note that Ms. Erica Yamat, and I may have mispronounced
that, with Health and Human Services, is here. She has sat here
the entire hearing.
I think that is of note because a lot of times, we have
administration witnesses who will testify and then leave. They
don't get the benefit of the testimony from sometimes the more
important witnesses like yourselves. But she is here, and we
appreciate that.
The Chair now will yield to Mr. Pitts.
Mr. Pitts. Thank you, Mr. Chairman. Mr. Okarma, if someone
were to take a cloned embryo out of your laboratory and implant
it into a woman's womb, under the Greenwood bill, you or your
company would not be liable, would you? The Greenwood bill, I
think, requires that for a violation to have occurred, the
person who created the cloned embryo had to have done so with
the intent to implant.
Mr. Okarma. I believe that is correct, and your point, I
think, underscores the fact that the Greenwood bill could be
tightened. Its intent we understand. If there are, in fact,
legal loopholes and difficulties in enforcement, I believe the
Greenwood and Deutsch group are very willing to improve the
language to achieve that end.
Mr. Pitts. Okay.
Mr. Greenwood. If the gentleman will yield for 3 seconds. I
would concur with that. We do intend to tighten that up.
Mr. Pitts. Your testimony hints that you are already doing
somatic cell nuclear transfer in humans. Have you already
attempted human somatic cell nuclear transfer using human
somatic cell nuclei or human egg cells?
Mr. Okarma. That was not my testimony. In fact, the work
that we are doing in the U.K. is all in animals. We do have
plans to perform nuclear transfer with human material. We have
not yet begun that.
Mr. Pitts. Okay. Now, as recently as March 28, before the
Oversight and Investigations Subcommittee, this BIO Group you
are representing testified that the FDA already has
jurisdiction to regulate cloning, and so no new legislation is
needed or appropriate.
Do you know why this--is this a change of position? Have
you concluded that the FDA does not currently have authority
over human cloning?
Mr. Okarma. I can't answer that. I just don't know the
legal foundation of that.
Mr. Pitts. One other question: What if it could be shown
that the only effective way to prevent reproductive cloning was
to stop the process at the first step, that all other measures
were almost certain to fail to do the job? Would you favor
that?
You said in your testimony that the Greenwood bill bans
reproductive cloning. Actually, it is a 10-year moratorium,
right?
Mr. Okarma. Certainly, sir, I am in favor of appropriate
legislation to prevent human reproductive cloning. The
hypothetical situation that you ask in your--in your question,
I don't think is valid. I think there are ways to do that,
short of prohibiting the research.
Mr. Pitts. Thank you, Mr. Chairman.
Mr. Bilirakis. Mr. Strickland?
Mr. Strickland. Thank you, Mr. Chairman. I will not take my
full time because I would like to yield to my friend, Mr.
Stupak in case he has need for additional questions. But I
would just like to make some observations.
Much of what we talked about today has involved, I think,
moral considerations. And I would like to ask each of the panel
members, if they are willing to do so, to share with us whether
or not they consider themselves and the position they take a
moral position?
Mr. Okarma. Thank you. I certainly view my position, and
that of our company, and the Ethics Advisory Board, who
continues to advise us in these matters, as being wholly
ethical and moral.
Mr. Strickland. Thank you.
Mr. Kass. The same.
Mr. Guenin. The view that I described was an attempt to
find that, indeed, there is a moral consensus. And so, I
contribute that, and that is my personal opinion, but as a
scholarly observation. And I think that that could puncture the
difficulty here, that there is an unrecognized common
understanding if we look to the deepest commitments of moral
views.
And that is why I mentioned Catholicism because it is the
most prominent articulation of a religious opposition, that
there isn't any ground for restraining ourselves when, at no
cost to a potential life, we can do good. If we forego this
research, not one more baby will be born.
Mr. Newman. Well, I think morality is about drawing lines,
and I think that drawing the line between cloning humans and
not cloning humans is a relevant and important moral line to
draw. So, yes, I think that the position that I have presented
to you is a moral position.
Mr. Strickland. May I interrupt? My understanding is that
every one of you here has taken the position that you oppose
the cloning of human beings, though. Is that not right?
Mr. Newman. I think that is the case for all the speakers
on this panel. But I think that the point has been made, and I
agree with it, that manipulating human embryos by cloning, or
by genetic engineering, is just an invitation to get used to
the idea, and eventually have people say well, it is out there;
it is a product; why can't I use it for my own purposes?
Mr. Strickland. Okay.
Mr. Guenin. To be completely forthcoming in answering your
question, I have to say that I am not prepared to defend
reproductive cloning because it is presently manifestly unsafe.
But if it were safe, then I think we--and we probably will in
some future time have a discussion again.
I am not prepared to say it would be wrong in all
instances, but it needs discussion.
Mr. Perry. I believe it is one of the highest moral
obligations to relieve human suffering, to extend the benefits
of health to as many of our fellows as possible, and to use our
brains and our free institutions to drive toward that goal.
Ms. Norsigian. I do think it is a moral position, and I
agree with what Dr. Newman just said. But I also think that it
is absolutely clear to any of us who have looked at our past
track record in related fields that there is no way to prevent
human reproductive cloning if we allow the development of
clonal embryos.
And so, if we feel very strongly about that moral line, and
that we really do not want to see human clones produced, we do
have to say no to human--to reproductive--excuse me, to embryo
clones being produced.
That may mean that some--although I think, at this point,
we don't have evidence. It is a very broad array of options.
Some options might not be pursued that would benefit humankind.
I will admit that.
But I think that it is a position, a moral position, to say
that we should not allow for that.
Mr. Doerflinger. Well, the Catholic Bishops Conference
certainly thinks that our position is the morally right one.
But it is not a position based solely on morality. We think
that on legal, practical, political, and even Constitutional
grounds, the Weldon bill is an effective and well-written ban
on cloning, and the Greenwood bill is not.
Mr. Fukuyama. Well, I have never encountered a speaker that
identified themselves as taking an immoral position, so I guess
my position is based on morality.
But I do think that morality cannot be reduced to utility,
and the relief of suffering is an important, you know, human
goal. But it is not the--it is not the only way to define how
you approach moral issues.
Mr. Strickland. The reason I asked the question I think is
very important because someone's morality may be someone else's
immorality. And I think--I think it is important for us to
understand that. We set priorities. Is the relief of human
suffering the highest good?
I guess what I am describing here is a kind of situational
ethic. And I am sorry, Mr. Stupak, I have taken all the time,
but I would just like to end with this comment.
I don't know which of these bills I am ultimately going to
support or endorse. But I think this issue is so complicated
and so important that I question whether or not many of us in
this Congress are informed well enough to proceed with making a
decision at this point in time.
I certainly feel that I am not. I respect each of you and
your points of view. But there is--there are variations here.
This is an important issue, and I hope we do not go down a path
which we will, at some point in the future, regret. And I yield
back the time I don't have, Mr. Chairman.
Mr. Bilirakis. Yield back the time you don't have, yeah. We
have three votes on the floor, so we are going to have to
finish up. Ms. DeGette?
Ms. DeGette. Thank you, Mr. Chairman.
Mr. Bilirakis. Again, we extend courtesy to you.
Ms. DeGette. I appreciate it. And I would like to speak on
behalf of all of the members of this panel for calling these--
both of these excellent panels.
I was just sitting here thinking I have books by many of
these panelists on my bookshelves. And I think it is a
wonderful panel.
Having said that, I just have a couple questions. First of
all, Mr. Doerflinger was correct about the Ottawa study. That
was done--that was a study done with pancreatic eyelet cells
from human cadavers.
The study I was talking about in my question earlier was an
NIH study using mouse embryonic stem cells. It was a different
study, and it was using mouse cells. So, just to clear the
record up on that; no need for an answer, sir, because I have a
lot of questions.
And one question I have for Mr. Okarma, do you know of any
research laboratories, biomedical research laboratories such as
yours, who do also in vitro fertilization techniques on
individuals?
Mr. Okarma. No, I do not.
Ms. DeGette. And I guess I--Ms., how do you pronounce your
name?
Ms. Norsigian. Norsigian.
Ms. DeGette. I should know since your book is one of my
great personal references--references. Do you know, in your
experience, of any in vitro fertilization clinics that also do
biomedical research?
Ms. Norsigian. There are some that are involved, but I
cannot name them right now. I could get it for you.
Ms. DeGette. So, they are actually performing----
Ms. Norsigian. The relate----
Ms. DeGette. [continuing] research?
Ms. Norsigian. There is a relationship in terms of
collaboration, but I am not sure about the----
Ms. DeGette. Are they actually performing research at the--
at the clinics, do you know?
Ms. Norsigian. Well, I hope not; not the kind you are
suggesting.
Ms. DeGette. Right, okay. The reason I ask that question is
because we were talking earlier about--about the issue that you
can't really differentiate between these cells.
And I believe the administration witness said well, for in
vitro fertilization, you will be able to tell because that is a
reproductive clinic where they are transplanting the embryos in
the uterus. But this kind of research is done in different
kinds of clinics.
And I think that--that you have to have that view
consistently throughout. A lot of folks are saying, ``Well, if
you allow the somatic cell research, then it will be--then it
will be too difficult to prevent actual humans from being
cloned.''
But I think you could set up that firewall because I think
those research and the reproductive clinics are two, totally
different things. And the evidence would bear that out.
I have a question, a couple questions, for Dr. Kass. I read
your recent New Republic article with great interest, and I
really agree with something you say in there, which is that we
have this problem with cultural pluralism and easygoing
relativism. So, we can't really tell what we support or not.
Most of the witnesses here seem to support in vitro
fertilization, but yet they don't support cloning even for
research purposes.
And then, you go on to say, actually earlier in your
article, that ``Some transforming powers are already here: the
Pill, in-vitro fertilization, bottled embryos, surrogate wombs,
cloning, genetic screening, genetic manipulation, organ
harvesting, mechanical spare parts, brain implants, Ritalin for
the young, Viagra for the old, Prozac for everyone.''
So, is what we should do, do you think, on a moral basis,
is just ban all of this, since all of this is, at essence,
messing with human biology?
Mr. Kass. No.
Ms. DeGette. And where--how do we figure out where that
line should be, Dr. Kass?
Mr. Kass. Of course not, no. Thank you very much for the
question.
Ms. DeGette. You are welcome.
Mr. Kass. It is very important, I think, that we not see
this isolated--this issue before us out of the larger context.
We are in the midst of acquiring wonderful powers for the
treatment of disease and the relief of suffering.
Some of those techniques have other uses that go beyond
therapy----
Ms. DeGette. Right.
Mr. Kass. [continuing] and we should wake up to that fact.
Ms. DeGette. Right.
Mr. Kass. Professor Fukuyama said that in most of the areas
that we will have to make decisions, legislative ban is a blunt
and inappropriate instrument.
Ms. DeGette. Right.
Mr. Kass. It is the wrong way to do most things because the
good--the benefits and the harms are very closely linked, and
one needs more sophisticated means of doing the regulation.
However, here you have an issue where, in fact, for all our
moral pluralism, the poles continue--and I am not--I don't take
my moral compass from the Pope, but the American----
Ms. DeGette. And thank God for that.
Mr. Kass. Well, the American people want to see
reproductive cloning stopped. And if we don't act--and this--
Congressman Strickland, if I might, Congress' silence this time
will be acquiescence if somebody does it while we are silent.
Ms. DeGette. Well, Doctor, everybody here would agree,
reproductive cloning should----
Mr. Kass. Fine.
Ms. DeGette. [continuing] be banned.
Mr. Kass. Okay.
Ms. DeGette. But let us say we could----
Mr. Bilirakis. Well----
Ms. DeGette. [continuing] we could somehow stop research--
or reproductive cloning without stopping the research----
Mr. Bilirakis. I apologize----
Ms. DeGette. [continuing] cloning. Would that be----
Mr. Bilirakis. [continuing] to the gentlelady----
Ms. DeGette. [continuing] acceptable?
Mr. Bilirakis. [continuing] but we have about 5 minutes
left for a vote. We are going to have to get going there. Can
you take 30 seconds to respond?
Ms. DeGette. Thank you.
Mr. Kass. I am very long-winded. No, I think--this is so
serious that I think we should not--we should lock the barn
door before the embryo clones get out into reproductive places.
Ms. DeGette. Thank you.
Mr. Bilirakis. Honestly, I agree with Ms. DeGette. This was
a terrific panel. We hold these hearings hopefully without pre-
deciding, hopefully to learn. If anyone sitting in on these
hearings has not learned an awful lot about this subject, I
think they have had their ears bottled up.
We appreciate you being here very, very much. We will have
questions in writing to you. We would hope that you would be
willing to respond to those in a timely fashion.
And second of all, any other ideas that you all have that
might be helpful in terms of helping us make our decisions on
this very complex and significant subject, we would welcome
them with open arms. And again, our gratitude. Thank you. This
hearing is now adjourned.
[Whereupon, at 2:22 p.m, the subcommittee was adjourned.]